
<html lang="en"     class="pb-page"  data-request-id="6bfe9fbc-b53c-4fb0-9c8e-bef902d52e63"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b00855;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors" /></meta><meta name="dc.Creator" content="Xiaobao  Yang" /></meta><meta name="dc.Creator" content="Fengling  Li" /></meta><meta name="dc.Creator" content="Kyle D.  Konze" /></meta><meta name="dc.Creator" content="Jamel  Meslamani" /></meta><meta name="dc.Creator" content="Anqi  Ma" /></meta><meta name="dc.Creator" content="Peter J.  Brown" /></meta><meta name="dc.Creator" content="Ming-Ming  Zhou" /></meta><meta name="dc.Creator" content="Cheryl H.  Arrowsmith" /></meta><meta name="dc.Creator" content="H. Ümit  Kaniskan" /></meta><meta name="dc.Creator" content="Masoud  Vedadi" /></meta><meta name="dc.Creator" content="Jian  Jin" /></meta><meta name="dc.Description" content="EZH2 or EZH1 (enhancer of zeste homologue 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27). PRC2 hyperactivity and..." /></meta><meta name="Description" content="EZH2 or EZH1 (enhancer of zeste homologue 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27). PRC2 hyperactivity and..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 11, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00855" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00855" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00855" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00855" /></link>
        
    
    

<title>Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00855" /></meta><meta property="og:title" content="Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0019.jpeg" /></meta><meta property="og:description" content="EZH2 or EZH1 (enhancer of zeste homologue 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27). PRC2 hyperactivity and/or hypertrimethylation of H3K27 are associated with numerous human cancers, therefore inhibition of PRC2 complex has emerged as a promising therapeutic approach. Recent studies have shown that EZH2 and EZH1 are not functionally redundant and inhibition of both EZH2 and EZH1 is necessary to block the progression of certain cancers such as mixed-lineage leukemia (MLL)-rearranged leukemias. Despite the significant advances in discovery of EZH2 inhibitors, there has not been a systematic structure–activity relationship (SAR) study to investigate the selectivity between EZH2 and EZH1 inhibition. Here, we report our SAR studies that focus on modifications to various regions of the EZH2/1 inhibitor UNC1999 (5) to investigate the impact of the structural changes on EZH2 and EZH1 inhibition and selectivity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00855"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00855">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00855&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00855&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00855&amp;href=/doi/10.1021/acs.jmedchem.6b00855" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7617-7633</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00698" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00860" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaobao++Yang">Xiaobao Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fengling++Li">Fengling Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyle+D.++Konze">Kyle D. Konze</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jamel++Meslamani">Jamel Meslamani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anqi++Ma">Anqi Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Brown">Peter J. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Ming++Zhou">Ming-Ming Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheryl+H.++Arrowsmith">Cheryl H. Arrowsmith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+%C3%9Cmit++Kaniskan">H. Ümit Kaniskan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masoud++Vedadi">Masoud Vedadi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jin">Jian Jin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Departments of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">#</span> <span class="aff-text">Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2M9, Canada</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada</span></div><div class="corresp-info"><strong>*</strong>For J.J.: phone, (212) 659-8699; fax: (212) 849-2456; E-mail, <a href="/cdn-cgi/l/email-protection#4f25262e21612526210f223c3c22612a2b3a"><span class="__cf_email__" data-cfemail="ff95969e91d1959691bf928c8c92d19a9b8a">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For M.V.: phone, (416) 946-0897; E-mail, <a href="/cdn-cgi/l/email-protection#036e2d75666762676a4376776c716c6d776c2d6062"><span class="__cf_email__" data-cfemail="b1dc9fc7d4d5d0d5d8f1c4c5dec3dedfc5de9fd2d0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00855&amp;href=/doi/10.1021%2Facs.jmedchem.6b00855" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7617–7633</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 June 2016</li><li><span class="item_label"><b>Published</b> online</span>11 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00855" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00855</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7617%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaobao%2BYang%252C%2BFengling%2BLi%252C%2BKyle%2BD.%2BKonze%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D16%26contentID%3Dacs.jmedchem.6b00855%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bfor%2BEnhancer%2Bof%2BZeste%2BHomologue%2B2%2B%2528EZH2%2529%2Band%2BEnhancer%2Bof%2BZeste%2BHomologue%2B1%2B%2528EZH1%2529%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7633%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00855"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2606</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00855" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaobao&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Fengling&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Kyle&quot;,&quot;last_name&quot;:&quot;D. Konze&quot;},{&quot;first_name&quot;:&quot;Jamel&quot;,&quot;last_name&quot;:&quot;Meslamani&quot;},{&quot;first_name&quot;:&quot;Anqi&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Brown&quot;},{&quot;first_name&quot;:&quot;Ming-Ming&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Cheryl&quot;,&quot;last_name&quot;:&quot;H. Arrowsmith&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;Ümit Kaniskan&quot;},{&quot;first_name&quot;:&quot;Masoud&quot;,&quot;last_name&quot;:&quot;Vedadi&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7617-7633&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00855&quot;},&quot;abstract&quot;:&quot;EZH2 or EZH1 (enhancer of zeste homologue 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27). PRC2 hyperactivity and/or hypertrimethylation of H3K27 are associated with numerous human cancers, therefore inhibition of PRC2 complex has emerged as a promising therapeutic approach. Recent studies have shown that EZH2 and EZH1 are not functionally redundant and inhibition of both EZH2 and EZH1 is necessary to block the progression of certain cancers such as mixed-lineage leukemia (MLL)-rearranged leukemias. Despite the significant advances in discovery of EZH2 inhibitors, there has not been a systematic structure–activity relationship (SAR) study to investigate the selectivity between EZH2 and EZH1 inhibition. Here, we report our SAR studies that focus on modifications to various regions of the EZH2/1 inhibitor UNC1999 (5) to investigate the impact of the structural changes on EZH2 and EZH1 inhibition and selectivity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00855&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00855" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00855&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00855" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00855&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00855" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00855&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00855&amp;href=/doi/10.1021/acs.jmedchem.6b00855" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00855" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00855" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00855%26sid%3Dliteratum%253Aachs%26pmid%3D27468126%26genre%3Darticle%26aulast%3DYang%26date%3D2016%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bfor%2BEnhancer%2Bof%2BZeste%2BHomologue%2B2%2B%2528EZH2%2529%2Band%2BEnhancer%2Bof%2BZeste%2BHomologue%2B1%2B%2528EZH1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D16%26spage%3D7617%26epage%3D7633%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/jmcmar.2016.59.issue-16/20160825/jmcmar.2016.59.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">EZH2 or EZH1 (enhancer of zeste homologue 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27). PRC2 hyperactivity and/or hypertrimethylation of H3K27 are associated with numerous human cancers, therefore inhibition of PRC2 complex has emerged as a promising therapeutic approach. Recent studies have shown that EZH2 and EZH1 are not functionally redundant and inhibition of both EZH2 and EZH1 is necessary to block the progression of certain cancers such as mixed-lineage leukemia (MLL)-rearranged leukemias. Despite the significant advances in discovery of EZH2 inhibitors, there has not been a systematic structure–activity relationship (SAR) study to investigate the selectivity between EZH2 and EZH1 inhibition. Here, we report our SAR studies that focus on modifications to various regions of the EZH2/1 inhibitor UNC1999 (<b>5</b>) to investigate the impact of the structural changes on EZH2 and EZH1 inhibition and selectivity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">EZH2 (enhancer of zeste homologue 2, also known as KMT6 (lysine methyltransferase 6) or KMT6A) or EZH1 (enhancer of zeste homologue 1, also known as KMT6B) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> PRC2 is a crucial, highly conserved chromatin-modifying complex that contains three core subunits: (1) EZH1 or EZH2, (2) SUZ12 (suppressor of zeste 12), (3) EED (embryonic ectoderm development), and additional subunits such as histone and DNA interacting proteins RbAp46/48 and AEBP2.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> While EZH2 or EZH1 is the catalytic subunit, their methyltransferase activity can only be activated as part of PRC2 complex via interactions with EED and the VEFS domain of SUZ12 (SUZ12–VEFS).<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6-10)</a> The importance of these interactions is supported by the fact that the isolated SET domain of EZH2 lacks H3K27 peptide and cofactor SAM (<i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine) recognition and it is inactive.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> These interactions have also been clearly demonstrated by the recent crystal structures of the PRC2 complex from a thermophilic fungus, <i>Chaetomium hermophilum</i> (<i>Ct</i>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and inhibitor-bound American chameleon (<i>Anolis carolinensis</i> (<i>Ac</i>))/human PRC2 complex<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> as well as human PRC2 in complex with the H3K27M mutant peptide.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">The trimethylation of H3K27 (H3K27me3) catalyzed by PRC2 is a transcriptionally repressive epigenetic mark that regulates gene expression, differentiation, and development.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> PRC2 hyperactivity and/or hypertrimethylation of H3K27 have been associated with a number of human cancers<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> such as breast,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> prostate,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> lymphoma,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> myeloma,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and leukemia.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Gain-of-function point mutations at tyrosine 641 in the C-terminal SET domain of EZH2 have been identified and are observed in 7% of follicular lymphomas and 22% of germinal center B-cell (GCB) and diffuse large B-cell lymphomas (DLBCLs).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> It is not yet determined whether EZH1 is also overexpressed in B-cell malignancies. It has also been demonstrated that EZH2 and EZH1 compensate for one another, and both of them are critical for sustaining aggressive <i>MLL</i>-rearranged leukemias by enforcing cell proliferation and suppressing cell differentiation programs.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a></div><div class="NLM_p">EZH2 and EZH1 are highly homologous with 76% overall sequence identity and 96% sequence identity in their catalytic SET domains.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, EZH2 and EZH1 have different expression patterns. While EZH1 is ubiquitously expressed and present in both dividing and differentiated cells, EZH2 is only expressed in actively dividing cells.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29-31)</a> EZH1 containing PRC2 complex (PRC2–EZH1) functions directly in chromatin compaction, while EZH2 containing PRC2 complex (PRC2–EZH2) does not.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Given these differences, it was proposed that PRC2 complexes differ in their differentiation roles.<a onclick="showRef(event, 'ref29 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref32">(29, 32)</a> Therefore, depending upon the cellular context, the loss of either EZH2 or EZH1 catalytic activity or the inactivation of their methyltransferase activity together might be needed to block the proliferation of tumor cells. For example, inhibition of EZH2 alone is sufficient to exert robust antiproliferative activity in DLBCLs.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> On the other hand, inhibition of both EZH2 and EZH1 is needed to block the progression of <i>MLL</i>-rearranged leukemias in cell-based and animal models.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Numerous highly potent and selective small-molecule inhibitors of PRC2 have recently been discovered. Most of these inhibitors contain a common pyridonemethyl-amide core constituting a highly optimized moiety for binding to EZH2 and EZH1 in a cofactor-competitive manner (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Some of these small molecules also feature an indazole ring attached to pyridonemethyl-amide core where the others contain an indole or aniline ring. The first two published EZH2 inhibitors are EPZ005687 (<b>1</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and GSK126 (<b>2</b>),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> which are highly selective for EZH2 over a range of other methyltransferases (50 and 150-fold selective for EZH2 over EZH1, respectively). GSK343 (<b>3</b>) and EI1 (<b>4</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> are also selective toward EZH2 over EZH1 (60- and 140-fold, respectively). UNC1999 (<b>5</b>) was the first reported orally bioavailable inhibitor of EZH2 and EZH1 and is a potent dual inhibitor of both enzymes with around 5-fold selectivity for EZH2 over EZH1.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> EPZ-6438 (<b>6</b>),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> an EZH2 inhibitor (35-fold selective over EZH1), as well as compound <b>2</b> are being evaluated in the clinic for the treatment of advanced solid tumors or B-cell lymphomas.<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38-41)</a> A new chemotype represented by inhibitor <b>7</b>, which contains a 4-amino-2,2′,6,6′-tetramethylpiperidine core, was discovered.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> However, the inhibitors featuring this new core have not demonstrated good pharmacokinetic (PK) properties and any in vivo activity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Replacing the core with dimethylpyridone and subsequent SAR studies resulted in the discovery of CPI-360 (<b>8</b>), which was 100-fold selective for EZH2 over EZH1.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Recently, CPI-1205, an analogue of <b>8</b> has entered phase 1 clinical trials for evaluation in patients with B-cell lymphomas.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> EPZ011989 (<b>9</b>), a potent and orally bioavailable EZH2 inhibitor, was obtained by replacing one of the phenyl rings with acetylene and modifying the pyran substituent of compound <b>6</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Again, on the basis of <b>6</b>, ZLD1039 (<b>10</b>), which is 12-fold selective for EZH2 over EZH1, has been discovered.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Most recently, compound <b>11</b>, a potent EZH2 inhibitor, was cocrystallized with the active <i>Ac</i>/human PRC2 complex.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported small-molecule inhibitors of EZH2 and EZH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although there have been very significant advances in discovery of EZH2 inhibitors as we discussed above, a systematic structure–activity relationship (SAR) study to investigate EZH2 and EZH1 selectivity has not been reported. Herein, we report our SAR studies that focus on modifications to several regions of our inhibitor <b>5</b> and investigate the impact of structural changes on EZH2 and EZH1 potency and selectivity. We describe the design, synthesis, and biochemical evaluation of novel compounds against both PRC2–EZH2 and PRC2–EZH1 and discuss structural features that lead to selectivity between EZH2 and EZH1.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We investigated the following three regions of the chemical series represented by compound <b>5</b>: (1) the crucial pyridonemethyl-amide core (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, red box), mainly focusing on the substitutions at positions 4, 5, and 6 of the pyridone ring (2-pyridone numbering); (2) the indazole moiety (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, orange box), including changes in connectivity of this ring to the pyridonemethyl-amide core and 3-pyridine moiety, as well as the replacement ring systems and various alkyl substituents on the indazole N-1 (indazole numbering); and (3) the pyridine-2-yl-piperazine substituent at the 6-position of the indazole ring (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, blue box), including different ring systems and substitutions at this position.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regions of compound <b>5</b> investigated for EZH2 and EZH1 selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We previously reported <b>5</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) as a very potent and selective pyridone containing dual inhibitor of EZH2 and EZH1 (IC<sub>50</sub> < 10 nM and 69 ± 14 nM, respectively).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The recently published cocrystal structure of inhibitor <b>11</b> in complex with the <i>Ac</i>/human PRC2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7">5IJ7</a>) has clearly demonstrated the significance of the pyridonemethyl-amide core in binding to EZH2.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> We docked inhibitor <b>5</b> into the human PRC2 crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> based on the binding mode of inhibitor <b>11</b> in complex with the <i>Ac</i>/human PRC2.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The docked structure of compound <b>5</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A,B) displays that the pyridonemethyl-amide core is anchored via hydrogen-bond interactions with backbone oxygen and nitrogen atoms of W624 and makes van der Waals contacts with N688, F665, and R685. In addition, the carbonyl oxygen of the amide makes a hydrogen-bond with the backbone NH of Y111 of the activation loop. The indazole moiety interacts with the I-SET helix of EZH2 and I109, M110 with van der Waals contacts. The pyridine moiety interacts with Y111 (activation loop) and Y661 (I-SET of EZH2) via π–π stacking while the piperazinium is involved in an ionic interaction with D237 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A,B). W624 is part of the conserved GXG motif of the SET domain and this region is occupied by the homocysteine moiety of the cofactor product SAH (<i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-homocysteine) in the absence of a ligand. The inhibitor and SAH partly share this binding site, resulting in cofactor-competitive inhibition (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). In addition, Y111 from the activation loop and Y661 from the I-SET region are in contact with each other and create an unanticipated groove where the activation loop forms the lid of this pocket.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The pyridine2-yl-piperazine tail of compound <b>5</b> interacts with this closed pocket to create further contacts with the complex (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked pose of compound <b>5</b> in the human PRC2 structure. (A) Docked pose of compound <b>5</b> (pink). (B) A 2D representation of molecular interactions between compound <b>5</b> and the residues of the binding site. (C) Superimposition of compound <b>5</b> and SAH (aligned from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). The pyridone moiety of compound <b>5</b> mimics the homocysteine moiety of SAH (green). (D) Binding site of PRC2 complex where compound <b>5</b> binds through a groove formed by the SET domain and the activation loop of EZH2 (aqua) and the EED complex (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As described above, we focused on three regions of inhibitor <b>5</b> for SAR investigation. The general syntheses of key intermediates and derivatives of <b>5</b> are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The pyridone-methylamine derivatives (<b>15</b>) were prepared by reacting corresponding α,β-unsaturated ketones (<b>12</b>) with the cyanoacetamide <b>13</b> in the presence of a base followed by air oxidation to give corresponding nitriles (<b>14</b>), which were then reduced to obtain the desired amines (<b>15</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A). The commercially available indazole <b>16</b> reacted with alkyl bromides to give a mixture of N-1 and N-2 substituted indazoles that were separated via column chromatography (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B). The desired alkylated indazoles (<b>17</b>) were then hydrolyzed to yield 6-bromo-indazole-4-carboxylates (<b>18</b>). Suzuki coupling of <b>17</b> with the boronic acid <b>20</b>, which was prepared from the bromide <b>19</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C), and subsequent hydrolysis resulted in carboxylic acid intermediates <b>21</b>, which were further converted to the desired derivatives (<b>23</b>) by amide coupling reactions with pyridone-methylamine derivatives (<b>15</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D). Alternatively, amide coupling between <b>15</b> and <b>18</b> gave intermediates <b>22</b>, which were subjected to Suzuki coupling with the boronic acid <b>20</b> to yield the desired derivatives (<b>23</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Syntheses of Key Intermediates and Derivatives of <b>5</b> for SAR Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the pyridone moiety forms critical interactions with the PRC2 complex, we first explored the substitutions at the 4, 5, and 6 positions (2-pyridone numbering) of the pyridone ring and synthesized the new derivatives outlined in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Because most of the known inhibitors in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> possess 4,6-alkyl substitution, we started with 4,6-dimethyl pyridone and we kept the 6-methyl substituent constant, as we altered the substituent at the 4-position (compounds <b>24</b>–<b>29</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). 4,6-Dimethyl (<b>24</b>) and 4-ethyl-6-methyl (<b>25</b>) substituted compounds inhibited EZH2 with an IC<sub>50</sub> of 12 ± 2 nM. While <b>24</b> did not display appreciable inhibitory activity against EZH1 (IC<sub>50</sub> > 2500 nM), <b>25</b> inhibited it with an IC<sub>50</sub> of 810 ± 70 nM with more than 3-fold increase in potency from <b>24</b>. Our inhibitor <b>5</b>, which contains 4-propyl-6-methyl substitution, inhibited EZH2 with an IC<sub>50</sub> of less than 10 nM, it was also potent against EZH1 (IC<sub>50</sub> = 69 ± 14 nM) with 5–8-fold selectivity favoring EZH2. As the hydrophobic interactions increased with the longer chain alkyl group at 4-position, the potency for EZH2 remained high around 10 nM while potency for EZH1 increased around 50-fold from methyl to propyl group. Further elongation of the carbon chain (<i>n</i>-butyl, <b>26</b>) or branched alkyl groups such as <i>iso</i>-propyl (<b>27</b>), cyclopentane (<b>28</b>), and <i>iso</i>-butyl (<b>29</b>) groups at this position were also tolerated: EZH1 potency varied between 86 to 320 nM while EZH2 potency remained below 10 nM. These results have indicated that the 4-position of the pyridone ring can accommodate a longer or larger hydrophobic group, which is most likely involved with van der Waals contacts with R685, F686, and F665 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Interestingly, changes at this position had more pronounced effects on EZH1 potency. It should be noted that most of these compounds have IC<sub>50</sub> values below the measurable limit of our assay conditions for EZH2. With these results in hand, we then kept the 4-methyl substitution constant and modified the substituent at 6-position (compounds <b>30</b>–<b>33</b>). While 6-ethyl (<b>30</b>) and 6-<i>sec</i>-butyl (<b>31</b>) substituents were tolerated by EZH2 albeit with reduced potency (IC<sub>50</sub> of 73 ± 15 and 32 ± 9 nM, respectively), these two compounds did not exhibit appreciable inhibitory activity against EZH1 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). On the other hand, 6-<i>tert</i>-butyl (<b>32</b>) and 6-phenyl (<b>33</b>) substituents resulted in a complete loss of potency for both enzymes. Our docking model (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) suggests that there is enough space for a primary or secondary alkyl group, but a bulkier and less flexible substituent (e.g., <i>t-</i>Bu or Ph) creates steric clash with the protein and abolishes the EZH2 inhibitory activity (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Overall, modifications at this position decreased EZH1 inhibitory activity. Removal of both substitutions (<b>34</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) from the pyridone ring resulted in >500-fold loss of potency. Comparison of the potency of compounds <b>24</b> and <b>34</b> clearly shows the significance of these pyridone substituents on inhibitory activity. A previous study on the effects of methyl groups in ligand–protein binding suggested that a methyl group positioned in a hydrophobic environment instead of a hydrogen may result in a 10-fold increase in potency.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, to observe an effect beyond that, the methyl group should also prompt a more favorable conformational change.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> A possible structural explanation for the pronounced effects of an alkyl substituent at the 4-and 6-positons of the pyridone ring on EZH2 inhibition is that the addition of more van der Waals contacts leads to positioning the pyridonemethyl-amide core in an optimal geometry for the hydrogen bond interactions with W624 and Y111 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), which in turn lowers enthalpic contribution to the free energy of binding. These observations are also in line with the literature precedent, showing the effects of 4, 6-methyl groups for EZH2 inhibition.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Adding a substituent at the 5-position of the pyridone ring largely diminishes the inhibitor activity of the compounds for both EZH2 and EZH1 (compounds <b>35</b>–<b>37</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As it can be seen from our docking model (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), substitution at the 5-position will clash with R685 backbone and F665. The side chain of F665 interacts with the pyridone moiety through hydrophobic contacts and altering the cofactor binding site such as to obstruct the methionine moiety of the cofactor to be anchored at that location (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00855/suppl_file/jm6b00855_si_001.pdf" class="ext-link">Figure S1</a>). The sterically less demanding and relatively more strained cyclopentyl ring (<b>38</b>), however, retains some potency toward EZH2 but not EZH1 with IC<sub>50</sub> of 32 ± 7 and >2500 nM, respectively. We have also investigated other modifications to the pyridone ring (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The 4-hydroxyl group (<b>39</b>) replacing the 4-propyl group (<b>5</b>) resulted in a total loss of potency for both enzymes, most likely because the favorable hydrophobic interactions are abolished. The 2-methyl-pyrimidine-4-one (<b>40</b>), pyrimidine-4-one (<b>41</b>), and 6-methyl-pyrimidine-2,4-dione (<b>42</b>) groups completely abrogated inhibitory activity against EZH2 and EZH1. Similarly, replacing the pyridone ring with the 4-amino-2,2′,6,6′-tetramethylpiperidine group (<b>43</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) led to a complete loss of potency for EZH2 and EZH1.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Potencies of Newly Synthesized Pyridone Derivatives for EZH2 and EZH1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0010.gif" alt="" id="fx2" /></img><div></div></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding site in the SET domain of EZH2. (A) Close view on the pyridone moiety of compound <b>5</b> from its docked pose in human PRC2 complex. Substitution at 4-position of the pyridone ring allows the compound to make more van der Waals contacts with F665, R685 and F686. (B) Close view on the pyridone moiety of compound <b>31</b> from its docked pose in human PRC2 complex. White surface, EZH2 binding pocket; purple, van der Waals surface of the ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Potencies of Newly Synthesized Inhibitors with Modified Pyridone Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0012.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Next, we turned our attention to the indazole ring of <b>5</b> and investigated various bicycles and connectivities to the pyridonemethyl-amide moiety and the pyridine-piperazine tail as well as various substituents at the N-1 (indazole numbering) of the indazole ring (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Moving the <i>i</i>-Pr group from N-1 to N-2 of the indazole (<b>44</b>) decreased the potency of the inhibitor more than 30-fold for both enzymes. Varying the connectivity of the indazole ring to the amide group from the 4-position to the 3-position (<b>45</b>) obliterated the inhibitory activity. In addition, simultaneously moving the pyridine-2-yl-piperazine tail connection from the 6- to the 5-position and the amide group from the 4-position to the 3-position (<b>46</b>) led to a complete loss of potency. Switching the amide and pyridine-tail connection (<b>47</b>) reduced the potency for EZH2 (IC<sub>50</sub> = 540 ± 91 nM) and abolished all EZH1 inhibition. Imidazo[1,2-<i>a</i>]pyridine compounds (<b>48</b> and <b>49</b>) did not display any inhibitory activity for EZH2 or EZH1, and pyrazolo[1,5-<i>a</i>]pyridine derivative (<b>50</b>) was inactive as well. With these results in hand, we chose to use the indazole ring system with the 4-amide and 6-pyridine connection for the rest of our SAR studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Potencies of Newly Synthesized Inhibitors with Modified Indazole Motif</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0013.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0014.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">Next, we probed the role of the substituent at the indazole N-1 (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). While isopropyl (<b>5</b>), <i>t-</i>butyl (<b>51</b>), 3-pentyl (<b>52</b>), cyclopentyl (<b>53</b>), and cyclohexyl (<b>54</b>) substituted inhibitors were very potent (IC<sub>50</sub> < 10 nM) for EZH2, they also had consistent potency for EZH1 (between 69 and 127 nM). The smaller methyl (<b>55</b>) and larger cycloheptyl (<b>56</b>) derivatives were 10–20-fold less potent for EZH2 and did not have appreciable inhibitory activity against EZH1. Compounds <b>57</b>–<b>61</b> displayed decreased potency with increasing size of the substituent (from cyclobutyl to cyclohexyl (<b>57</b>–<b>59</b>) and to phenyl (<b>60</b>) and a branched large alkyl (<b>61</b>)) for EZH2, and they were inactive against EZH1. Changing the cyclohexyl group (<b>54</b>) to the cyclohexylmethyl group (<b>59</b>) and further to the cyclohexylethyl group (<b>62</b>) led to a significant drop in potency. Similarly, replacing the cyclopentyl group (<b>53</b>) to the cyclopentylmethyl group (<b>58</b>) resulted in a > 15-fold potency loss. Overall, α-branched groups at this position displayed the best potency, and structural modifications at this position affected EZH1 inhibition to a greater extent than that of EZH2. Interestingly, the hexanol group (<b>63</b>) exhibited high potency for both EZH2 and EZH1 (IC<sub>50</sub> = 25 ± 5 nM and IC<sub>50</sub> = 394 ± 55 nM, respectively). Compound <b>63</b> might adopt two different conformations to interact with the PRC2 complex according to our docking poses. In the first pose, the indazole moiety rotates 180° as compared to compound <b>5</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) and the hexanol group interacts through hydrogen bonds with Y658 and R679. The second pose suggests that the hexanol group is outside the catalytic binding site and interacts with K211 of EED (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). In both poses, the hexanol tail is implicated in additional hydrogen bonds that enhance potency for EZH2.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Potencies of Newly Synthesized Inhibitors with Indazole N-1 Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0015.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0016.gif" alt="" id="fx8" /></img><div></div></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two possible docking poses for compound <b>63</b>. (A) The indazole moiety rotates 180° in relation to compound <b>5</b>, and the hexanol interacts through hydrogen bonds with Y658 and R679. (B) The hexanol group is outside the catalytic binding site and interacts with K211 of EED.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have also investigated the pyridine-2-yl-piperizine tail of compound <b>5</b> that is substituted at 6-position of the indazole ring (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). We believe that this part of compound <b>5</b> interacts with the closed pocket formed by the activation loop of EZH2 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). We made modifications including the replacement of the pyridine ring as well as truncation of this tail. Compounds <b>64</b> and <b>65</b> that replace the isopropyl group on the piperazine outer nitrogen with an ethyl group and hydrogen did not affect the potency for either of the proteins. We then shortened the tail by removing the piperazine ring all together and replaced the pyridine group with the phenyl group (<b>66</b>, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Compounds <b>67</b>–<b>68</b> contain different phenyl substitutions (<i>para</i>-fluoro (<b>67</b>) and <i>para</i>-trifluoromethyl (<b>68</b>)). While these compounds maintained relatively good potency for EZH2, they did not display appreciable inhibitory activity against EZH1 (IC<sub>50</sub> > 1250 nM). 2-Pyridine (<b>69</b>) and <i>para</i>-substituted pyridine derivatives (<i>para</i>-fluoro (<b>70</b>) and <i>para</i>-trifluoromethyl (<b>71</b>)) displayed a similar trend as the larger substituents led to the loss of EZH1 potency while maintaining the relatively good potency for EZH2. We also explored various nitrogen containing rings such as piperidine (<b>72</b>), piperazine (<b>73</b>), and homopiperazine (<b>74</b>), which are directly attached to the 6-position of the indazole ring. Again, the EZH2 potencies of the piperidine and piperazine analogues were high (IC<sub>50</sub> = 11 ± 1 and 17 ± 3 nM, respectively). On the other hand, their EZH1 potencies dropped more than 10-fold (IC<sub>50</sub> = 613 ± 29 and 880 ± 173 nM, respectively). The homopiperazine (<b>74</b>) and piperidine-4-amino (<b>75</b>) derivatives exhibited similar behavior. Interestingly, the 6-bromo analogue (<b>76</b>), which is the intermediate used for the synthesis of aforementioned compounds, showed good potency with only 3–4-fold drop in potency (IC<sub>50</sub> = 35 ± 8 nM) for EZH2. However, this compound did not display appreciable inhibitory activity against EZH1 (IC<sub>50</sub> > 5000 nM). Our in silico studies suggest that compound <b>76</b> can adopt two different bound conformations in the PRC2–EZH2 complex. In the first conformation (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A), the bromo group is an acceptor of hydrogen bond from C663<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> and the benzene ring of the indazole stacks with Y111 of the activation loop. In the second conformation (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B), a 180° rotation around the benzamide bond places both indazole rings to stack with Y111. Overall, these results emphasized that modifications to this tail are particularly important to EZH1 inhibition. The truncation of the tail does not significantly affect EZH2 potency but all truncated compounds suffered a drastic reduction in EZH1 potency.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Potencies of Newly Synthesized Inhibitors with Modifications to the Pyridine-2-yl-piperizine Tail Region</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0017.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0018.gif" alt="" id="fx10" /></img><div></div></div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Two possible docking poses for compound <b>76</b>. (A) The bromo group is an acceptor of hydrogen bond from C663 and the benzene ring of the indazole stacks with Y111 of the activation loop. (B) A 180° rotation around the benzamide bond leads to both indazole rings stacking with Y111.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we explored three main regions of our EZH2/1 inhibitor <b>5</b> in a systematic manner to identify moieties that affect EZH2 and EZH1 selectivity. We first investigated the core pyridone ring, namely the substitutions at positions 4, 5, and 6 of this ring. The potency difference between compounds <b>24</b> and <b>34</b>, caused by the removal of the two methyl groups at the 4 and 6 positions, clearly showed the importance of the methyl groups for inhibiting these two enzymes, especially EZH2. Interestingly, further changes from the methyl substitution (<b>24</b>) to the propyl substitution (<b>5</b>) at the 4-position of the pyridone ring affected the EZH1 potency to a greater extent than EZH2. These results underscore the importance of the subtle structural modifications in ligand structure. While the 6-methyl group is essential for potency, further modifications at this position did not improve the potency for either enzyme. In addition, structural alterations at the 5-position were not promising for improving the inhibitory activity as shown by our experimental results and supported by our docking studies. We next focused on the indazole ring after establishing that this ring was the best among the heterocyclic rings we explored and examined the effects of various substituents at the N-1 position of this ring system. We found that structural modifications at this position also had stronger effects on EZH1 potency than EZH2 potency. In general, these derivatives displayed high potency for EZH2. Furthermore, we probed the pyridinyl-piperazine tail of the inhibitor scaffold. This pendant tail group occupies the ligand binding site partially formed by the activation loop and is probably the most diverged moiety among the reported pyridonemethyl-amide based inhibitors. Therefore, on the basis of our results, one may speculate that this region can perhaps be exploited further to achieve better EZH1 potency and possibly selectivity.</div><div class="NLM_p">The cocrystal structure of PRC2 in complex with inhibitor <b>11</b> has established that the pyridone core mimics the amino acid moiety of the cofactor SAM rather than the adenine moiety and the inhibitor binding site overlaps only partially with the cofactor binding site.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Thus, earlier EZH2 homology models predicting that the inhibitor binding site completely overlaps with the cofactor binding site were incorrect. Because the binding pocket of EZH2 is nearly identical to that of EZH1, in the absence of structural data for EZH1, it is very difficult to predict the structural basis for the observed SAR differences for these two catalytic subunits. Any structural information on the PRC2–EZH1 complex would be extremely useful for developing EZH1 selective chemical tools.</div><div class="NLM_p last">In summary, our systematic SAR studies identified multiple structural features that affect EZH2 and EZH1 potency and selectivity. Taking advantage of the structural insight revealed by the recently published cocrystal structure of PRC2–EZH2 in complex with a pyridone-based inhibitor, we have conducted in silico analyses of our EZH2 SAR results and provided structural explanation for key SAR findings. We anticipate that this work will facilitate further development of EZH2 and/or EZH1 selective inhibitors and chemical tools.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry: General Procedures</h3><div class="NLM_p last">HPLC spectra for all compounds were acquired using an Agilent 1200 series system with DAD detector. Chromatography was performed on a 2.1 mm × 150 mm Zorbax 300SB-C18 5 μm column with water containing 0.1% formic acid as solvent A and acetonitrile containing 0.1% formic acid as solvent B at a flow rate of 0.4 mL/min. The gradient program was as follows: 1% B (0–1 min), 1–99% B (1–4 min), and 99% B (4–8 min). High-resolution mass spectra (HRMS) data were acquired in positive ion mode using an Agilent G1969A API-TOF with an electrospray ionization (ESI) source. Nuclear magnetic resonance (NMR) spectra were acquired on a Bruker DRX-600 spectrometer with 600 MHz for proton (<sup>1</sup>H NMR) and 150 MHz for carbon (<sup>13</sup>C NMR); chemical shifts are reported in (δ). Data are reported as follows: chemical shifts (δ), multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet); coupling constant(s) (<i>J</i>) in Hz; integration. Unless otherwise noted, NMR data were collected at 25 °C. Flash column chromatography was performed using a TeledyneISCO Rf+ system. Preparative HPLC was performed on Agilent Prep 1200 series with UV detector set to 254 nm. Samples were injected onto a Phenomenex Luna 75 mm × 30 mm, 5 mm, C<sub>18</sub> column at room temperature. The flow rate was 40 mL/min. A linear gradient was used with 10% (or 50%) of MeOH (A) in H<sub>2</sub>O (with 0.1% TFA) (B) to 100% of MeOH (A). All final compounds had >95% purity by either UV absorbance at 254 nm during tandem liquid chromatography/mass spectrometry (LCMS) or by the HPLC methods described above.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure A: Synthesis of Compounds <b>24</b>–<b>38</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and <b>39</b>–<b>43</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)</h3><div class="NLM_p">The crude 3-(aminomethyl)pyridin-2(1<i>H</i>)-one analogues (<b>15</b>) (0.1 mmol), 1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxylic acid (<b>21</b>) (0.05–0.08 mmol), NMM (0.15 mmol), HOAt (0.1 mmol), and EDCI (0.1 mmol) were dissolved in DMSO (2 mL). The contents were stirred at room temperature overnight, monitored by LC/MS, and the crude product was then purified by HPLC to yield the desired compound (<b>24</b>, <b>26</b>, <b>32</b>, <b>33</b>, <b>34</b>, <b>39</b>, <b>40</b>, <b>41</b>, <b>42</b>, <b>43</b>) as solid, or crude 3-(aminomethyl)pyridin-2(1<i>H</i>)-one analogues (<b>15</b>) (0.055 mmol), TBTU (0.075 mmol), and 1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxylic acid (<b>21</b>) (0.05 mmol) were dissolved in DMF (2 mL) prior to the addition of DIPEA (20 μL). The contents were stirred at room temperature overnight, monitored by LC/MS, and the crude product was purified by HPLC to yield the desired compound (<b>25</b>, <b>27</b>, <b>28</b>, <b>29</b>, <b>30</b>, <b>31</b>, <b>35</b>, <b>36</b>, <b>37</b>, <b>38</b>) as solid.</div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>N</i>-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Yield 4.6 mg (16%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.53 (s, 1H), 8.38 (s, 1H), 8.25 (d, 1H, <i>J</i> = 9.1 Hz), 7.99 (s, 1H), 7.78 (s, 1H), 7.21 (d, 1H, <i>J</i> = 9.1 Hz), 6.24 (s, 1H), 5.09 (td, 1H, <i>J</i> = 6.6 Hz, <i>J</i> = 13.2 Hz), 4.58 (s, 2H), 4.56 (br s, 4H), 3.63 (td, 1H, <i>J</i> = 6.6 Hz, <i>J</i> = 13.2 Hz), 3.47 (br s, 4H), 2.45 (s, 3H), 2.28 (s, 3H), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>31</sub>H<sub>40</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 542.3238, found 542.3247.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> <i>N</i>-((4-Ethyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>25</b>)</h4><div class="NLM_p last">Yield 9.4 mg (22%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.59 (d, 1H, <i>J</i> = 2.4 Hz), 8.39 (d, 1H, <i>J</i> = 6.2 Hz), 8.14 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.9 Hz), 7.98 (s, 1H), 7.79 (dd, 1H, <i>J</i> = 1.1 Hz, <i>J</i> = 3.8 Hz), 7.11 (d, 1H, <i>J</i> = 8.9 Hz), 6.22 (s, 1H), 5.13–5.09 (m, 1H), 4.62 (s, 2H), 4.61 (br s, 4H), 3.66–3.61 (m, 5H), 2.82 (q, 2H, <i>J</i> = 7.6 Hz), 2.30 (s, 3H), 1.59 (d, 6H, <i>J</i> = 6.6 Hz), 1.45 (d, 6H, <i>J</i> = 6.7 Hz), 1.26 (t, 3H, <i>J</i> = 7.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>32</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 556.3395, found 556.3394.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>-((4-Butyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Yield 52 mg (81%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.57 (d, 1H, J = 2.4 Hz), 8.36 (s, 1H), 8.03 (dd, 1H, <i>J</i> = 2.6 Hz, <i>J</i> = 8.8 Hz), 7.93 (s, 1H), 7.77 (d, 1H, <i>J</i> = 1.1 Hz), 6.99 (d, 1H, <i>J</i> = 8.9 Hz), 6.15 (s, 1H), 5.12–5.07 (m, 1H), 4.60 (s, 2H), 3.77 (br s, 4H), 3.21–3.17 (m, 1H), 3.08 (br s, 4H), 2.75 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 1.59–1.55 (m, 2H), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.46–1.40 (m, 2H), 1.28 (d, 6H, <i>J</i> = 6.6 Hz), 0.92 (t, 3H, <i>J</i> = 7.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 584.3708, found 584.3710.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 1-Isopropyl-<i>N</i>-((4-isopropyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Yield 28.5 mg (55%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 12.60 (s, 1H), 8.48 (d, 1H, <i>J</i> = 2.3 Hz), 8.38 (s, 1H), 7.89 (t, 1H, <i>J</i> = 5.7 Hz), 7.76 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.70 (d, 1H, <i>J</i> = 0.9 Hz), 7.57 (s, 1H), 6.69 (d, 1H, <i>J</i> = 8.9 Hz), 6.04 (s, 1H), 4.90–4.83 (m, 1H), 4.71 (d, 2H, <i>J</i> = 5.8 Hz), 3.59 (t, 4H, <i>J</i> = 5.0 Hz), 3.57–3.50 (m, 1H), 2.75–2.69 (m, 1H), 2.63 (t, 4H, <i>J</i> = 5.0 Hz), 2.19 (s, 3H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.21 (d, 6H, <i>J</i> = 6.8 Hz), 1.08 (d, 6H, <i>J</i> = 6.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 570.3551, found 570.3557.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-((4-Cyclopentyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>28</b>)</h4><div class="NLM_p last">Yield 26.0 mg (56%). <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 12.37 (s, 1H), 8.44 (d, 1H, <i>J</i> = 1.3 Hz), 8.41 (s, 1H), 8.02 (s, 1H), 7.75 (d, 1H, <i>J</i> = 7.2 Hz), 7.66 (s, 1H), 7.57 (s, 1H), 6.59 (d, 1H, <i>J</i> = 8.7 Hz), 6.06 (s, 1H), 4.91–4.86 (m, 1H), 4.72 (d, 2H, <i>J</i> = 4.8 Hz), 3.87 (br s, 4H), 3.59–3.50 (m, 1H), 3.45–3.44 (m, 1H), 3.09 (br s, 4H), 2.23 (s, 3H), 2.08–2.06 (m, 2H), 1.83–1.76 (m, 4H), 1.59 (d, 6H, <i>J</i> = 6.6 Hz), 1.56–1.53 (m, 2H), 1.34 (d, 6H, <i>J</i> = 6.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>35</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 596.3708, found 596.3713.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-((4-Isobutyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>29</b>)</h4><div class="NLM_p last">Yield 30.4 mg (62%). <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 12.97 (s, 1H), 8.50 (d, 1H, <i>J</i> = 1.5 Hz), 8.40 (s, 1H), 8.06 (t, 1H, <i>J</i> = 5.0 Hz), 7.78 (dd, 1H, <i>J</i> = 2.0 Hz, <i>J</i> = 8.7 Hz), 7.74 (s, 1H), 7.60 (s, 1H), 6.69 (d, 1H, <i>J</i> = 8.8 Hz), 5.92 (s, 1H), 4.91–4.86 (m, 1H), 4.68 (d, 2H, <i>J</i> = 5.4 Hz), 3.61 (br s, 4H), 2.77–2.74 (m, 1H), 2.66 (br s, 4H), 2.63 (d, 2H, <i>J</i> = 7.2 Hz), 2.17 (s, 3H), 1.93–1.88 (m, 1H), 1.60 (d, 6H, <i>J</i> = 6.5 Hz), 1.11 (d, 6H, <i>J</i> = 6.4 Hz), 0.99 (d, 6H, <i>J</i> = 6.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 584.3708, found 584.3713.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-((6-Ethyl-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Yield 20.3 mg (61%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (d, 1H, <i>J</i> = 2.4 Hz), 8.38 (s, 1H), 8.00 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.92 (s, 1H), 7.78 (d, 1H, <i>J</i> = 0.8 Hz), 6.97 (d, 1H, <i>J</i> = 8.9 Hz), 6.18 (s, 1H), 5.10–5.06 (m, 1H), 4.60 (s, 2H), 3.80 (br s, 4H), 3.16 (br s, 4H), 2.55 (q, 2H, <i>J</i> = 7.6 Hz), 2.45 (s, 3H), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.33 (d, 6H, <i>J</i> = 6.5 Hz), 1.24 (t, 3H, <i>J</i> = 7.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>32</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 556.3395, found 556.3408.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-((6-(<i>sec</i>-Butyl)-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Yield 24.5 mg (63%). <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 11.99 (s, 1H), 8.49 (s, 1H), 8.41 (s, 1H), 7.83 (s, 1H), 7.78 (dd, 1H, J = 1.7 Hz, <i>J</i> = 8.6 Hz), 7.71 (s, 1H), 7.60 (s, 1H), 6.69 (d, 1H, <i>J</i> = 8.7 Hz), 5.93 (s, 1H), 4.91–4.87 (m, 1H), 4.67 (d, 2H, <i>J</i> = 5.6 Hz), 3.66 (br s, 4H), 2.82 (br s, 1H), 2.71 (br s, 4H), 2.49–2.45 (m, 4H), 1.65–1.60 (m, 1H), 1.60 (d, 6H, <i>J</i> = 6.6 Hz), 1.52–1.45 (m, 1H), 1.17–1.14 (m, 9H), 0.73 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 584.3708, found 584.3713.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-((6-(<i>tert</i>-Butyl)-4-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>32</b>)</h4><div class="NLM_p last">Yield 14 mg (81%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.56 (s, 1H), 8.39 (s, 1H), 8.24 (d, 1H, <i>J</i> = 8.9 Hz), 7.99 (s, 1H), 7.79 (s, 1H), 7.21 (d, 1H, <i>J</i> = 8.9 Hz), 6.29 (s, 1H), 5.12–5.06 (m, 1H), 4.59 (s, 2H), 3.56 (br s, 4H), 3.66–3.60 (m, 5H), 2.48 (s, 3H), 1.57 (d, 6H, <i>J</i> = 6.5 Hz), 1.43 (d, 6H, <i>J</i> = 6.5 Hz), 1.32 (s, 9H). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 584.3708, found 584.3710.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((4-methyl-2-oxo-6-phenyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>33</b>)</h4><div class="NLM_p last">Yield 15 mg (71%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.57 (d, 1H, <i>J</i> = 2.4 Hz), 8.40 (s, 1H), 8.21 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 9.0 Hz), 7.98 (s, 1H), 7.81 (d, 1H, <i>J</i> = 1.0 Hz), 7.67–7.66 (m, 2H), 7.51–7.48 (m, 3H), 7.17 (d, 1H, <i>J</i> = 9.0 Hz), 6.61 (s, 1H), 5.12–5.07 (m, 1H), 4.65 (s, 2H), 4.56 (br s, 4H), 3.64–3.59 (m, 5H), 2.55 (s, 3H), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.42 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>36</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 604.3395, found 604.3399.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((2-oxo-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>34</b>)</h4><div class="NLM_p last">Yield: 16 mg (65%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.56 (d, 1H, <i>J</i> = 2.3 Hz), 8.39 (s, 1H), 8.23 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 9.0 Hz), 8.00 (s, 1H), 7.84 (d, 1H, <i>J</i> = 1.1 Hz), 7.64 (d, 1H, <i>J</i> = 5.8 Hz), 7.40 (dd, 1H, <i>J</i> = 1.8 Hz, <i>J</i> = 6.5 Hz), 7.20 (d, 1H, <i>J</i> = 9.1 Hz), 6.41 (t, 1H, <i>J</i> = 6.7 Hz), 5.10 (td, 1H, <i>J</i> = 6.6 Hz, <i>J</i> = 13.3 Hz), 4.60 (br s, 4H), 4.51 (s, 2H), 3.42 (br s, 4H), 3.63 (td, 1H, J = 6.6 Hz, <i>J</i> = 13.3 Hz), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>29</sub>H<sub>36</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 514.2925, found 514.2927.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-((4-Ethyl-5-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>35</b>)</h4><div class="NLM_p last">Yield: 32.9 mg (72%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.61 (d, 1H, <i>J</i> = 2.4 Hz), 8.40 (s, 1H), 8.19 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 9.2 Hz), 8.00 (s, 1H), 7.81 (s, 1H), 7.27 (s, 1H), 7.17 (d, 1H, <i>J</i> = 8.8 Hz), 5.14–5.09 (m, 1H), 4.69 (s, 2H), 4.61 (br s, 4H), 3.66–3.61 (m, 5H), 2.93 (q, 2H, <i>J</i> = 7.7 Hz), 2.18 (s, 3H), 1.60 (d, 6H, <i>J</i> = 6.4 Hz), 1.45 (d, 6H, <i>J</i> = 6.5 Hz), 1.24 (t, 3H, <i>J</i> = 7.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>32</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 556.3395, found 556.3403.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((4,5,6-trimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>36</b>)</h4><div class="NLM_p last">Yield: 18.7 mg (56%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.57 (d, 1H, <i>J</i> = 2.4 Hz), 8.38 (s, 1H), 8.02 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.93 (s, 1H), 7.78 (d, 1H, <i>J</i> = 1.0 Hz), 6.98 (d, 1H, <i>J</i> = 8.8 Hz), 5.11–5.07 (m, 1H), 4.65 (s, 2H), 3.66–3.56 (m, 5H), 3.23 (br s, 4H), 2.39 (s, 3H), 2.28 (s, 3H), 2.05 (s, 3H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>32</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> calculated 556.3395, found 556.3390.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolin-4-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>37</b>)</h4><div class="NLM_p last">Yield: 12.8 mg (42%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.57 (d, 1H, <i>J</i> = 2.4 Hz), 8.38 (s, 1H), 8.03 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.93 (s, 1H), 7.78 (s, 1H), 7.00 (d, 1H, <i>J</i> = 8.8 Hz), 5.11–5.06 (m, 1H), 4.61 (s, 2H), 3.88 (br s, 4H), 3.53–3.44 (m, 1H), 3.32 (br s, 4H), 2.96 (t, 2H, <i>J</i> = 5.9 Hz), 2.50 (t, 2H, <i>J</i> = 5.6 Hz), 2.22 (s, 3H), 1.80–1.74 (m, 4H), 1.57 (d, 6H, <i>J</i> = 6.6 Hz), 1.39 (d, 6H, <i>J</i> = 6.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> calculated 582.3551, found 582.3555.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((1-methyl-3-oxo-3,5,6,7-tetrahydro-2<i>H</i>-cyclopenta[<i>c</i>]pyridin-4-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>38</b>)</h4><div class="NLM_p last">Yield: 11.8 mg (42%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.57 (s, 1H), 8.39 (s, 1H), 8.17 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 9.0 Hz), 7.99 (s, 1H), 7.81 (d, 1H, <i>J</i> = 1.3 Hz), 7.15 (d, 1H, <i>J</i> = 8.0 Hz), 5.12–5.05 (m, 1H), 4.54 (s, 2H), 3.65–3.57 (m, 1H), 3.48 (br s, 8H), 3.13 (t, 2H, <i>J</i> = 7.6 Hz), 2.77 (t, 2H, <i>J</i> = 7.3 Hz), 2.28 (s, 3H), 2.16–2.08 (m, 2H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> calculated 568.3395, found 568.3397.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-((4-Hydroxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>39</b>)</h4><div class="NLM_p last">Yield: 7.8 mg (39%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.59 (d, 1H, <i>J</i> = 2.1 Hz), 8.40 (s, 1H), 8.15 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 9.0 Hz), 8.00 (s, 1H), 7.85 (s, 1H), 7.13 (d, 1H, <i>J</i> = 8.7 Hz), 6.13 (s, 1H), 5.12–5.07 (m, 1H), 4.65 (br s, 4H), 4.54 (s, 2H), 3.65–3.58 (m, 5H), 2.29 (s, 3H), 1.58 (d, 6H, <i>J</i> = 6.8 Hz), 1.43 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>30</sub>H<sub>38</sub>N<sub>7</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 544.3031, found 544.3030.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((2-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>40</b>)</h4><div class="NLM_p last">Yield: 12.0 mg (63%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.61 (s, 1H), 8.39 (s, 1H), 8.20 (d, 1H, <i>J</i> = 10.2 Hz), 8.02 (s, 1H), 7.99 (s, 1H), 7.86 (s, 1H), 7.18 (d, 1H, <i>J</i> = 9.0 Hz), 5.13–5.08 (m, 1H), 4.59 (br s, 4H), 4.45 (s, 2H), 3.66–3.58 (m, 5H), 2.55 (s, 3H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>29</sub>H<sub>37</sub>N<sub>8</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> calculated 529.3034, found 529.3033.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-oxo-1,6-dihydropyrimidin-5-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>41</b>)</h4><div class="NLM_p last">Yield: 11.2 mg (60%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.59 (d, 1H, <i>J</i> = 2.3 Hz), 8.54 (br s, 1H), 8.39 (s, 1H), 8.23 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 9.0 Hz), 8.12 (br s, 1H), 8.02 (s, 1H), 7.85 (d, 1H, <i>J</i> = 0.9 Hz), 7.21 (d, 1H, <i>J</i> = 9.0 Hz), 5.13–5.08 (m, 1H), 4.50 (br s, 4H), 4.48 (s, 2H) 3.65–3.60 (m, 1H), 3.50 (br s, 4H), 2.66 (s, 3H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.43 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>28</sub>H<sub>35</sub>N<sub>8</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 515.2877, found 515.2878.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>42</b>)</h4><div class="NLM_p last">Yield: 5.9 mg (30%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.60 (s, 1H), 8.35 (s, 1H), 8.11 (dd, 1H, <i>J</i> = 1.3 Hz, <i>J</i> = 8.9 Hz), 7.95 (s, 1H), 7.76 (s, 1H), 7.09 (d, 1H, <i>J</i> = 8.8 Hz), 5.11–5.06 (m, 1H), 4.60 (br s, 4H), 4.38 (s, 2H), 3.63–3.57 (m, 5H), 2.39 (s, 3H), 1.57 (d, 6H, <i>J</i> = 6.5 Hz), 1.43 (d, 6H, <i>J</i> = 6.6 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>29</sub>H<sub>37</sub>N<sub>8</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 545.2983, found 545.2980.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)-1<i>H</i>-indazole-4-carboxamide (<b>43</b>)</h4><div class="NLM_p last">Yield: 33.0 mg (78%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.61 (d, 1H, <i>J</i> = 2.3 Hz), 8.38 (s, 1H), 8.32 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 9.1 Hz), 8.05 (s, 1H), 7.84 (d, 1H, <i>J</i> = 1.0 Hz), 7.30 (d, 1H, <i>J</i> = 9.1 Hz), 5.15–5.08 (m, 1H), 4.68–4.58 (m, 5H), 3.67–3.56 (m, 5H), 2.20 (dd, 2H, <i>J</i> = 3.6 Hz, <i>J</i> = 13.8 Hz), 1.76 (t, 2H, <i>J</i> = 13.0 Hz), 1.61 (s, 6H), 1.58 (d, 6H, <i>J</i> = 6.6 Hz), 1.49 (s, 6H), 1.42 (d, 6H, <i>J</i> = 6.7 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>32</sub>H<sub>48</sub>N<sub>7</sub>O<sup>+</sup> [M + H]<sup>+</sup>: calculated 546.3915, found 546.3922.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure B: Synthesis of compounds <b>44</b>–<b>50</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) and <b>51</b>–<b>63</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), and <b>66</b>, <b>68</b>, <b>69</b>, and <b>71</b>–<b>76</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>)</h3><div class="NLM_p">The crude 3-(aminomethyl)pyridin-2(1<i>H</i>)-one analogues (<b>15</b>) (0.1 mmol), 6-bromo-1-alkyl-1<i>H</i>-indazole-4-carboxylic acid (<b>18</b>) (0.05–0.08 mmol), NMM (0.15 mmol), HOAt (11 mg, 0.10 mmol), and EDCI (0.10 mmol) were dissolved in DMSO (2 mL). The contents were stirred at room temperature overnight, monitored by LC/MS, quenched with water, and the desired product (<b>22</b>) was separated out and filtered to get the compound (<b>22</b>) as solid. Then compound (<b>22</b>) (0.10 mmol, 1.0 equiv), (6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)boronic acid (<b>20</b>) (0.12 mmol, 1.2 equiv), and potassium acetate (0.30 mmol, 3.0 equiv) were mixed with 1,4-dioxane (50 mL) and water (10 mL) in a flask. To this mixture, 1,1′-bis(diphenylphosphino)ferrocene–palladium(II)dichloride dichloromethane complex (10–20 wt %) was added under argon atmosphere at room temperature. The mixture was heated to 80 °C for overnight and cooled to room temperature. The crude product was then purified by flash column chromatography (gradient from 100% hexane to 100% ethyl acetate, then from 100% ethyl acetate to 10% methanol) to yield the desired compound (<b>44</b>–<b>63</b>, <b>66</b>, <b>68</b>, <b>69</b>, <b>71</b>, <b>72</b>). For the synthesis of compounds <b>73</b>–<b>75</b>, intermediate <b>22</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) (0.10 mmol, 1.0 equiv), corresponding amines (0.15 mmol, 1.5 equiv), <i>t</i>-BuONa (0.15 mmol, 1.5 equiv), and BINAP (0.02 mmol, 0.2 equiv) were mixed with 1,4-dioxane (50 mL) in a flask. To this mixture, Pd<sub>2</sub>(dba)<sub>3</sub> (0.01 mmol, 0.1 equiv) was added under argon atmosphere at room temperature. The mixture was heated to 80 °C for overnight and cooled to room temperature. The crude product was then purified by flash column chromatography (gradient from 100% hexane to 100% ethyl acetate, then from 100% ethyl acetate to 10% methanol) or purified by HPLC to yield the desired product (<b>73</b>, <b>74</b>, and <b>75</b>). Synthesis and full characterization of compounds <b>5</b>, <b>64</b>, <b>65</b>, <b>67</b>, and <b>70</b> have been previously published.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-2<i>H</i>-indazole-4-carboxamide (<b>44</b>)</h4><div class="NLM_p last">Yield: 4.6 mg (7%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.60 (s, 1H), 8.56 (s, 1H), 8.09 (dd, 1H, <i>J</i> = 1.5 Hz, <i>J</i> = 8.9 Hz), 7.93 (s, 1H), 7.79 (s, 1H), 7.10 (d, 1H, <i>J</i> = 9.0 Hz), 6.17 (s, 1H), 4.93–4.89 (m, 1H), 4.60 (br s, 4H), 4.59 (s, 2H), 3.64–3.57 (m, 5H), 2.75 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 1.67 (d, 6H, <i>J</i> = 6.7 Hz), 1.66–1.61 (m, 2H), 1.42 (d, 6H, <i>J</i> = 6.6 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 570.3551, found 570.3542.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-3-carboxamide (<b>45</b>)</h4><div class="NLM_p last">Yield: 50 mg (86%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.45 (d, 1H, <i>J</i> = 2.1 Hz), 7.92 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.7 Hz), 7.83 (d, 1H, <i>J</i> = 8.7 Hz), 7.80 (s, 1H), 7.42 (d, 1H, <i>J</i> = 8.2 Hz), 6.96 (d, 1H, <i>J</i> = 8.8 Hz), 6.14 (s, 1H), 5.59–5.53 (m, 1H), 4.59 (s, 2H), 3.72 (br s, 4H), 3.11–3.06 (m, 1H), 2.98 (br s, 4H), 2.74 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 1.68–1.60 (m, 2H), 1.61 (d, 6H, <i>J</i> = 6.6 Hz), 1.24 (d, 6H, <i>J</i> = 6.5 Hz), 1.03 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 570.3551, found 570.3553.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-Isopropyl-5-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-3-carboxamide (<b>46</b>)</h4><div class="NLM_p last">Yield: 58 mg (64%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (d, 1H, <i>J</i> = 2.4 Hz), 8.00–7.98 (m, 2H), 7.74 (d, 1H, <i>J</i> = 9.0 Hz), 7.60 (dd, 1H, J = 1.5 Hz, <i>J</i> = 9.0 Hz), 6.98 (d, 1H, <i>J</i> = 8.8 Hz), 6.13 (s, 1H), 5.62–5.56 (m, 1H), 4.59 (s, 2H), 3.75 (br s, 4H), 3.22–3.18 (m, 1H), 3.09 (t, 4H, <i>J</i> = 4.8 Hz), 2.74 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 1.68–1.61 (m, 2H), 1.61 (d, 6H, <i>J</i> = 6.6 Hz), 1.29 (d, 6H, <i>J</i> = 6.7 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 570.3551, found 570.3554.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-Isopropyl-4-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-6-carboxamide (<b>47</b>)</h4><div class="NLM_p last">Yield: 71 mg (79%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.50 (d, 1H, <i>J</i> = 2.3 Hz), 8.16 (s, 1H), 8.04 (s, 1H), 7.97 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.61 (d, 1H, <i>J</i> = 1.1 Hz), 6.99 (d, 1H, <i>J</i> = 8.9 Hz), 6.14 (s, 1H), 5.07–5.03 (m, 1H), 4.57 (s, 2H), 3.67 (br s, 4H), 2.86–2.81 (m, 1H), 2.78 (t, 4H, <i>J</i> = 4.5 Hz), 2.72 (t, 2H, <i>J</i> = 8.1 Hz), 2.26 (s, 3H), 1.66–1.60 (m, 2H), 1.58 (d, 6H, <i>J</i> = 6.7 Hz), 1.17 (d, 6H, <i>J</i> = 6.5 Hz), 1.00 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>33</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 570.3551, found 570.3555.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)imidazo[1,2-<i>a</i>]pyridine-8-carboxamide (<b>48</b>)</h4><div class="NLM_p last">Yield: 42 mg (40%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.72 (d, 1H, <i>J</i> = 6.8 Hz), 8.47 (s, 1H), 8.37 (d, 1H, <i>J</i> = 7.3 Hz), 8.08 (s, 1H), 7.94 (d, 1H, <i>J</i> = 9.8 Hz), 7.49 (t, 1H, <i>J</i> = 7.0 Hz), 7.16 (d, 1H, <i>J</i> = 8.9 Hz), 6.17 (s, 1H), 4.74–4.72 (d, 2H, <i>J</i> = 12.0 Hz), 4.61 (s, 2H), 3.65–3.59 (m, 2H), 3.31–3.20 (m, 4H), 2.72 (t, 2H, J = 7.8 Hz), 2.27 (s, 3H), 1.67–1.61 (m, 2H), 1.43 (d, 6H, <i>J</i> = 6.6 Hz), 1.01 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>30</sub>H<sub>38</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 528.3081, found 528.3079.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 7-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide (<b>49</b>)</h4><div class="NLM_p last">Yield: 50 mg (48%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.63 (s, 1H), 8.40 (s, 1H), 8.22 (d, 1H, <i>J</i> = 8.8 Hz), 8.14 (d, 1H, <i>J</i> = 8.9 Hz), 7.50 (t, 1H, <i>J</i> = 7.8 Hz), 7.09 (d, 1H, <i>J</i> = 6.7 Hz), 6.94 (d, 1H, <i>J</i> = 9.0 Hz), 6.14 (s, 1H), 4.53 (s, 2H), 3.69 (br s, 4H), 2.80–2.66 (m, 7H), 2.26 (s, 3H), 1.65–1.58 (m, 2H), 1.14 (d, 6H, <i>J</i> = 6.3 Hz), 0.99 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>30</sub>H<sub>38</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 528.3081, found 528.3082.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 7-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)imidazo[1,2-<i>a</i>]pyridine-2-carboxamide (<b>50</b>)</h4><div class="NLM_p last">Yield: 53 mg (50%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.78 (d, 1H, <i>J</i> = 7.0 Hz), 8.69 (d, 1H, <i>J</i> = 1.8 Hz), 8.56 (s, 1H), 8.15 (dd, 1H, <i>J</i> = 2.1 Hz, <i>J</i> = 8.9 Hz), 7.98 (s, 1H), 7.79 (d, 1H, <i>J</i> = 7.0 Hz), 7.11 (d, 1H, <i>J</i> = 9.0 Hz), 6.19 (s, 1H), 4.70 (br s, 4H), 4.56 (s, 2H), 3.64–3.58 (m, 5H), 2.67 (m, 2H), 2.28 (s, 3H), 1.63 (m, 2H), 1.42 (d, 6H, <i>J</i> = 6.6 Hz), 1.00 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>30</sub>H<sub>38</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 528.3081, found 528.3088.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(<i>tert</i>-Butyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>51</b>)</h4><div class="NLM_p last">Yield: 25 mg (83%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.50 (d, 1H, <i>J</i> = 2.5 Hz), 8.28 (s, 1H), 8.03 (s, 1H), 7.98 (dd, 1H, <i>J</i> = 2.6 Hz, <i>J</i> = 8.8 Hz), 7.72 (d, 1H, <i>J</i> = 1.1 Hz), 6.98 (d, 1H, <i>J</i> = 8.9 Hz), 6.15 (s, 1H), 4.59 (s, 2H), 3.71 (br s, 4H), 3.02–2.98 (m, 1H), 2.92 (br s, 4H), 2.75–2.73 (m, 2H), 2.26 (s, 3H), 1.81 (s, 9H), 1.68–1.61 (m, 2H), 1.22 (d, 6H, <i>J</i> = 6.5 Hz), 1.02 (t, 3H, <i>J</i> = 7.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 584.3708, found 584.3709.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1-(pentan-3-yl)-1<i>H</i>-indazole-4-carboxamide (<b>52</b>)</h4><div class="NLM_p last">Yield: 40 mg (61%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.56 (d, 1H, <i>J</i> = 1.8 Hz), 8.41 (s, 1H), 8.03 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.8 Hz), 7.94 (s, 1H), 7.76 (s, 1H), 7.00 (d, 1H, <i>J</i> = 8.8 Hz), 6.15 (s, 1H), 4.60 (s, 2H), 4.59–4.55 (m, 1H), 3.81 (br s, 4H), 3.17 (br s, 4H), 2.74 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 2.11–2.03 (m, 2H), 1.98–1.91 (m, 3H), 1.67–1.61 (m, 2H), 1.32 (d, 6H, <i>J</i> = 6.6 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz), 0.70 (t, 6H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>35</sub>H<sub>48</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 598.3864, found 598.3868.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-Cyclopentyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>53</b>)</h4><div class="NLM_p last">Yield: 78 mg (62%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.49 (s, 1H), 8.33 (s, 1H), 7.94 (d, 1H, <i>J</i> = 8.7 Hz), 7.89 (s, 1H), 7.75 (s, 1H), 6.87 (d, 1H, <i>J</i> = 8.7 Hz), 6.12 (s, 1H), 5.24–5.20 (m, 1H), 4.58 (s, 2H), 3.59 (br s, 4H), 2.76–2.70 (m, 7H), 2.24 (s, 3H), 2.21–2.18 (m, 2H), 2.12–2.08 (m, 2H), 1.98–1.94 (m, 2H), 1.79–1.75 (m, 2H), 1.65–1.61 (m, 2H), 1.13 (d, 6H, <i>J</i> = 6.1 Hz), 1.00 (t, 3H, <i>J</i> = 7.1 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>35</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 596.3708, found 596.3711.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-Cyclohexyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>54</b>)</h4><div class="NLM_p last">Yield: 10 mg (16%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.52 (d, 1H, <i>J</i> = 2.4 Hz), 8.34 (s, 1H), 7.99 (dd, 1H, <i>J</i> = 2.6 Hz, <i>J</i> = 8.9 Hz), 7.91 (s, 1H), 7.75 (d, 1H, <i>J</i> = 1.2 Hz), 6.92 (d, 1H, <i>J</i> = 8.9 Hz), 6.14 (s, 1H), 4.70–4.64 (m, 1H), 4.59 (s, 2H), 3.61 (t, 4H, <i>J</i> = 4.5 Hz), 2.78–2.70 (m, 7H), 2.25 (s, 3H), 2.03–1.92 (m, 6H), 1.80–1.77 (m, 1H), 1.67–1.56 (m, 4H), 1.40–1.32 (m, 1H), 1.14 (d, 6H, <i>J</i> = 6.5 Hz), 1.01 (t, 3H, <i>J</i> = 7.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>36</sub>H<sub>48</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 610.3864, found 610.3865.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-1-methyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>55</b>)</h4><div class="NLM_p last">Yield: 50 mg (77%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (d, 1H, <i>J</i> = 2.1 Hz), 8.31 (s, 1H), 7.99 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.8 Hz), 7.86 (s, 1H), 7.76 (s, 1H), 6.95 (d, 1H, <i>J</i> = 8.8 Hz), 6.14 (s, 1H), 4.58 (s, 2H), 4.11 (s, 3H), 3.81 (br s, 4H), 3.36–3.34 (m, 1H), 3.20 (br s, 4H), 2.73 (t, 2H, <i>J</i> = 7.8 Hz), 2.25 (s, 3H), 1.66–1.60 (m, 2H), 1.34 (d, 6H, <i>J</i> = 6.4 Hz), 1.01 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>31</sub>H<sub>40</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 542.3238, found 542.3246.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-Cycloheptyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>56</b>)</h4><div class="NLM_p last">Yield: 53 mg (84%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.56 (s, 1H), 8.34 (s, 1H), 8.02 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.8 Hz), 7.90 (s, 1H), 7.75 (s, 1H), 6.97 (d, 1H, <i>J</i> = 8.8 Hz), 6.14 (s, 1H), 4.91–4.89 (m, 1H), 4.59 (s, 2H), 3.79 (br s, 4H), 3.28–3.24 (m, 1H), 3.13 (br s, 4H), 2.73 (t, 2H, <i>J</i> = 7.8 Hz), 2.25 (s, 3H), 2.20–2.15 (m, 2H), 2.08–2.06 (m, 2H), 1.89–1.87 (m, 2H), 1.77–1.61 (m, 8H), 1.30 (d, 6H, <i>J</i> = 6.6 Hz), 1.01 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>37</sub>H<sub>50</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 624.4021, found 624.4027.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(Cyclobutylmethyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>57</b>)</h4><div class="NLM_p last">Yield: 60 mg (86%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.52 (s, 1H), 8.32 (s, 1H), 7.99 (d, 1H, <i>J</i> = 8.2 Hz), 7.91 (s, 1H), 7.76 (s, 1H), 6.94 (d, 1H, <i>J</i> = 8.7 Hz), 6.14 (s, 1H), 4.59 (s, 2H), 4.50 (d, 2H, <i>J</i> = 3.3 Hz), 3.64 (br s, 4H), 2.96–2.88 (m, 1H), 2.83–2.80 (m, 1H), 2.76–2.72 (m, 6H), 2.25 (s, 3H), 2.00–1.88 (m, 6H), 1.66–1.62 (m, 2H), 1.16 (d, 6H, <i>J</i> = 6.1 Hz), 1.01 (t, 3H, <i>J</i> = 7.1 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>35</sub>H<sub>46</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 596.3708, found 596.3716.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(Cyclopentylmethyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>58</b>)</h4><div class="NLM_p last">Yield: 54 mg (85%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.54 (d, 1H, <i>J</i> = 2.2 Hz), 8.34 (s, 1H), 8.00 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 8.8 Hz), 7.89 (s, 1H), 7.76 (s, 1H), 6.98 (d, 1H, <i>J</i> = 8.8 Hz), 6.13 (s, 1H), 4.59 (s, 2H), 4.40 (d, 2H, <i>J</i> = 7.4 Hz), 3.83 (br s, 4H), 3.40–3.36 (m, 1H), 3.22 (t, 4H, <i>J</i> = 4.5 Hz), 2.72 (t, 2H, <i>J</i> = 7.8 Hz), 2.56–2.51 (m, 1H), 2.25 (s, 3H), 1.70–1.50 (m, 8H), 1.34 (d, 8H, <i>J</i> = 6.6 Hz), 1.00 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>36</sub>H<sub>48</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 610.3864, found 610.3870.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(Cyclohexylmethyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>59</b>)</h4><div class="NLM_p last">Yield: 97 mg (76%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.48 (d, 1H, <i>J</i> = 1.3 Hz), 8.34 (s, 1H), 7.92 (d, 1H, <i>J</i> = 6.9 Hz), 7.83 (s, 1H), 7.75 (s, 1H), 6.85 (d, 1H, <i>J</i> = 8.8 Hz), 6.10 (s, 1H), 4.58 (s, 2H), 4.28 (d, 2H, <i>J</i> = 7.0 Hz), 3.59 (br s, 4H), 2.81–2.72 (m, 1H), 2.72–2.68 (m, 6H), 2.23 (s, 3H), 1.99–1.95 (m, 1H), 1.68–1.51 (m, 8H) 1.19–1.15 (m, 2H), 1.13 (d, 6H, <i>J</i> = 6.4 Hz), 1.08–1.03 (m, 2H), 1.00 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>37</sub>H<sub>50</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 624.4021, found 624.4028.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-Benzyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>60</b>)</h4><div class="NLM_p last">Yield: 68 mg (77%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.42 (s, 1H), 8.39 (s, 1H), 7.88 (d, 1H, <i>J</i> = 7.2 Hz), 7.81 (s, 1H), 7.76 (s, 1H), 7.29–7.20 (m, 5H), 6.86 (d, 1H, <i>J</i> = 8.8 Hz), 6.13 (s, 1H), 5.70 (s, 2H), 4.58 (s, 2H), 3.58 (br s, 4H), 2.75–2.66 (m, 7H), 2.24 (s, 3H), 1.66–1.60 (m, 2H), 1.13 (d, 6H, <i>J</i> = 6.4 Hz), 1.01 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>37</sub>H<sub>44</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 618.3551, found 618.3550.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-Ethylhexyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>61</b>)</h4><div class="NLM_p last">Yield: 53 mg (85%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (d, 1H, <i>J</i> = 1.9 Hz), 8.35 (s, 1H), 8.01 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.8 Hz), 7.86 (s, 1H), 7.77 (s, 1H), 6.99 (d, 1H, <i>J</i> = 8.8 Hz), 6.14 (s, 1H), 4.59 (s, 2H), 4.38 (d, 2H, <i>J</i> = 6.9 Hz), 3.81 (br s, 4H), 3.30–3.28 (m, 1H), 3.16 (br s, 4H), 2.73 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 2.06–2.03 (m, 1H), 1.70–1.61 (m, 2H), 1.32–1.20 (m, 14H), 1.01 (t, 3H, <i>J</i> = 7.3 Hz), 0.91 (t, 3H, <i>J</i> = 7.4 Hz), 0.83 (t, 3H, <i>J</i> = 6.9 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>38</sub>H<sub>54</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 640.4334, found 640.4336.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(2-Cyclohexylethyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>62</b>)</h4><div class="NLM_p last">Yield: 53 mg (85%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.53 (d, 1H, <i>J</i> = 2.3 Hz), 8.34 (s, 1H), 7.98 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 8.8 Hz), 7.85 (s, 1H), 7.76 (s, 1H), 6.95 (d, 1H, <i>J</i> = 8.8 Hz), 6.13 (s, 1H), 4.58 (s, 2H), 4.49 (t, 2H, <i>J</i> = 7.1 Hz), 3.79 (s, 4H), 3.30–3.26 (m, 1H), 3.14 (t, 4H, <i>J</i> = 4.7 Hz), 2.72 (t, 2H, <i>J</i> = 7.8 Hz), 2.25 (s, 3H), 1.79–1.74 (m, 4H), 1.68–1.60 (m, 5H), 1.30 (d, 6H, <i>J</i> = 6.6 Hz), 1.20–1.12 (m, 4H), 1.00 (t, 3H, <i>J</i> = 7.3 Hz), 1.00–0.93 (m, 2H). HRMS (<i>m</i>/<i>z</i>) for C<sub>38</sub>H<sub>52</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 638.4177, found 638.4177.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(6-Hydroxyhexyl)-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>63</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.48 (d, 1H, <i>J</i> = 2.0 Hz), 8.32 (s, 1H), 7.94 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.9 Hz), 7.84 (s, 1H), 7.74 (s, 1H), 6.88 (d, 1H, <i>J</i> = 8.9 Hz), 6.10 (s, 1H), 4.57 (s, 2H), 4.46 (t, 2H, <i>J</i> = 6.8 Hz), 3.59 (t, 4H, <i>J</i> = 4.8 Hz), 3.46 (t, 2H, <i>J</i> = 6.4 Hz), 2.80–2.71 (m, 7H), 2.23 (s, 3H), 1.94–1.87 (m, 2H), 1.66–1.51 (m, 2H), 1.49–1.42 (m, 2H), 1.39–1.25 (m, 4H), 1.12 (d, 6H, <i>J</i> = 6.5 Hz), 0.99 (t, 3H, <i>J</i> = 7.3 Hz). MS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup>: 628.2.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-phenyl-1<i>H</i>-indazole-4-carboxamide (<b>66</b>)</h4><div class="NLM_p last">Yield: 37 mg (75%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.42 (s, 1H), 7.83 (s, 1H), 7.75 (s, 1H), 7.68 (s, 1H), 7.64 (d, 2H, <i>J</i> = 8.0 Hz), 7.43 (t, 2H, <i>J</i> = 6.0 Hz), 7.36 (t, 1H, <i>J</i> = 6.0 Hz), 6.07 (s, 1H), 4.94–4.87 (m, 1H), 4.68 (d, 2H, <i>J</i> = 4.0 Hz), 2.78 (t, 2H, <i>J</i> = 8.0 Hz), 2.20 (s, 3H), 1.68–1.61 (m, 2H), 1.60 (d, 6H, <i>J</i> = 6.0 Hz), 1.03 (t, 3H, <i>J</i> = 6.0 Hz). MS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup>: 443.2.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-4-carboxamide (<b>68</b>)</h4><div class="NLM_p last">Yield: 10 mg (18%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.42 (s, 1H), 7.74 (m, 7H), 6.14 (s, 1H), 4.94–4.90 (m, 1H), 4.69 (d, 2H, <i>J</i> = 4.0 Hz), 2.81 (t, 2H, <i>J</i> = 8.0 Hz), 2.26 (s, 3H), 1.69–1.62 (m, 2H), 1.61 (d, 6H, <i>J</i> = 4.0 Hz), 1.03 (t, 3H, <i>J</i> = 6.0 Hz). MS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup>: 511.2.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(pyridin-2-yl)-1<i>H</i>-indazole-4-carboxamide (<b>69</b>)</h4><div class="NLM_p last">Yield: 20 mg (63%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.94 (d, 1H, <i>J</i> = 4.9 Hz), 8.46 (s, 1H), 8.31 (s, 1H), 8.12 (t, 1H, <i>J</i> = 7.3 Hz), 8.02 (d, 1H, <i>J</i> = 8.0 Hz), 7.97 (s, 1H), 7.59–7.56 (m, 2H), 6.48 (s, 1H), 5.04–4.97 (m, 1H), 4.70 (d, 2H, <i>J</i> = 5.5 Hz), 2.92 (t, 2H, <i>J</i> = 8.0 Hz), 2.44 (s, 3H), 1.73–1.64 (m, 2H), 1.62 (d, 6H, <i>J</i> = 6.7 Hz), 1.05 (t, 3H, <i>J</i> = 7.3 Hz). MS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup>: 444.3.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-indazole-4-carboxamide (<b>71</b>)</h4><div class="NLM_p last">Yield: 38 mg (67%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 13.02 (s, 1H), 8.92 (s, 1H), 8.46 (s, 1H), 8.36 (s, 1H), 8.17 (s, 1H), 7.99 (m, 3H), 6.03 (s, 1H), 5.03–4.96 (m, 1H), 4.69 (d, 2H, <i>J</i> = 4.0 Hz), 2.75 (t, 2H, <i>J</i> = 8.0 Hz), 2.22 (s, 3H), 1.64–1.60 (m, 2H), 1.61 (d, 6H, <i>J</i> = 8.0 Hz), 1.02 (t, 3H, <i>J</i> = 6.0 Hz). MS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup>: 512.3.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(piperidin-4-yl)-1<i>H</i>-indazole-4-carboxamide (<b>72</b>)</h4><div class="NLM_p last">To a solution of 1-isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)-1<i>H</i>-indazole-4-carboxamide in methanol (30 mL) was added Raney Ni (20 mg) under nitrogen atmosphere. The contents were purged and kept under H<sub>2</sub> overnight. The reaction was monitored by LC/MS. After completion, the mixture was concentrated in vacuo and then purifed by HPLC to yield the title compound (3 mg, 12%) as solid. <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.29 (s, 1H), 7.63 (s, 1H), 7.46 (s, 1H), 6.16 (s, 1H), 5.02–4.97 (m, 1H), 4.58 (s, 2H), 3.54 (d, 2H, <i>J</i> = 12.7 Hz), 3.18 (dt, 2H, <i>J</i> = 2.3 Hz, <i>J</i> = 12.8 Hz), 3.14–3.09 (m, 1H), 2.75 (t, 2H, <i>J</i> = 7.8 Hz), 2.26 (s, 3H), 2.17 (d, 2H, <i>J</i> = 14.2 Hz), 2.04–1.96 (m, 2H), 1.67–1.61 (m, 2H), 1.55 (d, 6H, <i>J</i> = 6.6 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 450.2864, found 450.2868.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(piperazin-1-yl)-1<i>H</i>-indazole-4-carboxamide (<b>73</b>)</h4><div class="NLM_p last">Yield: 12.8 mg (15%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.21 (s, 1H), 7.36 (d, 1H, <i>J</i> = 1.6 Hz), 7.17 (s, 1H), 6.18 (s, 1H), 4.97–4.90 (m, 1H), 4.56 (s, 2H), 3.53 (t, 4H, <i>J</i> = 5.1 Hz), 3.41 (t, 4H, <i>J</i> = 4.8 Hz), 2.73 (t, 2H, <i>J</i> = 6.0 Hz), 2.27 (s, 3H), 1.66–1.60 (m, 2H), 1.52 (d, 6H, <i>J</i> = 6.6 Hz), 1.01 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>35</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 451.2816, found 451.2826.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-(1,4-Diazepan-1-yl)-1-isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>74</b>)</h4><div class="NLM_p last">Yield: 17.7 mg (20%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.14 (s, 1H), 7.19 (d, 1H, <i>J</i> = 1.7 Hz), 6.90 (s, 1H), 6.22 (s, 1H), 4.95–4.89 (m, 1H), 4.57 (s, 2H), 3.91 (t, 2H, <i>J</i> = 5.4 Hz), 3.71 (t, 2H, <i>J</i> = 6.1 Hz), 3.46 (t, 2H, <i>J</i> = 5.1 Hz), 3.31–3.29 (m, 2H), 2.75 (t, 2H, <i>J</i> = 7.8 Hz), 2.28 (s, 3H), 2.27–2.23 (m, 2H), 1.67–1.60 (m, 2H), 1.50 (d, 6H, <i>J</i> = 6.6 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 465.2973, found 465.2974.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-Isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(piperidin-4-ylamino)-1<i>H</i>-indazole-4-carboxamide (<b>75</b>)</h4><div class="NLM_p last">Yield: 3.7 mg (4.5%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.07 (s, 1H), 6.98 (s, 1H), 6.75 (s, 1H), 6.20 (s, 1H), 4.92–4.84 (m, 1H), 4.56 (s, 2H), 3.78–3.74 (m, 1H), 3.48–3.44 (m, 2H), 3.23–3.17 (m, 2H), 2.74 (t, 2H, <i>J</i> = 7.8 Hz), 2.30–2.25 (m, 5H), 1.76–1.55 (m, 4H), 1.50 (d, 6H, <i>J</i> = 6.6 Hz), 1.02 (t, 3H, <i>J</i> = 7.3 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 465.2973, found 465.2978.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Bromo-1-isopropyl-<i>N</i>-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1<i>H</i>-indazole-4-carboxamide (<b>76</b>)</h4><div class="NLM_p last">Yield: 380 mg (96%). <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.34 (s, 1H), 8.03 (s, 1H), 7.63 (d, 1H, <i>J</i> = 1.4 Hz), 6.14 (s, 1H), 4.98–4.94 (m, 1H), 4.55 (s, 2H), 2.72 (t, 2H, <i>J</i> = 7.4 Hz), 2.26 (s, 3H), 1.66–1.60 (m, 2H), 1.53 (d, 6H, <i>J</i> = 6.6 Hz), 1.01 (t, 3H, <i>J</i> = 7.4 Hz). HRMS (<i>m</i>/<i>z</i>) for C<sub>21</sub>H<sub>26</sub>BrN<sub>4</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>: calculated 445.1234 and 447.1213 found 445.1237 and 447.1219. .</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Biochemical Assays</h3><div class="NLM_p last">Methyltransferase activity assays for EZH2 trimeric complex (EZH2:EED:SUZ12) and EZH1 pentameric complex (EZH1:EED:SUZ12:RBBP4:AEBP2) were performed by monitoring the incorporation of tritium-labeled methyl group to lysine 27 of H3 (21–44) peptide using the Scintillation Proximity Assay (SPA). The enzymatic reactions were performed at 23 °C with 1 h incubation of 10 μL of reaction mixture in 20 mM Tris-HCl, pH 8, 5 mM DTT, and 0.01% Triton X-100 containing 2 and 4 μM of <sup>3</sup>H-SAM (catalogue no. NET155 V250UC; PerkinElmer; <a href="http://www.perkinelmer.com" class="extLink">www.perkinelmer.com</a>) for reactions including EZH2 and EZH1 complexes, respectively, and 1 μM of biotinylated H3 (21–44). In all assays, 20 nM EZH2 complex or 10 nM EZH1complex was used. Compounds were titrated from 0.3 nM to 5 μM. To stop the reactions, 10 μL of 7.5 M guanidine hydrochloride was added, followed by 50 μL of buffer (20 mM Tris, pH 8.0), mixed, and transferred to a 384-well streptavidin coated flash plate (catalogue no. SMP410A001PK, PerkinElmer, <a href="http://www.perkinelmer.ca" class="extLink">http://www.perkinelmer.ca</a>). After mixing, the mixtures in flash-plate were incubated for 2 h and the CPM counts were measured using Topcount plate reader (PerkinElmer, <a href="http://www.perkinelmer.com" class="extLink">www.perkinelmer.com</a>). The CPM counts in the absence of compound for each data set were defined as 100% activity. In the absence of the enzyme, the CPM counts in each data set were defined as background (0%). All enzymatic reactions were performed in triplicate and IC<sub>50</sub> values were determined by fitting the data to the Four Parameter Logistic equation using GraphPad Prism 7 software.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Structure of PRC2–EZH2 Complex</h3><div class="NLM_p last">The complex structure of the human PRC2–EZH2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>) was used for molecular docking. The coordinates of the I-SET helix (I646 to N668) of this structure were modified according to the I-SET helix of the complex PRC2–<i>Ac</i>EZH2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7">5IJ7</a>, cocrystallized with a pyridone inhibitor) in order to take into account the induced fit effect by the inhibitor on the positioning of this helix. Both crystal structures were prepared using the structure preparation tool available in Schrödinger 2015-3 (Schrödinger Release 2015-3: Maestro, version 10.3, Schrödinger, LLC, New York, NY, 201.) with hydrogen optimization and default settings following their download from the PDB.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Molecular Docking</h3><div class="NLM_p last">Prior to docking, all compounds were ionized using the <i>fixpka</i> program of OpenEye QUACPAC 1.5.0 (OpenEye Scientific Software, Santa Fe, NM, <a href="http://www.eyesopen.com" class="extLink">http://www.eyesopen.com</a>.). Their three-dimensional structures were generated using LigPrep (Schrödinger Release 2015-3: LigPrep, version 3.5, Schrödinger, LLC, New York, NY, 201.) with OPLS_2005 force field. The softwares PLANTS<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and Glide<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> were used to dock the inhibitors to the modified structure of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a> (modified I-SET helix). The PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7">5IJ7</a> was superimposed with the modified <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a> structure, and the centroid of “<i>Inhibitor 1</i>” (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7">5IJ7</a>) was defined as a center of the binding site for PLANTS docking. The binding site radius was set to 12 Å, and hydrogen bond constraints were set on backbone oxygen and nitrogen atoms of W624 and the nitrogen atom of backbone Y111 in order to place the pyridonemethyl-amide in the proper region. Similarly, the centroid of “<i>Inhibitor 1</i>” was defined as a center of the Glide receptor grid. The pyridonemethyl-amide scaffold was constrained with a tolerance of 0.6 Å, and the Glide standard precision (SP) mode with its default parameters was set. A maximum number of 10 different poses per docking software was used for each ligand. A Tanimoto coefficient was applied to compute the similarity of the interaction fingerprints<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> generated for each pose with the reference “<i>Inhibitor 1</i>”. For each ligand, we kept the pose that exhibits the most similar interactions (highest Tanimoto coefficient) as “<i>Inhibitor 1</i>”. Each kept complex was refined using Prime by selecting OPLS_3 as force field, VSGB as solvation mode, and atoms within 5 Å of any heavy ligand atoms were optimized using the local optimization protocol.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00855">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00855" class="ext-link">10.1021/acs.jmedchem.6b00855</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic methods and conditions for the synthesis of intermediates and spectral data for these intermediates (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00855/suppl_file/jm6b00855_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00855/suppl_file/jm6b00855_si_001.pdf">jm6b00855_si_001.pdf (4.02 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00855" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masoud Vedadi</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, University
of Toronto, Toronto, Ontario M5S 1A8, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7914570f1c1d181d10390c0d160b16170d16571a18"><span class="__cf_email__" data-cfemail="335e1d45565752575a7346475c415c5d475c1d5052">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jin</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abc1c2cac585c1c2c5ebc6d8d8c685cecfde"><span class="__cf_email__" data-cfemail="076d6e6669296d6e69476a74746a29626372">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaobao Yang</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fengling Li</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyle D. Konze</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jamel Meslamani</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anqi Ma</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Brown</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Ming Zhou</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheryl H. Arrowsmith</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Princess
Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2M9, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. Ümit Kaniskan</span> - <span class="hlFld-Affiliation affiliation">Departments
of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Room 16-20B, Box 1677, New York, New York 10029, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4994-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The research described here was supported by the grant R01GM103893 (to J.J.) from the U.S. National Institutes of Health. The Structural Genomics Consortium (SGC) is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. X.Y. and A.M. were supported by a postdoctoral fellowship from the SGC. K.D.K. was supported by a predoctoral fellowship from the Medicinal Chemistry Division of the American Chemical Society. This work was supported in part through the computational resources provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. We thank OpenEye Scientific Software for providing us with a free academic license.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i69" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i69"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i70" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i70"> Abbreviations Used</h2><tr><td class="NLM_term">EZH2</td><td class="NLM_def"><p class="first last">enhancer of zeste 2 polycomb repressive complex 2 subunit</p></td></tr><tr><td class="NLM_term">KMT6</td><td class="NLM_def"><p class="first last">lysine methyltransferase 6</p></td></tr><tr><td class="NLM_term">EZH1</td><td class="NLM_def"><p class="first last">enhancer of zeste homologue 1</p></td></tr><tr><td class="NLM_term">PRC2</td><td class="NLM_def"><p class="first last">polycomb repressive complex 2</p></td></tr><tr><td class="NLM_term">EED</td><td class="NLM_def"><p class="first last">embryonic ectoderm development</p></td></tr><tr><td class="NLM_term">SUZ12</td><td class="NLM_def"><p class="first last">suppressor of zeste 12</p></td></tr><tr><td class="NLM_term">RbAp46</td><td class="NLM_def"><p class="first last">retinoblastoma binding protein 7</p></td></tr><tr><td class="NLM_term">RbAp48</td><td class="NLM_def"><p class="first last">retinoblastoma binding protein 4</p></td></tr><tr><td class="NLM_term">AEBP2</td><td class="NLM_def"><p class="first last">adipocyte enhancer-binding protein 2</p></td></tr><tr><td class="NLM_term">H3K27</td><td class="NLM_def"><p class="first last">histone 3, lysine 27</p></td></tr><tr><td class="NLM_term">PRC2–EZH1</td><td class="NLM_def"><p class="first last">EZH1 containing PRC2 complex</p></td></tr><tr><td class="NLM_term">PRC2–EZH2</td><td class="NLM_def"><p class="first last">EZH2 containing PRC2 complex</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last"><i>S</i>-5′-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine</p></td></tr><tr><td class="NLM_term">H3K27me3</td><td class="NLM_def"><p class="first last">trimethylation of H3K27</p></td></tr><tr><td class="NLM_term">SET</td><td class="NLM_def"><p class="first last">Su(var.)3–9 (the suppressor of position-effect variegation 3–9), en(zeste) (an enhancer of the eye color mutant zeste), and trithorax (the homeotic gene regulator)</p></td></tr><tr><td class="NLM_term">GCB</td><td class="NLM_def"><p class="first last">germinal center B-cell</p></td></tr><tr><td class="NLM_term">DLBCLs</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphomas</p></td></tr><tr><td class="NLM_term">MLL</td><td class="NLM_def"><p class="first last">mixed lineage leukemia</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">SAH</td><td class="NLM_def"><p class="first last"><i>S</i>-5′-adenosyl-<span class="smallcaps smallerCapital">l</span>-homocysteine</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-minimal (50%) inhibitory concentration</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">Ph</td><td class="NLM_def"><p class="first last">phenyl</p></td></tr><tr><td class="NLM_term"><i>t</i>-Bu</td><td class="NLM_def"><p class="first last">tertiary butyl</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-bis(diphenylphosphino)-1,1′-binaphthyl</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Role of histone H3 lysine 27 methylation in Polycomb-group silencing</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span><span class="refDoi"> DOI: 10.1126/science.1076997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1126%2Fscience.1076997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12351676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot12rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1039-1043&author=R.+Caoauthor=L.+Wangauthor=H.+Wangauthor=L.+Xiaauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=R.+S.+Jonesauthor=Y.+Zhang&title=Role+of+histone+H3+lysine+27+methylation+in+Polycomb-group+silencing&doi=10.1126%2Fscience.1076997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing</span></div><div class="casAuthors">Cao, Ru; Wang, Liangjun; Wang, Hengbin; Xia, Li; Erdjument-Bromage, Hediye; Tempst, Paul; Jones, Richard S.; Zhang, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5595</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins play important roles in maintaining the silent state of HOX genes.  Recent studies have implicated histone methylation in long-term gene silencing.  However, a connection between PcG-mediated gene silencing and histone methylation has not been established.  Here the authors report the purifn. and characterization of an EED-EZH2 complex, the human counterpart of the Drosophila ESC-E(Z) complex.  They demonstrate that the complex specifically methylates nucleosomal histone H3 at lysine 27 (H3-K27).  Using chromatin immunopptn. assays, the authors show that H3-K27 methylation colocalizes with, and is dependent on, E(Z) binding at an Ultrabithorax med° (Ubx) Polycomb response element (PRE), and that this methylation correlates with Ubx repression.  Methylation on H3-K27 facilitates binding of Polycomb (PC), a component of the PRC1 complex, to histone H3 amino-terminal tail.  Thus, these studies establish a link between histone methylation and PcG-mediated gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnqusXKZEbLVg90H21EOLACvtfcHk0ljTHtqpaImfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot12rs7g%253D&md5=8f24c05ec935c9110b2ff85b65911396</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076997%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DRole%2520of%2520histone%2520H3%2520lysine%252027%2520methylation%2520in%2520Polycomb-group%2520silencing%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1039%26epage%3D1043%26doi%3D10.1126%2Fscience.1076997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kuzmichev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span><span class="refDoi"> DOI: 10.1101/gad.1035902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1101%2Fgad.1035902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12435631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVejsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2893-2905&author=A.+Kuzmichevauthor=K.+Nishiokaauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+Reinberg&title=Histone+methyltransferase+activity+associated+with+a+human+multiprotein+complex+containing+the+Enhancer+of+Zeste+protein&doi=10.1101%2Fgad.1035902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein</span></div><div class="casAuthors">Kuzmichev, Andrei; Nishioka, Kenichi; Erdjument-Bromage, Hediye; Tempst, Paul; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2893-2905</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Enhancer of Zeste [E(z)] is a Polycomb-group transcriptional repressor and one of the founding members of the family of SET domain-contg. proteins.  Several SET-domain proteins possess intrinsic histone methyltransferase (HMT) activity.  However, recombinant E(z) protein was found to be inactive in a HMT assay.  Here we report the isolation of a multiprotein E(z) complex that contains extra sex combs, suppressor of zeste-12 [Su(z)12], and the histone binding proteins RbAp46/RbAp48.  This complex, which we termed Polycomb repressive complex (PRC) 2, possesses HMT activity with specificity for Lys 9 (K9) and Lys 27 (K27) of histone H3.  The HMT activity of PRC2 is dependent on an intact SET domain in the E(z) protein.  We hypothesize that transcriptional repression by the E(z) protein involves methylation-dependent recruitment of PRC1.  The presence of Su(z)12, a strong suppressor of position effect variegation, in PRC2 suggests that PRC2 may play a widespread role in heterochromatin-mediated silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxD09IiaeCvLVg90H21EOLACvtfcHk0ljTHtqpaImfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVejsLY%253D&md5=b61767bc9b30b403f5fc7bb202281da1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.1035902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1035902%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmichev%26aufirst%3DA.%26aulast%3DNishioka%26aufirst%3DK.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DHistone%2520methyltransferase%2520activity%2520associated%2520with%2520a%2520human%2520multiprotein%2520complex%2520containing%2520the%2520Enhancer%2520of%2520Zeste%2520protein%26jtitle%3DGenes%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D2893%26epage%3D2905%26doi%3D10.1101%2Fgad.1035902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">The Polycomb complex PRC2 and its mark in life</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1038/nature09784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature09784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=21248841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=343-349&author=R.+Margueronauthor=D.+Reinberg&title=The+Polycomb+complex+PRC2+and+its+mark+in+life&doi=10.1038%2Fnature09784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Polycomb complex PRC2 and its mark in life</span></div><div class="casAuthors">Margueron, Raphael; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7330</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure.  In mammals, 2 main Polycomb group complexes exist: Polycomb repressive complex 1 (PRC1) and 2 (PRC2).  PRC1 compacts chromatin and catalyzes the monoubiquitination of histone H2A.  PRC2 also contributes to chromatin compaction, and catalyzes the methylation of histone H3 at Lys-27.  PRC2 is involved in various biol. processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity.  Recent studies of PRC2 have expanded the perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fYmuBqnMA7Vg90H21EOLACvtfcHk0lilkDKuHbyR0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D&md5=5f15e91cc6ff765f649842041f333841</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09784%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DThe%2520Polycomb%2520complex%2520PRC2%2520and%2520its%2520mark%2520in%2520life%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D343%26epage%3D349%26doi%3D10.1038%2Fnature09784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Di Croce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Transcriptional regulation by polycomb group proteins</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1038/nsmb.2669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnsmb.2669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24096405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOiurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1147-1155&author=L.+Di+Croceauthor=K.+Helin&title=Transcriptional+regulation+by+polycomb+group+proteins&doi=10.1038%2Fnsmb.2669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional regulation by Polycomb group proteins</span></div><div class="casAuthors">Di Croce, Luciano; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1147-1155</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group (PcG) proteins are epigenetic regulators of transcription that have key roles in stem-cell identity, differentiation and disease.  Mechanistically, they function within multiprotein complexes, called Polycomb repressive complexes (PRCs), which modify histones (and other proteins) and silence target genes.  The dynamics of PRC1 and PRC2 components has been the focus of recent research.  Here we discuss our current knowledge of the PRC complexes, how they are targeted to chromatin and how the high diversity of the PcG proteins allows these complexes to influence cell identity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNyrbNU897Vg90H21EOLACvtfcHk0lilkDKuHbyR0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOiurrP&md5=004c2682edbda681e9f6de84ba87e639</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2669%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCroce%26aufirst%3DL.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DTranscriptional%2520regulation%2520by%2520polycomb%2520group%2520proteins%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1147%26epage%3D1155%26doi%3D10.1038%2Fnsmb.2669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Vizan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Croce, L.</span><span> </span><span class="NLM_article-title">Role of PRC2-associated factors in stem cells and disease</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span><span class="refDoi"> DOI: 10.1111/febs.13083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1111%2Ffebs.13083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=1723-1735&author=P.+Vizanauthor=M.+Beringerauthor=C.+Ballareauthor=L.+Di+Croce&title=Role+of+PRC2-associated+factors+in+stem+cells+and+disease&doi=10.1111%2Ffebs.13083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13083%26sid%3Dliteratum%253Aachs%26aulast%3DVizan%26aufirst%3DP.%26aulast%3DBeringer%26aufirst%3DM.%26aulast%3DBallare%26aufirst%3DC.%26aulast%3DDi%2BCroce%26aufirst%3DL.%26atitle%3DRole%2520of%2520PRC2-associated%2520factors%2520in%2520stem%2520cells%2520and%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D1723%26epage%3D1735%26doi%3D10.1111%2Ffebs.13083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.molcel.2004.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.molcel.2004.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=15225548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFejurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=57-67&author=R.+Caoauthor=Y.+Zhang&title=SUZ12+is+required+for+both+the+histone+methyltransferase+activity+and+the+silencing+function+of+the+EED-EZH2+complex&doi=10.1016%2Fj.molcel.2004.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex</span></div><div class="casAuthors">Cao, Ru; Zhang, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies have revealed the intrinsic histone methyltransferase (HMTase) activity of the EED-EZH2 complex and its role in Hox gene silencing, X inactivation, and cancer metastasis.  In this study, we focus on the function of individual components.  We found that the HMTase activity requires a min. of three components - EZH2, EED, and SUZ12 - while AEBP2 is required for optimal enzymic activity.  Using a stable SUZ12 knockdown cell line, we show SUZ12 knockdown results in cell growth defects, which correlate with genome-wide alteration on H3-K27 methylation as well as upregulation of a no. of Hox genes.  Chromatin immunopptn. (ChIP) assay identified a 500 bp region located 4 kb upstream of the HoxA9 transcription initiation site as a SUZ12 binding site, which responds to SUZ12 knockdown and might play an important role in regulating HoxA9 expression.  Thus, our study establishes a crit. role of SUZ12 in H3-lysine 27 methylation and Hox gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWQGRfTk9TrVg90H21EOLACvtfcHk0ljpSF-QjpZWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFejurc%253D&md5=4b26382db05fda3e55b5f05dc2e1da9a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSUZ12%2520is%2520required%2520for%2520both%2520the%2520histone%2520methyltransferase%2520activity%2520and%2520the%2520silencing%2520function%2520of%2520the%2520EED-EZH2%2520complex%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fj.molcel.2004.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Montgomery, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalantry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, T.</span><span> </span><span class="NLM_article-title">The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1016/j.cub.2005.04.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.cub.2005.04.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=15916951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=942-947&author=N.+D.+Montgomeryauthor=D.+Yeeauthor=A.+Chenauthor=S.+Kalantryauthor=S.+J.+Chamberlainauthor=A.+P.+Otteauthor=T.+Magnuson&title=The+murine+polycomb+group+protein+Eed+is+required+for+global+histone+H3+lysine-27+methylation&doi=10.1016%2Fj.cub.2005.04.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation</span></div><div class="casAuthors">Montgomery, Nathan D.; Yee, Della; Chen, Andrew; Kalantry, Sundeep; Chamberlain, Stormy J.; Otte, Arie P.; Magnuson, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">942-947</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PcG proteins mediate heritable transcriptional silencing by generating and recognizing covalent histone modifications.  One conserved PcG complex, PRC2, is composed of several proteins including the histone methyltransferase (HMTase) Ezh2, the WD-repeat protein Eed, and the Zn-finger protein Suz12.  Ezh2 methylates histone H3 on lysine 27 (H3K27) [1-4], which serves as an epigenetic mark mediating silencing.  H3K27 can be mono-, di-, or trimethylated (1mH3K27, 2mH3K27, and 3mH3K27, resp.) [5].  Hence, either PRC2 must be regulated so as to add one Me group to certain nucleosomes but two or three to others, or distinct complexes must be responsible for 1m-, 2m-, and 3mH3K27.  Consistent with the latter possibility, 2mH3K27 and 3mH3K27, but not 1mH3K27, are absent in Suz12-/- embryos, which lack both Suz12 and Ezh2 protein [6].  Mammalian proteins required for 1mH3K27 have not been identified.  Here, authors demonstrate that unlike Suz12 and Ezh2, Eed is required not only for 2m- and 3mH3K27 but also global 1mH3K27.  These results provide a functionally important distinction between PRC2 complex components and implicate Eed in PRC2-independent histone methylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5aUVC-VrdLVg90H21EOLACvtfcHk0ljpSF-QjpZWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gjt7k%253D&md5=2d378f554b3593f129cf512a04a69b75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.04.051%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DN.%2BD.%26aulast%3DYee%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKalantry%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DS.%2BJ.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DMagnuson%26aufirst%3DT.%26atitle%3DThe%2520murine%2520polycomb%2520group%2520protein%2520Eed%2520is%2520required%2520for%2520global%2520histone%2520H3%2520lysine-27%2520methylation%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D942%26epage%3D947%26doi%3D10.1016%2Fj.cub.2005.04.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drury, W. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Role of the polycomb protein EED in the propagation of repressive histone marks</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">762</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span><span class="refDoi"> DOI: 10.1038/nature08398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature08398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=19767730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=762-767&author=R.+Margueronauthor=N.+Justinauthor=K.+Ohnoauthor=M.+L.+Sharpeauthor=J.+Sonauthor=W.+J.+Druryauthor=P.+Voigtauthor=S.+R.+Martinauthor=W.+R.+Taylorauthor=V.+De+Marcoauthor=V.+Pirrottaauthor=D.+Reinbergauthor=S.+J.+Gamblin&title=Role+of+the+polycomb+protein+EED+in+the+propagation+of+repressive+histone+marks&doi=10.1038%2Fnature08398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the polycomb protein EED in the propagation of repressive histone marks</span></div><div class="casAuthors">Margueron, Raphael; Justin, Neil; Ohno, Katsuhito; Sharpe, Miriam L.; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Pirrotta, Vincenzo; Reinberg, Danny; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7265</span>),
    <span class="NLM_cas:pages">762-767</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb group proteins have an essential role in the epigenetic maintenance of repressive chromatin states.  The gene-silencing activity of the Polycomb repressive complex 2 (PRC2) depends on its ability to trimethylate lysine 27 of histone H3 (H3K27) by the catalytic SET domain of the EZH2 subunit, and at least two other subunits of the complex: SUZ12 and EED.  Here we show that the carboxy-terminal domain of EED specifically binds to histone tails carrying trimethyl-lysine residues assocd. with repressive chromatin marks, and that this leads to the allosteric activation of the methyltransferase activity of PRC2.  Mutations in EED that prevent it from recognizing repressive trimethyl-lysine marks abolish the activation of PRC2 in vitro and, in Drosophila, reduce global methylation and disrupt development.  These findings suggest a model for the propagation of the H3K27me3 mark that accounts for the maintenance of repressive chromatin domains and for the transmission of a histone modification from mother to daughter cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSke4t5N1P3LVg90H21EOLACvtfcHk0ljg4Q7oQfCbgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjt73N&md5=63ee782ee42fb9c711a5d2fdf7d4e022</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08398%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DOhno%26aufirst%3DK.%26aulast%3DSharpe%26aufirst%3DM.%2BL.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DDrury%26aufirst%3DW.%2BJ.%26aulast%3DVoigt%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DPirrotta%26aufirst%3DV.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DRole%2520of%2520the%2520polycomb%2520protein%2520EED%2520in%2520the%2520propagation%2520of%2520repressive%2520histone%2520marks%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D762%26epage%3D767%26doi%3D10.1038%2Fnature08398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">The polycomb group protein Suz12 is required for embryonic stem cell differentiation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3779</span><span class="refDoi"> DOI: 10.1128/MCB.01432-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1128%2FMCB.01432-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=17339329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlant7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3769-3779&author=D.+Pasiniauthor=A.+P.+Brackenauthor=J.+B.+Hansenauthor=M.+Capilloauthor=K.+Helin&title=The+polycomb+group+protein+Suz12+is+required+for+embryonic+stem+cell+differentiation&doi=10.1128%2FMCB.01432-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein Suz12 is required for embryonic stem cell differentiation</span></div><div class="casAuthors">Pasini, Diego; Bracken, Adrian P.; Hansen, Jacob B.; Capillo, Manuela; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3769-3779</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins form multi-protein complexes, called Polycomb repressive complexes (PRCs).  PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through methylation of lysine (K) 27 of histone H3.  Suz12 is essential for PRC2 activity and its inactivation results in early lethality of mouse embryos.  Here, we demonstrate that Suz12-/- mouse embryonic stem (ES) cells can be established and expanded in tissue culture.  The Suz12-/- ES cells are characterized by global loss of H3K27 trimethylation (H3K27me3) and higher expression levels of differentiation-specific genes.  Moreover, Suz12-/- ES cells are impaired in proper differentiation, resulting in a lack of repression of ES cell markers as well as activation of differentiation-specific genes.  Finally, we demonstrate that the PcGs are actively recruited to several genes during ES cell differentiation, which despite an increase in H3K27me3 levels is not always sufficient to prevent transcriptional activation.  In summary, we demonstrate that Suz12 is required for the establishment of specific expression programs required for ES cell differentiation.  Furthermore, we provide evidence that PcGs have different mechanisms to regulate transcription during cellular differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLmYgFw82E7Vg90H21EOLACvtfcHk0ljg4Q7oQfCbgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlant7w%253D&md5=43476df10242b490e5f819551bfb58fe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.01432-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01432-06%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26aulast%3DCapillo%26aufirst%3DM.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DThe%2520polycomb%2520group%2520protein%2520Suz12%2520is%2520required%2520for%2520embryonic%2520stem%2520cell%2520differentiation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D3769%26epage%3D3779%26doi%3D10.1128%2FMCB.01432-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzerini Denchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4061</span><span class="NLM_x">–</span> <span class="NLM_lpage">4071</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fsj.emboj.7600402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4061-4071&author=D.+Pasiniauthor=A.+P.+Brackenauthor=M.+R.+Jensenauthor=E.+Lazzerini+Denchiauthor=K.+Helin&title=Suz12+is+essential+for+mouse+development+and+for+EZH2+histone+methyltransferase+activity&doi=10.1038%2Fsj.emboj.7600402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600402%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DLazzerini%2BDenchi%26aufirst%3DE.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DSuz12%2520is%2520essential%2520for%2520mouse%2520development%2520and%2520for%2520EZH2%2520histone%2520methyltransferase%2520activity%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D4061%26epage%3D4071%26doi%3D10.1038%2Fsj.emboj.7600402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83737</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1371%2Fjournal.pone.0083737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83737&author=H.+Wuauthor=H.+Zengauthor=A.+Dongauthor=F.+Liauthor=H.+Heauthor=G.+Senisterraauthor=A.+Seitovaauthor=S.+Duanauthor=P.+J.+Brownauthor=M.+Vedadiauthor=C.+H.+Arrowsmithauthor=M.+Schapira&title=Structure+of+the+catalytic+domain+of+EZH2+reveals+conformational+plasticity+in+cofactor+and+substrate+binding+sites+and+explains+oncogenic+mutations&doi=10.1371%2Fjournal.pone.0083737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083737%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DSeitova%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520EZH2%2520reveals%2520conformational%2520plasticity%2520in%2520cofactor%2520and%2520substrate%2520binding%2520sites%2520and%2520explains%2520oncogenic%2520mutations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83737%26doi%3D10.1371%2Fjournal.pone.0083737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Antonysamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druzina, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanno, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately Luz, J.</span><span> </span><span class="NLM_article-title">Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84147</span><span class="refDoi"> DOI: 10.1371/journal.pone.0084147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1371%2Fjournal.pone.0084147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24367637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e84147&author=S.+Antonysamyauthor=B.+Condonauthor=Z.+Druzinaauthor=J.+B.+Bonannoauthor=T.+Gheyiauthor=F.+Zhangauthor=I.+MacEwanauthor=A.+Zhangauthor=S.+Ashokauthor=L.+Rodgersauthor=M.+Russellauthor=J.+Gately+Luz&title=Structural+context+of+disease-associated+mutations+and+putative+mechanism+of+autoinhibition+revealed+by+X-ray+crystallographic+analysis+of+the+EZH2-SET+domain&doi=10.1371%2Fjournal.pone.0084147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain</span></div><div class="casAuthors">Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Bonanno, Jeffrey B.; Gheyi, Tarun; Zhang, Feiyu; MacEwan, Iain; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e84147/1-e84147/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The enhancer-of-zeste homolog 2 (EZH2) gene product is an 87 kDa polycomb group (PcG) protein contg. a C-terminal methyltransferase SET domain.  EZH2, along with binding partners, i.e., EED and SUZ12, upon which it is dependent for activity forms the core of the polycomb repressive complex 2 (PRC2).  PRC2 regulates gene silencing by catalyzing the methylation of histone H3 at lysine 27.  Both overexpression and mutation of EZH2 are assocd. with the incidence and aggressiveness of various cancers.  The novel crystal structure of the SET domain was detd. in order to understand disease-assocd. EZH2 mutations and derive an explanation for its inactivity independent of complex formation.  The 2.00 Å crystal structure reveals that, in its uncomplexed form, the EZH2 C-terminus folds back into the active site blocking engagement with substrate.  Furthermore, the S-adenosyl-L-methionine (SAM) binding pocket obsd. in the crystal structure of homologous SET domains is notably absent.  This suggests that a conformational change in the EZH2 SET domain, dependent upon complex formation, must take place for cofactor and substrate binding activities to be recapitulated.  In addn., the data provide a structural context for clin. significant mutations found in the EZH2 SET domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj6NrYMrUF8rVg90H21EOLACvtfcHk0ljtmb8FM8zlNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVeqtrk%253D&md5=a9b259a7e1a5cabd80294be481d7b70b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0084147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0084147%26sid%3Dliteratum%253Aachs%26aulast%3DAntonysamy%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DDruzina%26aufirst%3DZ.%26aulast%3DBonanno%26aufirst%3DJ.%2BB.%26aulast%3DGheyi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DMacEwan%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DAshok%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DGately%2BLuz%26aufirst%3DJ.%26atitle%3DStructural%2520context%2520of%2520disease-associated%2520mutations%2520and%2520putative%2520mechanism%2520of%2520autoinhibition%2520revealed%2520by%2520X-ray%2520crystallographic%2520analysis%2520of%2520the%2520EZH2-SET%2520domain%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De84147%26doi%3D10.1371%2Fjournal.pone.0084147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">aac4383</span><span class="refDoi"> DOI: 10.1126/science.aac4383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1126%2Fscience.aac4383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26472914" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac4383&author=L.+Jiaoauthor=X.+Liu&title=Structural+basis+of+histone+H3K27+trimethylation+by+an+active+polycomb+repressive+complex+2&doi=10.1126%2Fscience.aac4383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac4383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac4383%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520of%2520histone%2520H3K27%2520trimethylation%2520by%2520an%2520active%2520polycomb%2520repressive%2520complex%25202%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac4383%26doi%3D10.1126%2Fscience.aac4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grable, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span> </span><span class="NLM_article-title">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11384</span><span class="refDoi"> DOI: 10.1038/ncomms11384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fncomms11384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=27122193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11384&author=A.+Broounauthor=K.+S.+Gajiwalaauthor=Y.+L.+Dengauthor=W.+Liuauthor=B.+Bolanosauthor=P.+Binghamauthor=Y.+A.+Heauthor=W.+Diehlauthor=N.+Grableauthor=P.+P.+Kungauthor=S.+Suttonauthor=K.+A.+Maegleyauthor=X.+Yuauthor=A.+E.+Stewart&title=Polycomb+repressive+complex+2+structure+with+inhibitor+reveals+a+mechanism+of+activation+and+drug+resistance&doi=10.1038%2Fncomms11384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span></div><div class="casAuthors">Brooun, Alexei; Gajiwala, Ketan S.; Deng, Ya-Li; Liu, Wei; Bolanos, Ben; Bingham, Patrick; He, You-Ai; Diehl, Wade; Grable, Nicole; Kung, Pei-Pei; Sutton, Scott; Maegley, Karen A.; Yu, Xiu; Stewart, Al E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11384</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) mediates gene silencing through chromatin reorganization by methylation of histone H3 lysine 27 (H3K27).  Overexpression of the complex and point mutations in the individual subunits of PRC2 have been shown to contribute to tumorigenesis.  Several inhibitors of the PRC2 activity have shown efficacy in EZH2-mutated lymphomas and are currently in clin. development, although the mol. basis of inhibitor recognition remains unknown.  Here we report the crystal structures of the inhibitor-bound wild-type and Y641N PRC2.  The structures illuminate an important role played by a stretch of 17 residues in the N-terminal region of EZH2, we call the activation loop, in the stimulation of the enzyme activity, inhibitor recognition and the potential development of the mutation-mediated drug resistance.  The work presented here provides new avenues for the design and development of next-generation PRC2 inhibitors through establishment of a structure-based drug design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuWyWQoRoObVg90H21EOLACvtfcHk0ljtmb8FM8zlNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D&md5=15ded613fdc3cafe35bee914678ab65e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms11384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11384%26sid%3Dliteratum%253Aachs%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DGrable%26aufirst%3DN.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26atitle%3DPolycomb%2520repressive%2520complex%25202%2520structure%2520with%2520inhibitor%2520reveals%2520a%2520mechanism%2520of%2520activation%2520and%2520drug%2520resistance%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11384%26doi%3D10.1038%2Fncomms11384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haire, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11316</span><span class="refDoi"> DOI: 10.1038/ncomms11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fncomms11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=27121947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11316&author=N.+Justinauthor=Y.+Zhangauthor=C.+Tarriconeauthor=S.+R.+Martinauthor=S.+Chenauthor=E.+Underwoodauthor=V.+De+Marcoauthor=L.+F.+Haireauthor=P.+A.+Walkerauthor=D.+Reinbergauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Structural+basis+of+oncogenic+histone+H3K27M+inhibition+of+human+polycomb+repressive+complex+2&doi=10.1038%2Fncomms11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span></div><div class="casAuthors">Justin, Neil; Zhang, Ying; Tarricone, Cataldo; Martin, Stephen R.; Chen, Shuyang; Underwood, Elizabeth; De Marco, Valeria; Haire, Lesley F.; Walker, Philip A.; Reinberg, Danny; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11316</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) silences gene expression through trimethylation of K27 of histone H3 (H3K27me3) via its catalytic SET domain.  A missense mutation in the substrate of PRC2, histone H3K27M, is assocd. with certain pediatric brain cancers and is linked to a global decrease of H3K27me3 in the affected cells thought to be mediated by inhibition of PRC2 activity.  We present here the crystal structure of human PRC2 in complex with the inhibitory H3K27M peptide bound to the active site of the SET domain, with the methionine residue located in the pocket that normally accommodates the target lysine residue.  The structure and binding studies suggest a mechanism for the oncogenic inhibition of H3K27M.  The structure also reveals how binding of repressive marks, like H3K27me3, to the EED subunit of the complex leads to enhancement of the catalytic efficiency of the SET domain and thus the propagation of this repressive histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwqJGbneSdbVg90H21EOLACvtfcHk0lggnE2d1eo0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D&md5=516a8ef27712c9776e8ee0681cd91289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11316%26sid%3Dliteratum%253Aachs%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520oncogenic%2520histone%2520H3K27M%2520inhibition%2520of%2520human%2520polycomb%2520repressive%2520complex%25202%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11316%26doi%3D10.1038%2Fncomms11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosperini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5335</span><span class="refDoi"> DOI: 10.1093/emboj/cdg542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1093%2Femboj%2Fcdg542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5323-5335&author=A.+P.+Brackenauthor=D.+Pasiniauthor=M.+Capraauthor=E.+Prosperiniauthor=E.+Colliauthor=K.+Helin&title=EZH2+is+downstream+of+the+pRB-E2F+pathway%2C+essential+for+proliferation+and+amplified+in+cancer&doi=10.1093%2Femboj%2Fcdg542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg542%26sid%3Dliteratum%253Aachs%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DColli%26aufirst%3DE.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DEZH2%2520is%2520downstream%2520of%2520the%2520pRB-E2F%2520pathway%252C%2520essential%2520for%2520proliferation%2520and%2520amplified%2520in%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5323%26epage%3D5335%26doi%3D10.1093%2Femboj%2Fcdg542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. A.</span><span> </span><span class="NLM_article-title">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">647</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.mrfmmm.2008.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.mrfmmm.2008.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=18723033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=647&publication_year=2008&pages=21-29&author=J.+A.+Simonauthor=C.+A.+Lange&title=Roles+of+the+EZH2+histone+methyltransferase+in+cancer+epigenetics&doi=10.1016%2Fj.mrfmmm.2008.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span></div><div class="casAuthors">Simon, Jeffrey A.; Lange, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">647</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  EZH2 is the catalytic subunit of Polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3.  This methylated H3-K27 chromatin mark is commonly assocd. with silencing of differentiation genes in organisms ranging from plants to flies to humans.  Studies on human tumors show that EZH2 is frequently over-expressed in a wide variety of cancerous tissue types, including prostate and breast.  Although the mechanistic contributions of EZH2 to cancer progression are not yet detd., functional links between EZH2-mediated histone methylation and DNA methylation suggest partnership with the gene silencing machinery implicated in tumor suppressor loss.  Here we review the basic mol. biol. of EZH2 and the findings that implicate EZH2 in different cancers.  We also discuss EZH2 connections to other silencing enzymes, such as DNA methyltransferases and histone deacetylases, and we consider progress on deciphering mechanistic consequences of EZH2 overabundance and its potential roles in tumorigenesis.  Finally, we review recent findings that link EZH2 roles in stem cells and cancer, and we consider prospects for integrating EZH2 blockade into strategies for developing epigenetic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_YxVHv1IGDrVg90H21EOLACvtfcHk0lggnE2d1eo0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP&md5=e80ac4a2ba07b9e1ab4256ba6c73b23f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2008.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2008.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DLange%26aufirst%3DC.%2BA.%26atitle%3DRoles%2520of%2520the%2520EZH2%2520histone%2520methyltransferase%2520in%2520cancer%2520epigenetics%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2008%26volume%3D647%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.mrfmmm.2008.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ding, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merajver, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span> </span><span class="NLM_article-title">Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4099</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1158%2F0008-5472.CAN-05-4300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4095-4099&author=L.+Dingauthor=C.+Erdmannauthor=A.+M.+Chinnaiyanauthor=S.+D.+Merajverauthor=C.+G.+Kleer&title=Identification+of+EZH2+as+a+molecular+marker+for+a+precancerous+state+in+morphologically+normal+breast+tissues&doi=10.1158%2F0008-5472.CAN-05-4300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4300%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DL.%26aulast%3DErdmann%26aufirst%3DC.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DMerajver%26aufirst%3DS.%2BD.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26atitle%3DIdentification%2520of%2520EZH2%2520as%2520a%2520molecular%2520marker%2520for%2520a%2520precancerous%2520state%2520in%2520morphologically%2520normal%2520breast%2520tissues%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4095%26epage%3D4099%26doi%3D10.1158%2F0008-5472.CAN-05-4300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11606</span><span class="NLM_x">–</span> <span class="NLM_lpage">11611</span><span class="refDoi"> DOI: 10.1073/pnas.1933744100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1933744100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=14500907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11606-11611&author=C.+G.+Kleerauthor=Q.+Caoauthor=S.+Varamballyauthor=R.+Shenauthor=I.+Otaauthor=S.+A.+Tomlinsauthor=D.+Ghoshauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=D.+F.+Hayesauthor=M.+S.+Sabelauthor=D.+Livantauthor=S.+J.+Weissauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=EZH2+is+a+marker+of+aggressive+breast+cancer+and+promotes+neoplastic+transformation+of+breast+epithelial+cells&doi=10.1073%2Fpnas.1933744100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span></div><div class="casAuthors">Kleer, Celina G.; Cao, Qi; Varambally, Sooryanarayana; Shen, Ronglai; Ota, Ichiro; Tomlins, Scott A.; Ghosh, Debashis; Sewalt, Richard G. A. B.; Otte, Arie P.; Hayes, Daniel F.; Sabel, Michael S.; Livant, Donna; Weiss, Stephen J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11606-11611</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer.  Here the authors investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression.  EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia.  Tissue microarray anal., which included 917 samples from 280 patients, demonstrated that EZH2 protein levels were strongly assocd. with breast cancer aggressiveness.  Overexpression of EZH2 in immortalized human mammary epithelial cell lines promotes anchorage-independent growth and cell invasion.  EZH2-mediated cell invasion required an intact SET domain and histone deacetylase activity.  This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3vRwhSLDh7Vg90H21EOLACvtfcHk0lh0EDvYX6pPfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D&md5=a362e2d0f3c61c8e8b3afd5cea992255</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1933744100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1933744100%26sid%3Dliteratum%253Aachs%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DSabel%26aufirst%3DM.%2BS.%26aulast%3DLivant%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520is%2520a%2520marker%2520of%2520aggressive%2520breast%2520cancer%2520and%2520promotes%2520neoplastic%2520transformation%2520of%2520breast%2520epithelial%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11606%26epage%3D11611%26doi%3D10.1073%2Fpnas.1933744100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrette, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">The polycomb group protein EZH2 is involved in progression of prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1038/nature01075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature01075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12374981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=624-629&author=S.+Varamballyauthor=S.+M.+Dhanasekaranauthor=M.+Zhouauthor=T.+R.+Barretteauthor=C.+Kumar-Sinhaauthor=M.+G.+Sandaauthor=D.+Ghoshauthor=K.+J.+Pientaauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=The+polycomb+group+protein+EZH2+is+involved+in+progression+of+prostate+cancer&doi=10.1038%2Fnature01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is involved in progression of prostate cancer</span></div><div class="casAuthors">Varambally, Sooryanarayana; Dhanasekaran, Saravana M.; Zhou, Ming; Barrette, Terrence R.; Kumar-Sinha, Chandan; Sanda, Martin G.; Ghosh, Debashis; Pienta, Kenneth J.; Sewalt, Richard G. A. B.; Otte, Arie P.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6907</span>),
    <span class="NLM_cas:pages">624-629</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer.  Although effective surgical and radiation treatments exist for clin. localized prostate cancer, metastatic prostate cancer remains essentially incurable.  Here we show, through gene expression profiling, that the polycomb group protein enhancer of zeste homolog 2 (EZH2) is overexpressed in hormone-refractory, metastatic prostate cancer.  Small interfering RNA (siRNA) duplexes targeted against EZH2 reduce the amts. of EZH2 protein present in prostate cells and also inhibit cell proliferation in vitro.  Ectopic expression of EZH2 in prostate cells induces transcriptional repression of a specific cohort of genes.  Gene silencing mediated by EZH2 requires the SET domain and is attenuated by inhibiting histone deacetylase activity.  Amts. of both EZH2 mRNA and EZH2 protein are increased in metastatic prostate cancer; in addn., clin. localized prostate cancers that express higher concns. of EZH2 show a poorer prognosis.  Thus, dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.  Supplementary information on the gene expression profile can be obtained at: http://www.nature.com/nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW_h7gunzd7Vg90H21EOLACvtfcHk0lh0EDvYX6pPfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D&md5=c38f80915b4183472aa7be4f9f3ecc67</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01075%26sid%3Dliteratum%253Aachs%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DBarrette%26aufirst%3DT.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DSanda%26aufirst%3DM.%2BG.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DThe%2520polycomb%2520group%2520protein%2520EZH2%2520is%2520involved%2520in%2520progression%2520of%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D624%26epage%3D629%26doi%3D10.1038%2Fnature01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Velichutina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elemento, O.</span><span> </span><span class="NLM_article-title">EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">5247</span><span class="NLM_x">–</span> <span class="NLM_lpage">5255</span><span class="refDoi"> DOI: 10.1182/blood-2010-04-280149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1182%2Fblood-2010-04-280149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=20736451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1I%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=5247-5255&author=I.+Velichutinaauthor=R.+Shaknovichauthor=H.+Gengauthor=N.+A.+Johnsonauthor=R.+D.+Gascoyneauthor=A.+M.+Melnickauthor=O.+Elemento&title=EZH2-mediated+epigenetic+silencing+in+germinal+center+B+cells+contributes+to+proliferation+and+lymphomagenesis&doi=10.1182%2Fblood-2010-04-280149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis</span></div><div class="casAuthors">Velichutina, Irina; Shaknovich, Rita; Geng, Huimin; Johnson, Nathalie A.; Gascoyne, Randy D.; Melnick, Ari M.; Elemento, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5247-5255</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">EZH2 is the catalytic subunit of the PRC2 Polycomb complex and mediates transcriptional repression through its histone methyltransferase activity.  EZH2 is up-regulated in normal germinal center (GC) B cells and is implicated in lymphomagenesis.  To explore the transcriptional programs controlled by EZH2, we performed chromatin immunopptn. (ChIP-on-chip) in GC cells and found that it binds approx. 1800 promoters, often assocd. with DNA sequences similar to Drosophila Polycomb response elements.  While EZH2 targets overlapped extensively between GC B cells and embryonic stem cells, we also obsd. a large GC-specific EZH2 regulatory program.  These genes are preferentially histone 3 lysine 27-trimethylated and repressed in GC B cells and include several key cell cycle-related tumor suppressor genes.  Accordingly, siRNA-mediated down-regulation of EZH2 in diffuse large B-cell lymphoma (DLBCL) cells resulted in acute cell cycle arrest at the G1/S transition and up-regulation of its tumor suppressor target genes.  At the DNA level, EZH2-bound promoters are hypomethylated in GC B cells, but many of them are aberrantly hypermethylated in DLBCL, suggesting disruption of normal epigenetic processes in these cells.  EZH2 is thus involved in regulating a specific epigenetic program in normal GCs, including silencing of antiproliferative genes, which may contribute to the malignant transformation of GC B cells into DLBCLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobqjlF41Jsh7Vg90H21EOLACvtfcHk0ljMIXdHyiX_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1I%253D&md5=4f50ce144655d0b3a3b4de12c069ee22</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-04-280149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-04-280149%26sid%3Dliteratum%253Aachs%26aulast%3DVelichutina%26aufirst%3DI.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%2BM.%26aulast%3DElemento%26aufirst%3DO.%26atitle%3DEZH2-mediated%2520epigenetic%2520silencing%2520in%2520germinal%2520center%2520B%2520cells%2520contributes%2520to%2520proliferation%2520and%2520lymphomagenesis%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D5247%26epage%3D5255%26doi%3D10.1182%2Fblood-2010-04-280149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Morin, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungall, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolcock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchenbauer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimbara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashkin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlot, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherpakov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varhol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smailus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moksa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birol, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M. A.</span><span> </span><span class="NLM_article-title">Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1038/ng.518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fng.518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=20081860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=181-185&author=R.+D.+Morinauthor=N.+A.+Johnsonauthor=T.+M.+Seversonauthor=A.+J.+Mungallauthor=J.+Anauthor=R.+Goyaauthor=J.+E.+Paulauthor=M.+Boyleauthor=B.+W.+Woolcockauthor=F.+Kuchenbauerauthor=D.+Yapauthor=R.+K.+Humphriesauthor=O.+L.+Griffithauthor=S.+Shahauthor=H.+Zhuauthor=M.+Kimbaraauthor=P.+Shashkinauthor=J.+F.+Charlotauthor=M.+Tcherpakovauthor=R.+Corbettauthor=A.+Tamauthor=R.+Varholauthor=D.+Smailusauthor=M.+Moksaauthor=Y.+Zhaoauthor=A.+Delaneyauthor=H.+Qianauthor=I.+Birolauthor=J.+Scheinauthor=R.+Mooreauthor=R.+Holtauthor=D.+E.+Horsmanauthor=J.+M.+Connorsauthor=S.+Jonesauthor=S.+Aparicioauthor=M.+Hirstauthor=R.+D.+Gascoyneauthor=M.+A.+Marra&title=Somatic+mutations+altering+EZH2+%28Tyr641%29+in+follicular+and+diffuse+large+B-cell+lymphomas+of+germinal-center+origin&doi=10.1038%2Fng.518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin</span></div><div class="casAuthors">Morin, Ryan D.; Johnson, Nathalie A.; Severson, Tesa M.; Mungall, Andrew J.; An, Jianghong; Goya, Rodrigo; Paul, Jessica E.; Boyle, Merrill; Woolcock, Bruce W.; Kuchenbauer, Florian; Yap, Damian; Humphries, R. Keith; Griffith, Obi L.; Shah, Sohrab; Zhu, Henry; Kimbara, Michelle; Shashkin, Pavel; Charlot, Jean F.; Tcherpakov, Marianna; Corbett, Richard; Tam, Angela; Varhol, Richard; Smailus, Duane; Moksa, Michelle; Zhao, Yongjun; Delaney, Allen; Qian, Hong; Birol, Inanc; Schein, Jacqueline; Moore, Richard; Holt, Robert; Horsman, Doug E.; Connors, Joseph M.; Jones, Steven; Aparicio, Samuel; Hirst, Martin; Gascoyne, Randy D.; Marra, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-185</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL) derive from germinal center B cells.  Targeted resequencing studies have revealed mutations in various genes encoding proteins in the NF-κB pathway that contribute to the activated B-cell (ABC) DLBCL subtype, but thus far few GCB-specific mutations have been identified.  Here the authors report recurrent somatic mutations affecting the polycomb-group oncogene EZH2, which encodes a histone methyltransferase responsible for trimethylating Lys27 of histone H3 (H3K27).  After the recent discovery of mutations in KDM6A (UTX), which encodes the histone H3K27me3 demethylase UTX, in several cancer types, EZH2 is the second histone methyltransferase gene mutated in cancer.  These mutations, which result in the replacement of a single tyrosine in the SET domain of the EZH2 protein (Tyr641), occur in 21.7% of GCB DLBCLs and 7.2% of FLs and are absent from ABC DLBCLs.  The authors' data are consistent with the notion that EZH2 proteins with mutant Tyr641 have reduced enzymic activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvpFnajONCXbVg90H21EOLACvtfcHk0ljMIXdHyiX_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVGitQ%253D%253D&md5=ab68fe6e8932e720c4e7be82fe35932a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fng.518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.518%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DR.%2BD.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DSeverson%26aufirst%3DT.%2BM.%26aulast%3DMungall%26aufirst%3DA.%2BJ.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DGoya%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DJ.%2BE.%26aulast%3DBoyle%26aufirst%3DM.%26aulast%3DWoolcock%26aufirst%3DB.%2BW.%26aulast%3DKuchenbauer%26aufirst%3DF.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DHumphries%26aufirst%3DR.%2BK.%26aulast%3DGriffith%26aufirst%3DO.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DKimbara%26aufirst%3DM.%26aulast%3DShashkin%26aufirst%3DP.%26aulast%3DCharlot%26aufirst%3DJ.%2BF.%26aulast%3DTcherpakov%26aufirst%3DM.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DVarhol%26aufirst%3DR.%26aulast%3DSmailus%26aufirst%3DD.%26aulast%3DMoksa%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDelaney%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DBirol%26aufirst%3DI.%26aulast%3DSchein%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DR.%26aulast%3DHolt%26aufirst%3DR.%26aulast%3DHorsman%26aufirst%3DD.%2BE.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DHirst%26aufirst%3DM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMarra%26aufirst%3DM.%2BA.%26atitle%3DSomatic%2520mutations%2520altering%2520EZH2%2520%2528Tyr641%2529%2520in%2520follicular%2520and%2520diffuse%2520large%2520B-cell%2520lymphomas%2520of%2520germinal-center%2520origin%26jtitle%3DNat.%2520Genet.%26date%3D2010%26volume%3D42%26spage%3D181%26epage%3D185%26doi%3D10.1038%2Fng.518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hernando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelato, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesche, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steigemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stresemann, C.</span><span> </span><span class="NLM_article-title">EZH2 Inhibition blocks multiple myeloma mell mrowth through upregulation of epithelial tumor suppressor genes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1158%2F1535-7163.MCT-15-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26590165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVWrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=287-298&author=H.+Hernandoauthor=K.+A.+Gelatoauthor=R.+Lescheauthor=G.+Beckmannauthor=S.+Koehrauthor=S.+Ottoauthor=P.+Steigemannauthor=C.+Stresemann&title=EZH2+Inhibition+blocks+multiple+myeloma+mell+mrowth+through+upregulation+of+epithelial+tumor+suppressor+genes&doi=10.1158%2F1535-7163.MCT-15-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes</span></div><div class="casAuthors">Hernando, Henar; Gelato, Kathy A.; Lesche, Ralf; Beckmann, Georg; Koehr, Silke; Otto, Saskia; Steigemann, Patrick; Stresemann, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-298</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple myeloma is a plasma cell malignancy characterized by marked heterogeneous genomic instability including frequent genetic alterations in epigenetic enzymes.  In particular, the histone methyltransferase Enhancer of Zeste Homolog 2 (EZH2) is overexpressed in multiple myeloma.  EZH2 is the catalytic component of the polycomb repressive complex 2 (PRC2), a master transcriptional regulator of differentiation.  EZH2 catalyzes methylation of lysine 27 on histone H3 and its deregulation in cancer has been reported to contribute to silencing of tumor suppressor genes, resulting in a more undifferentiated state, and thereby contributing to the multiple myeloma phenotype.  In this study, we propose the use of EZH2 inhibitors as a new therapeutic approach for the treatment of multiple myeloma.  We demonstrate that EZH2 inhibition causes a global redn. of H3K27me3 in multiple myeloma cells, promoting reexpression of EZH2-repressed tumor suppressor genes in a subset of cell lines.  As a result of this transcriptional activation, multiple myeloma cells treated with EZH2 inhibitors become more adherent and less proliferative compared with untreated cells.  The antitumor efficacy of EZH2 inhibitors is also confirmed in vivo in a multiple myeloma xenograft model in mice.  Together, our data suggest that EZH2 inhibition may provide a new therapy for multiple myeloma treatment and a promising addn. to current treatment options.  Mol Cancer Ther; 15(2); 287-98. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuIp0VXeZaHLVg90H21EOLACvtfcHk0li9W78a9bnmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVWrs70%253D&md5=9412dddc1ca18950a9250519db0828dc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0486%26sid%3Dliteratum%253Aachs%26aulast%3DHernando%26aufirst%3DH.%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DLesche%26aufirst%3DR.%26aulast%3DBeckmann%26aufirst%3DG.%26aulast%3DKoehr%26aufirst%3DS.%26aulast%3DOtto%26aufirst%3DS.%26aulast%3DSteigemann%26aufirst%3DP.%26aulast%3DStresemann%26aufirst%3DC.%26atitle%3DEZH2%2520Inhibition%2520blocks%2520multiple%2520myeloma%2520mell%2520mrowth%2520through%2520upregulation%2520of%2520epithelial%2520tumor%2520suppressor%2520genes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D287%26epage%3D298%26doi%3D10.1158%2F1535-7163.MCT-15-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Shih, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span> </span><span class="NLM_article-title">The role of mutations in epigenetic regulators in myeloid malignancies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.1038/nrc3343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnrc3343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=22898539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=599-612&author=A.+H.+Shihauthor=O.+Abdel-Wahabauthor=J.+P.+Patelauthor=R.+L.+Levine&title=The+role+of+mutations+in+epigenetic+regulators+in+myeloid+malignancies&doi=10.1038%2Fnrc3343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutations in epigenetic regulators in myeloid malignancies</span></div><div class="casAuthors">Shih, Alan H.; Abdel-Wahab, Omar; Patel, Jay P.; Levine, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">599-612</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent genomic studies have identified novel recurrent somatic mutations in patients with myeloid malignancies, including myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).  In some cases these mutations occur in genes with known roles in regulating chromatin and/or methylation states in haematopoietic progenitors, and in other cases genetic and functional studies have elucidated a role for specific mutations in altering epigenetic patterning in myeloid malignancies.  In this Review we discuss recent genetic and functional data implicating mutations in epigenetic modifiers, including tet methylcytosine dioxygenase 2 (TET2), isocitrate dehydrogenase 1 (IDH1), IDH2, addnl. sex combs-like 1 (ASXL1), enhancer of zeste homolog 2 (EZH2) and DNA methyltransferase 3A (DNMT3A), in the pathogenesis of MPN, MDS and AML, and discuss how this knowledge is leading to novel clin., biol. and therapeutic insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxgjNkbc-nkrVg90H21EOLACvtfcHk0li9W78a9bnmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt7zF&md5=d892316de7dc7d677e971913b9ecf156</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrc3343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3343%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DA.%2BH.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DPatel%26aufirst%3DJ.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26atitle%3DThe%2520role%2520of%2520mutations%2520in%2520epigenetic%2520regulators%2520in%2520myeloid%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D599%26epage%3D612%26doi%3D10.1038%2Fnrc3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Neff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khattab, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orkin, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, S. A.</span><span> </span><span class="NLM_article-title">Polycomb repressive complex 2 is required for MLL-AF9 leukemia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5028</span><span class="NLM_x">–</span> <span class="NLM_lpage">5033</span><span class="refDoi"> DOI: 10.1073/pnas.1202258109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1202258109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5028-5033&author=T.+Neffauthor=A.+U.+Sinhaauthor=M.+J.+Klukauthor=N.+Zhuauthor=M.+H.+Khattabauthor=L.+Steinauthor=H.+Xieauthor=S.+H.+Orkinauthor=S.+A.+Armstrong&title=Polycomb+repressive+complex+2+is+required+for+MLL-AF9+leukemia&doi=10.1073%2Fpnas.1202258109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202258109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202258109%26sid%3Dliteratum%253Aachs%26aulast%3DNeff%26aufirst%3DT.%26aulast%3DSinha%26aufirst%3DA.%2BU.%26aulast%3DKluk%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DN.%26aulast%3DKhattab%26aufirst%3DM.%2BH.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26atitle%3DPolycomb%2520repressive%2520complex%25202%2520is%2520required%2520for%2520MLL-AF9%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5028%26epage%3D5033%26doi%3D10.1073%2Fpnas.1202258109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.1038/onc.2012.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fonc.2012.110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=930-938&author=J.+Shiauthor=E.+Wangauthor=J.+Zuberauthor=A.+Rappaportauthor=M.+Taylorauthor=C.+Johnsauthor=S.+W.+Loweauthor=C.+R.+Vakoc&title=The+Polycomb+complex+PRC2+supports+aberrant+self-renewal+in+a+mouse+model+of+MLL-AF9%3BNras%28G12D%29+acute+myeloid+leukemia&doi=10.1038%2Fonc.2012.110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.110%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DRappaport%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Polycomb%2520complex%2520PRC2%2520supports%2520aberrant%2520self-renewal%2520in%2520a%2520mouse%2520model%2520of%2520MLL-AF9%253BNras%2528G12D%2529%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D930%26epage%3D938%26doi%3D10.1038%2Fonc.2012.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">On, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span> </span><span class="NLM_article-title">Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1182/blood-2014-06-581082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1182%2Fblood-2014-06-581082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=346-357&author=B.+Xuauthor=D.+M.+Onauthor=A.+Maauthor=T.+Partonauthor=K.+D.+Konzeauthor=S.+G.+Pattendenauthor=D.+F.+Allisonauthor=L.+Caiauthor=S.+Rockowitzauthor=S.+Liuauthor=Y.+Liuauthor=F.+Liauthor=M.+Vedadiauthor=S.+V.+Fryeauthor=B.+A.+Garciaauthor=D.+Zhengauthor=J.+Jinauthor=G.+G.+Wang&title=Selective+inhibition+of+EZH2+and+EZH1+enzymatic+activity+by+a+small+molecule+suppresses+MLL-rearranged+leukemia&doi=10.1182%2Fblood-2014-06-581082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-06-581082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-06-581082%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.%26aulast%3DOn%26aufirst%3DD.%2BM.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DAllison%26aufirst%3DD.%2BF.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DRockowitz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DZheng%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%2BG.%26atitle%3DSelective%2520inhibition%2520of%2520EZH2%2520and%2520EZH1%2520enzymatic%2520activity%2520by%2520a%2520small%2520molecule%2520suppresses%2520MLL-rearranged%2520leukemia%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26spage%3D346%26epage%3D357%26doi%3D10.1182%2Fblood-2014-06-581082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aller, G. S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machutta, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/ml3003346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1091-1096&author=S.+K.+Vermaauthor=X.+Tianauthor=L.+V.+LaFranceauthor=C.+Duquenneauthor=D.+P.+Suarezauthor=K.+A.+Newlanderauthor=S.+P.+Romerilauthor=J.+L.+Burgessauthor=S.+W.+Grantauthor=J.+A.+Brackleyauthor=A.+P.+Gravesauthor=D.+A.+Scherzerauthor=A.+Shuauthor=C.+Thompsonauthor=H.+M.+Ottauthor=G.+S.+V.+Allerauthor=C.+A.+Machuttaauthor=E.+Diazauthor=Y.+Jiangauthor=N.+W.+Johnsonauthor=S.+D.+Knightauthor=R.+G.+Krugerauthor=M.+T.+McCabeauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Creasyauthor=W.+H.+Miller&title=Identification+of+potent%2C+selective%2C+cell-active+inhibitors+of+the+histone+lysine+methyltransferase+EZH2&doi=10.1021%2Fml3003346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2</span></div><div class="casAuthors">Verma, Sharad K.; Tian, Xinrong; LaFrance, Louis V.; Duquenne, Celine; Suarez, Dominic P.; Newlander, Kenneth A.; Romeril, Stuart P.; Burgess, Joelle L.; Grant, Seth W.; Brackley, James A.; Graves, Alan P.; Scherzer, Daryl A.; Shu, Art; Thompson, Christine; Ott, Heidi M.; Van Aller, Glenn S.; Machutta, Carl A.; Diaz, Elsie; Jiang, Yong; Johnson, Neil W.; Knight, Steven D.; Kruger, Ryan G.; McCabe, Michael T.; Dhanak, Dashyant; Tummino, Peter J.; Creasy, Caretha L.; Miller, William H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1091-1096</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The histone H3-lysine 27 (H3K27) methyltransferase EZH2 plays a crit. role in regulating gene expression, and its aberrant activity is linked to the onset and progression of cancer.  As part of a drug discovery program targeting EZH2, we have identified highly potent, selective, S-(S'-adenosyl)-L-methionine (SAM)-competitive, and cell-active EZH2 inhibitors, including GSK926 I (R1 = Me, R2 = Q) and GSK343 I (R1 = n-Pr, R2 = Q1).  These compds. are small mol. chem. tools that would be useful to further explore the biol. of EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NUzf0zjo0bVg90H21EOLACvtfcHk0ljreVKhrBoTcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChs77K&md5=a6540bb712ee52cba05bd0b074d8b26a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fml3003346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003346%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DSuarez%26aufirst%3DD.%2BP.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DBrackley%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%2BA.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DAller%26aufirst%3DG.%2BS.%2BV.%26aulast%3DMachutta%26aufirst%3DC.%2BA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DIdentification%2520of%2520potent%252C%2520selective%252C%2520cell-active%2520inhibitors%2520of%2520the%2520histone%2520lysine%2520methyltransferase%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1091%26epage%3D1096%26doi%3D10.1021%2Fml3003346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavadil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynlacht, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/j.molcel.2008.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.molcel.2008.11.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=503-518&author=R.+Margueronauthor=G.+Liauthor=K.+Sarmaauthor=A.+Blaisauthor=J.+Zavadilauthor=C.+L.+Woodcockauthor=B.+D.+Dynlachtauthor=D.+Reinberg&title=Ezh1+and+Ezh2+maintain+repressive+chromatin+through+different+mechanisms&doi=10.1016%2Fj.molcel.2008.11.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DBlais%26aufirst%3DA.%26aulast%3DZavadil%26aufirst%3DJ.%26aulast%3DWoodcock%26aufirst%3DC.%2BL.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DEzh1%2520and%2520Ezh2%2520maintain%2520repressive%2520chromatin%2520through%2520different%2520mechanisms%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D32%26spage%3D503%26epage%3D518%26doi%3D10.1016%2Fj.molcel.2008.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Laible, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nislow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebersorger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popkin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenuwein, T.</span><span> </span><span class="NLM_article-title">Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3219</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span><span class="refDoi"> DOI: 10.1093/emboj/16.11.3219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1093%2Femboj%2F16.11.3219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=3219-3232&author=G.+Laibleauthor=A.+Wolfauthor=R.+Dornauthor=G.+Reuterauthor=C.+Nislowauthor=A.+Lebersorgerauthor=D.+Popkinauthor=L.+Pillusauthor=T.+Jenuwein&title=Mammalian+homologues+of+the+Polycomb-group+gene+Enhancer+of+zeste+mediate+gene+silencing+in+Drosophila+heterochromatin+and+at+S.+cerevisiae+telomeres&doi=10.1093%2Femboj%2F16.11.3219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.11.3219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.11.3219%26sid%3Dliteratum%253Aachs%26aulast%3DLaible%26aufirst%3DG.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DR.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DNislow%26aufirst%3DC.%26aulast%3DLebersorger%26aufirst%3DA.%26aulast%3DPopkin%26aufirst%3DD.%26aulast%3DPillus%26aufirst%3DL.%26aulast%3DJenuwein%26aufirst%3DT.%26atitle%3DMammalian%2520homologues%2520of%2520the%2520Polycomb-group%2520gene%2520Enhancer%2520of%2520zeste%2520mediate%2520gene%2520silencing%2520in%2520Drosophila%2520heterochromatin%2520and%2520at%2520S.%2520cerevisiae%2520telomeres%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D3219%26epage%3D3232%26doi%3D10.1093%2Femboj%2F16.11.3219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Visser, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunster, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluin-Nelemans, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manders, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaphorst, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span> </span><span class="NLM_article-title">The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span><span class="refDoi"> DOI: 10.1046/j.1365-2141.2001.02641.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1046%2Fj.1365-2141.2001.02641.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=11298590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsV2ru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2001&pages=950-958&author=H.+P.+Visserauthor=M.+J.+Gunsterauthor=H.+C.+Kluin-Nelemansauthor=E.+M.+Mandersauthor=F.+M.+Raaphorstauthor=C.+J.+Meijerauthor=R.+Willemzeauthor=A.+P.+Otte&title=The+Polycomb+group+protein+EZH2+is+upregulated+in+proliferating%2C+cultured+human+mantle+cell+lymphoma&doi=10.1046%2Fj.1365-2141.2001.02641.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma</span></div><div class="casAuthors">Visser, Hein P. J.; Gunster, Marco J.; Kluin-Nelemans, Hanneke C.; Manders, Erik M. M.; Raaphorst, Frank M.; Meijer, Chris J. L. M.; Willemze, Roel; Otte, Arie P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">950-958</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins are involved in the stable transmittance of the repressive state of their gene targets throughout the cell cycle.  Mis-expression of PcG proteins can lead to proliferative defects and tumorigenesis.  There are 2 sep. multimeric PcG protein complexes: an EED-EZH2-contg. complex and a BMI1-RING1-contg. complex.  In the normal human follicle mantle, both PcG complexes have mutually exclusive expression patterns.  BMI1-RING1 is expressed, but EZH2-EED is not.  Here, the authors studied the expression of both complexes in 6 cases of mantle cell lymphoma (MCL), which is derived from the follicle mantle.  MCL cells can be cultured in vitro and stimulated to proliferation.  We found that resting MCL cells expressed BMI1-RING1, but not EZH2-EED, like normal mantle cells.  Proliferating MCL cells, however, showed strongly enhanced expression of EZH2.  Also, BMI1 and RING1 continued to be expressed in proliferating MCL.  This is the first demonstration that EZH2 expression can be upregulated in fresh lymphoma cells.  To test whether the enhanced EZH2 expression was causal for the increased proliferation in MCL, the authors overexpressed EZH2 in 2 different cell lines.  In the B cell-derived Ramos cell line, EZH2 overexpression caused an increase in the proliferation rate.  This suggests a possible causal effect between EZH2 upregulation and increased proliferation in hematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9euSBA7jIrVg90H21EOLACvtfcHk0lj2tlUCMVt7bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsV2ru70%253D&md5=7858a0d35ee29de952670e6701165dd1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2001.02641.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2001.02641.x%26sid%3Dliteratum%253Aachs%26aulast%3DVisser%26aufirst%3DH.%2BP.%26aulast%3DGunster%26aufirst%3DM.%2BJ.%26aulast%3DKluin-Nelemans%26aufirst%3DH.%2BC.%26aulast%3DManders%26aufirst%3DE.%2BM.%26aulast%3DRaaphorst%26aufirst%3DF.%2BM.%26aulast%3DMeijer%26aufirst%3DC.%2BJ.%26aulast%3DWillemze%26aufirst%3DR.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26atitle%3DThe%2520Polycomb%2520group%2520protein%2520EZH2%2520is%2520upregulated%2520in%2520proliferating%252C%2520cultured%2520human%2520mantle%2520cell%2520lymphoma%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2001%26volume%3D112%26spage%3D950%26epage%3D958%26doi%3D10.1046%2Fj.1365-2141.2001.02641.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2677</span><span class="refDoi"> DOI: 10.1101/gad.225888.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1101%2Fgad.225888.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2663-2677&author=J.+Sonauthor=S.+S.+Shenauthor=R.+Margueronauthor=D.+Reinberg&title=Nucleosome-binding+activities+within+JARID2+and+EZH1+regulate+the+function+of+PRC2+on+chromatin&doi=10.1101%2Fgad.225888.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1101%2Fgad.225888.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.225888.113%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DS.%2BS.%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DNucleosome-binding%2520activities%2520within%2520JARID2%2520and%2520EZH1%2520regulate%2520the%2520function%2520of%2520PRC2%2520on%2520chromatin%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D2663%26epage%3D2677%26doi%3D10.1101%2Fgad.225888.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span> </span><span class="NLM_article-title">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1038/nchembio.1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnchembio.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23023262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=890-896&author=S.+K.+Knutsonauthor=T.+J.+Wigleauthor=N.+M.+Warholicauthor=C.+J.+Sneeringerauthor=C.+J.+Allainauthor=C.+R.+Klausauthor=J.+D.+Sacksauthor=A.+Raimondiauthor=C.+R.+Majerauthor=J.+Songauthor=M.+P.+Scottauthor=L.+Jinauthor=J.+J.+Smithauthor=E.+J.+Olhavaauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=V.+M.+Richonauthor=R.+A.+Copelandauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=K.+W.+Kuntz&title=A+selective+inhibitor+of+EZH2+blocks+H3K27+methylation+and+kills+mutant+lymphoma+cells&doi=10.1038%2Fnchembio.1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span></div><div class="casAuthors">Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27).  Point mutations of EZH2 at Tyr 641 and Ala 677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation.  Here the authors report the discovery of EPZ005687, a potent inhibitor of EZH2 (Ki of 24 nM).  EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1.  The compd. reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr 641 or Ala 677 mutant cells, with minimal effects on the proliferation of wild-type cells.  These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr 641 or Ala 677) results in a crit. dependency on enzymic activity for proliferation (i.e., the equiv. of oncogene addiction), thus portending the clin. use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohlduVbTgWJrVg90H21EOLACvtfcHk0lhJFVyN4Lr40w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP&md5=a9ad7a41505e3fd4aa087d9f5dae8825</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1084%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DSacks%26aufirst%3DJ.%2BD.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520EZH2%2520blocks%2520H3K27%2520methylation%2520and%2520kills%2520mutant%2520lymphoma%2520cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D890%26epage%3D896%26doi%3D10.1038%2Fnchembio.1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iii, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span> </span><span class="NLM_article-title">EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature11606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23051747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=108-112&author=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+Ganjiauthor=S.+Korenchukauthor=C.+Thompsonauthor=G.+S.+Van+Allerauthor=Y.+Liuauthor=A.+P.+Gravesauthor=A.+D.+Iiiauthor=E.+Diazauthor=L.+V.+Lafranceauthor=M.+Mellingerauthor=C.+Duquenneauthor=X.+Tianauthor=R.+G.+Krugerauthor=C.+F.+McHughauthor=M.+Brandtauthor=W.+H.+Millerauthor=D.+Dhanakauthor=S.+K.+Vermaauthor=P.+J.+Tumminoauthor=C.+L.+Creasy&title=EZH2+inhibition+as+a+therapeutic+strategy+for+lymphoma+with+EZH2-activating+mutations&doi=10.1038%2Fnature11606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations</span></div><div class="casAuthors">McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Graves, Alan P.; Della Pietra, Anthony , III; Diaz, Elsie; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Brandt, Martin; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7427</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In eukaryotes, post-translational modification of histones is crit. for regulation of chromatin structure and gene expression.  EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and is involved in repressing gene expression through methylation of histone H3 on lysine 27 (H3K27).  EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumor types.  Addnl., somatic heterozygous mutations of Y641 and A677 residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.  The Y641 residue is the most frequently mutated residue, with up to 22% of germinal center B-cell DLBCL and follicular lymphoma harbouring mutations at this site.  These lymphomas have increased H3K27 tri-methylation (H3K27me3) owing to altered substrate preferences of the mutant enzymes.  However, it is unknown whether specific, direct inhibition of EZH2 methyltransferase activity will be effective in treating EZH2 mutant lymphomas.  Here we demonstrate that GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-mol. inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes.  GSK126 effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice.  Together, these data demonstrate that pharmacol. inhibition of EZH2 activity may provide a promising treatment for EZH2 mutant lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxw5cLmW3Lc7Vg90H21EOLACvtfcHk0lhJFVyN4Lr40w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyktbjL&md5=a1dff99556de004c48aae88bc45dffab</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11606%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DIii%26aufirst%3DA.%2BD.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DLafrance%26aufirst%3DL.%2BV.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26atitle%3DEZH2%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520lymphoma%2520with%2520EZH2-activating%2520mutations%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardayfio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span> </span><span class="NLM_article-title">Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">21360</span><span class="NLM_x">–</span> <span class="NLM_lpage">21365</span><span class="refDoi"> DOI: 10.1073/pnas.1210371110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1210371110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23236167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21360-21365&author=W.+Qiauthor=H.+Chanauthor=L.+Tengauthor=L.+Liauthor=S.+Chuaiauthor=R.+Zhangauthor=J.+Zengauthor=M.+Liauthor=H.+Fanauthor=Y.+Linauthor=J.+Guauthor=O.+Ardayfioauthor=J.-H.+Zhangauthor=X.+Yanauthor=J.+Fangauthor=Y.+Miauthor=M.+Zhangauthor=T.+Zhouauthor=G.+Fengauthor=Z.+Chenauthor=G.+Liauthor=T.+Yangauthor=K.+Zhaoauthor=X.+Liuauthor=Z.+Yuauthor=C.+X.+Luauthor=P.+Atadjaauthor=E.+Li&title=Selective+inhibition+of+Ezh2+by+a+small+molecule+inhibitor+blocks+tumor+cells+proliferation&doi=10.1073%2Fpnas.1210371110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation</span></div><div class="casAuthors">Qi, Wei; Chan, Homan; Teng, Lin; Li, Ling; Chuai, Shannon; Zhang, Ruipeng; Zeng, Jue; Li, Min; Fan, Hong; Lin, Ying; Gu, Justin; Ardayfio, Ophelia; Zhang, Ji-Hu; Yan, Xiaoxia; Fang, Jialuo; Mi, Yuan; Zhang, Man; Zhou, Tao; Feng, Grace; Chen, Zijun; Li, Guobin; Yang, Teddy; Zhao, Kehao; Liu, Xianghui; Yu, Zhengtian; Lu, Chris X.; Atadja, Peter; Li, En</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">21360-21365, S21360/1-S21360/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ezh2 (Enhancer of zeste homolog 2) protein is the enzymic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by methylating lysine 27 of histone H3 (H3K27) and regulates cell proliferation and differentiation during embryonic development.  Recently, hot-spot mutations of Ezh2 were identified in diffused large B-cell lymphomas and follicular lymphomas.  To investigate if tumor growth is dependent on the enzymic activity of Ezh2, the authors developed a potent and selective small mol. inhibitor, EI1, which inhibits the enzymic activity of Ezh2 through direct binding to the enzyme and competing with the Me group donor S-Adenosyl methionine.  EI1-treated cells exhibit genome-wide loss of H3K27 methylation and activation of PRC2 target genes.  Furthermore, inhibition of Ezh2 by EI1 in diffused large B-cell lymphomas cells carrying the Y641 mutations results in decreased proliferation, cell cycle arrest, and apoptosis.  These results provide strong validation of Ezh2 as a potential therapeutic target for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR1oWnCAdMmrVg90H21EOLACvtfcHk0li_qgu4n8WYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSnsA%253D%253D&md5=b85578201119e39887e323aad25d959b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210371110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210371110%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChuai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DArdayfio%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DC.%2BX.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DE.%26atitle%3DSelective%2520inhibition%2520of%2520Ezh2%2520by%2520a%2520small%2520molecule%2520inhibitor%2520blocks%2520tumor%2520cells%2520proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21360%26epage%3D21365%26doi%3D10.1073%2Fpnas.1210371110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNevin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1021/cb400133j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400133j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1324-1334&author=K.+D.+Konzeauthor=A.+Maauthor=F.+Liauthor=D.+Barsyte-Lovejoyauthor=T.+Partonauthor=C.+J.+MacNevinauthor=F.+Liuauthor=C.+Gaoauthor=X.+P.+Huangauthor=E.+Kuznetsovaauthor=M.+Rougieauthor=A.+Jiangauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=L.+I.+Jamesauthor=B.+L.+Rothauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=K.+M.+Hahnauthor=G.+G.+Wangauthor=M.+Vedadiauthor=J.+Jin&title=An+orally+bioavailable+chemical+probe+of+the+lysine+methyltransferases+EZH2+and+EZH1&doi=10.1021%2Fcb400133j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span></div><div class="casAuthors">Konze, Kyle D.; Ma, Anqi; Li, Fengling; Barsyte-Lovejoy, Dalia; Parton, Trevor; MacNevin, Christopher J.; Liu, Feng; Gao, Cen; Huang, Xi-Ping; Kuznetsova, Ekaterina; Rougie, Marie; Jiang, Alice; Pattenden, Samantha G.; Norris, Jacqueline L.; James, Lindsey I.; Roth, Bryan L.; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Hahn, Klaus M.; Wang, Gang Greg; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1324-1334</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylation of histone H3 lysine 27 (H3K27).  The trimethylation of H3K27 (H3K27me3) is a transcriptionally repressive post-translational modification.  Overexpression of EZH2 and hypertrimethylation of H3K27 have been implicated in a no. of cancers.  Several selective inhibitors of EZH2 have been reported recently.  Herein we disclose UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wild-type and mutant EZH2 as well as EZH1, a closely related H3K27 methyltransferase that shares 96% sequence identity with EZH2 in their resp. catalytic domains.  UNC1999 was highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM and non-competitive with the peptide substrate.  This inhibitor potently reduced H3K27me3 levels in cells and selectively killed diffused large B cell lymphoma cell lines harboring the EZH2Y641N mutant.  Importantly, UNC1999 was orally bioavailable in mice, making this inhibitor a valuable tool for investigating the role of EZH2 and EZH1 in chronic animal studies.  We also designed and synthesized UNC2400, a close analog of UNC1999 with potency >1,000-fold lower than that of UNC1999 as a neg. control for cell-based studies.  Finally, we created a biotin-tagged UNC1999 (UNC2399), which enriched EZH2 in pull-down studies, and a UNC1999-dye conjugate (UNC2239) for co-localization studies with EZH2 in live cells.  Taken together, these compds. represent a set of useful tools for the biomedical community to investigate the role of EZH2 and EZH1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzhUO0iAe8BbVg90H21EOLACvtfcHk0li_qgu4n8WYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D&md5=311d77f5f0cc0b9e2610d8d002a6709c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400133j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400133j%26sid%3Dliteratum%253Aachs%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DMacNevin%26aufirst%3DC.%2BJ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DKuznetsova%26aufirst%3DE.%26aulast%3DRougie%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DA.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DJames%26aufirst%3DL.%2BI.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DHahn%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DG.%2BG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DAn%2520orally%2520bioavailable%2520chemical%2520probe%2520of%2520the%2520lysine%2520methyltransferases%2520EZH2%2520and%2520EZH1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1324%26epage%3D1334%26doi%3D10.1021%2Fcb400133j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span> </span><span class="NLM_article-title">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7922</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1073/pnas.1303800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1303800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23620515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=7922-7927&author=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=T.+J.+Wigleauthor=C.+R.+Klausauthor=C.+J.+Allainauthor=A.+Raimondiauthor=M.+Porter+Scottauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=V.+M.+Richonauthor=R.+M.+Pollockauthor=K.+W.+Kuntzauthor=H.+Keilhack&title=Durable+tumor+regression+in+genetically+altered+malignant+rhabdoid+tumors+by+inhibition+of+methyltransferase+EZH2&doi=10.1073%2Fpnas.1303800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span></div><div class="casAuthors">Knutson, Sarah K.; Warholic, Natalie M.; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Scott, Margaret Porter; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Pollock, Roy M.; Kuntz, Kevin W.; Keilhack, Heike</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7922-7927, S7922/1-S7922/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid rhabdoid tumors.  This alteration is hypothesized to confer oncogenic dependency on EZH2 in these cancers.  The authors report the discovery of a potent, selective, and orally bioavailable small-mol. inhibitor of EZH2 enzymic activity, (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide).  The compd. induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.  Treatment of xenograft-bearing mice with (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide) leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation.  These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRIJfPhwLA7Vg90H21EOLACvtfcHk0ljfGQyQO-pzQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D&md5=c2c6470d48a13ab8343db0a09465ba42</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1303800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1303800110%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DPorter%2BScott%26aufirst%3DM.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26atitle%3DDurable%2520tumor%2520regression%2520in%2520genetically%2520altered%2520malignant%2520rhabdoid%2520tumors%2520by%2520inhibition%2520of%2520methyltransferase%2520EZH2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D7922%26epage%3D7927%26doi%3D10.1073%2Fpnas.1303800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT02082977. A study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2816126 in subjects with relapsed/refractory diffuse large B cell and transformed follicular lymphoma (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT02082977.+A+study+to+investigate+the+safety%2C+pharmacokinetics%2C+pharmacodynamics+and+clinical+activity+of+GSK2816126+in+subjects+with+relapsed%2Frefractory+diffuse+large+B+cell+and+transformed+follicular+lymphoma+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT01897571. An open-label, multicenter, phase 1/2 study of E7438 (EZH2 histone methyl transferase [HMT] inhibitor) as a single agent in subjects with advanced solid tumors or with B-cell lymphomas (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT01897571.+An+open-label%2C+multicenter%2C+phase+1%2F2+study+of+E7438+%28EZH2+histone+methyl+transferase+%5BHMT%5D+inhibitor%29+as+a+single+agent+in+subjects+with+advanced+solid+tumors+or+with+B-cell+lymphomas+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kaniskan, H. Ü.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Selective inhibitors of protein methyltransferases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span><span class="refDoi"> DOI: 10.1021/jm501234a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501234a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1596-1629&author=H.+%C3%9C.+Kaniskanauthor=K.+D.+Konzeauthor=J.+Jin&title=Selective+inhibitors+of+protein+methyltransferases&doi=10.1021%2Fjm501234a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of protein methyltransferases</span></div><div class="casAuthors">Kaniskan, H. Umit; Konze, Kyle D.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1596-1629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mounting evidence suggests that protein methyltransferases (PMTs), which catalyze the methylation of histone and non-histone proteins, play a crucial role in diverse biol. processes and human diseases.  In particular, PMTs have been recognized as major players in regulating gene expression and chromatin state.  PMTs are divided into 2 categories: protein lysine methyltransferases (PKMTs) and protein arginine methyltransferases (PRMTs).  There has been a steadily growing interest in these enzymes as potential therapeutic targets and therefore discovery of PMT inhibitors has also been pursued increasingly over the past decade.  Here, the authors present a perspective on selective, small-mol. inhibitors of PMTs with an emphasis on their discovery, characterization, and applicability as chem. tools for deciphering the target PMTs' physiol. functions and involvement in human diseases.  The authors highlight the current state of PMT inhibitors and discuss future directions and opportunities for PMT inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEWF_XeLEY1rVg90H21EOLACvtfcHk0lgVOqn8mPWM6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtbbJ&md5=8fb2b2d21d306c02a2da60a3fb88c430</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm501234a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501234a%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibitors%2520of%2520protein%2520methyltransferases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1596%26epage%3D1629%26doi%3D10.1021%2Fjm501234a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kaniskan, H. Ü.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Chemical probes of histone lysine methyltransferases</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1021/cb500785t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500785t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOht7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=40-50&author=H.+%C3%9C.+Kaniskanauthor=J.+Jin&title=Chemical+probes+of+histone+lysine+methyltransferases&doi=10.1021%2Fcb500785t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probes of histone lysine methyltransferases</span></div><div class="casAuthors">Kaniskan, H. Umit; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Growing evidence suggests that histone-lysine methyltransferases (HMTs, also known as protein methyltransferases (PMTs)) play an important role in diverse biol. processes and human diseases by regulating gene expression and the chromatin state.  Therefore, HMTs have been increasingly recognized by the biomedical community as a class of potential therapeutic targets.  High quality chem. probes of HMTs, as tools for deciphering their physiol. functions and roles in human diseases and testing therapeutic hypotheses, are crit. for advancing this promising field.  Here, the authors focus on the discovery, characterization, and biol. applications of chem. probes for HMTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8kb_c7Xl57Vg90H21EOLACvtfcHk0lgVOqn8mPWM6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOht7%252FE&md5=4eb8a696e2227c60686df8d3c60777ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcb500785t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500785t%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DChemical%2520probes%2520of%2520histone%2520lysine%2520methyltransferases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D40%26epage%3D50%26doi%3D10.1021%2Fcb500785t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.chembiol.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24183969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1329-1339&author=S.+Garapaty-Raoauthor=C.+Nasveschukauthor=A.+Gagnonauthor=E.+Y.+Chanauthor=P.+Sandyauthor=J.+Busbyauthor=S.+Balasubramanianauthor=R.+Campbellauthor=F.+Zhaoauthor=L.+Bergeronauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.+C.+Harmangeauthor=R.+Cummingsauthor=P.+Trojer&title=Identification+of+EZH2+and+EZH1+small+molecule+inhibitors+with+selective+impact+on+diffuse+large+B+cell+lymphoma+cell+growth&doi=10.1016%2Fj.chembiol.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span></div><div class="casAuthors">Garapaty-Rao, Shivani; Nasveschuk, Christopher; Gagnon, Alexandre; Chan, Eric Y.; Sandy, Peter; Busby, Jennifer; Balasubramanian, Srividya; Campbell, Robert; Zhao, Feng; Bergeron, Louise; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe; Cummings, Richard; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of Zeste homolog 2 (EZH2) is a candidate oncogene due to its prevalent overexpression in malignant diseases, including late stage prostate and breast cancers.  The dependency of cancer cells on EZH2 activity is also predicated by recurrent missense mutations residing in the catalytic domain of EZH2 that have been identified in subtypes of diffuse large B cell lymphoma, follicular lymphoma and melanoma.  Herein, we report the identification of a highly selective small mol. inhibitor series of EZH2 and EZH1.  These compds. inhibit wild-type and mutant versions of EZH2 with nanomolar potency, suppress global histone H3-lysine 27 methylation, affect gene expression, and cause selective proliferation defects.  These compds. represent a structurally distinct EZH2 inhibitor chemotype for the exploration of the role of Polycomb Repressive Complex 2-mediated H3K27 methylation in various biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNGhFRO6LRbVg90H21EOLACvtfcHk0lgVOqn8mPWM6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP&md5=6079ba01ae1f1964ac1d8108aa5e1227</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DNasveschuk%26aufirst%3DC.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DE.%2BY.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520EZH2%2520and%2520EZH1%2520small%2520molecule%2520inhibitors%2520with%2520selective%2520impact%2520on%2520diffuse%2520large%2520B%2520cell%2520lymphoma%2520cell%2520growth%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.chembiol.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design, and synthesis of indole-based EZH2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+synthesis+of+indole-based+EZH2+inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520synthesis%2520of%2520indole-based%2520EZH2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bradley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">EZH2 inhibitor efficacy in non-Hodgkin’s lymphoma does not require suppression of H3K27 monomethylation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.chembiol.2014.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=25457180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1463-1475&author=W.+D.+Bradleyauthor=S.+Aroraauthor=J.+Busbyauthor=S.+Balasubramanianauthor=V.+S.+Gehlingauthor=C.+G.+Nasveschukauthor=R.+G.+Vaswaniauthor=C.+C.+Yuanauthor=C.+Hattonauthor=F.+Zhaoauthor=K.+E.+Williamsonauthor=P.+Iyerauthor=J.+Mendezauthor=R.+Campbellauthor=N.+Cantoneauthor=S.+Garapaty-Raoauthor=J.+E.+Audiaauthor=A.+S.+Cookauthor=L.+A.+Dakinauthor=B.+K.+Albrechtauthor=J.+C.+Harmangeauthor=D.+L.+Danielsauthor=R.+T.+Cummingsauthor=B.+M.+Bryantauthor=E.+Normantauthor=P.+Trojer&title=EZH2+inhibitor+efficacy+in+non-Hodgkin%E2%80%99s+lymphoma+does+not+require+suppression+of+H3K27+monomethylation&doi=10.1016%2Fj.chembiol.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span></div><div class="casAuthors">Bradley, William D.; Arora, Shilpi; Busby, Jennifer; Balasubramanian, Srividya; Gehling, Victor S.; Nasveschuk, Christopher G.; Vaswani, Rishi G.; Yuan, Chih-Chi; Hatton, Charlie; Zhao, Feng; Williamson, Kaylyn E.; Iyer, Priyadarshini; Mendez, Jacqui; Campbell, Robert; Cantone, Nico; Garapaty-Rao, Shivani; Audia, James E.; Cook, Andrew S.; Dakin, Les A.; Albrecht, Brian K.; Harmange, Jean-Christophe; Daniels, Danette L.; Cummings, Richard T.; Bryant, Barbara M.; Normant, Emmanuel; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1475</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone lysine methyltransferase (MT) Enhancer of Zeste Homolog 2 (EZH2) is considered an oncogenic driver in a subset of germinal center B-cell-like diffuse large B cell lymphoma (GCB-DLBCL) and follicular lymphoma due to the presence of recurrent, monoallelic mutations in the EZH2 catalytic domain.  These genomic data suggest that targeting the EZH2 MT activity is a valid therapeutic strategy for the treatment of lymphoma patients with EZH2 mutations.  Here we report the identification of highly potent and selective EZH2 small mol. inhibitors, their validation by a cellular thermal shift assay, application across a large cell panel representing various non-Hodgkin's lymphoma (NHL) subtypes, and their efficacy in EZH2 mutant-contg. GCB-DLBCL xenograft models.  Surprisingly, our EZH2 inhibitors selectively affect the turnover of trimethylated, but not monomethylated histone H3 lysine 27 at pharmacol. relevant doses.  Importantly, we find that these inhibitors are broadly efficacious also in NHL models with wild-type EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxrMoLW0OWCbVg90H21EOLACvtfcHk0lgoNs4BVA1lvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE&md5=40b8f604e762dda9420afedede75fd36</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DW.%2BD.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DYuan%26aufirst%3DC.%2BC.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWilliamson%26aufirst%3DK.%2BE.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DMendez%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DEZH2%2520inhibitor%2520efficacy%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520does%2520not%2520require%2520suppression%2520of%2520H3K27%2520monomethylation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1463%26epage%3D1475%26doi%3D10.1016%2Fj.chembiol.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT02395601. A study evaluating CPI-1205 in patients with B-cell lymphomas (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT02395601.+A+study+evaluating+CPI-1205+in+patients+with+B-cell+lymphomas+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">EPZ011989, A potent, orally-available EZH2 inhibitor with robust in vivo activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=491-495&author=J.+E.+Campbellauthor=K.+W.+Kuntzauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=H.+Keilhackauthor=T.+J.+Wigleauthor=A.+Raimondiauthor=C.+R.+Klausauthor=N.+Riouxauthor=A.+Yokoiauthor=S.+Kawanoauthor=Y.+Minoshimaauthor=H.+W.+Choiauthor=M.+Porter+Scottauthor=N.+J.+Watersauthor=J.+J.+Smithauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copeland&title=EPZ011989%2C+A+potent%2C+orally-available+EZH2+inhibitor+with+robust+in+vivo+activity&doi=10.1021%2Facsmedchemlett.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity</span></div><div class="casAuthors">Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Porter Scott, Margaret; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications.  The ability of the scientific community to explore fully the spectrum of EZH2-assocd. pathobiol. has been hampered by the lack of in vivo-active tool compds. for this enzyme.  Here the authors report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties.  EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma.  Hence, this compd. represents a powerful tool for the expanded exploration of EZH2 activity in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqfVfbr3kS67Vg90H21EOLACvtfcHk0lhrD3BEMoRuSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D&md5=21fa182b2474678f663459a9dc2878e6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DYokoi%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DS.%26aulast%3DMinoshima%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DPorter%2BScott%26aufirst%3DM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEPZ011989%252C%2520A%2520potent%252C%2520orally-available%2520EZH2%2520inhibitor%2520with%2520robust%2520in%2520vivo%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D491%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span> </span><span class="NLM_article-title">Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">20864</span><span class="refDoi"> DOI: 10.1038/srep20864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fsrep20864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26868841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=20864&author=X.+Songauthor=T.+Gaoauthor=N.+Wangauthor=Q.+Fengauthor=X.+Youauthor=T.+Yeauthor=Q.+Leiauthor=Y.+Zhuauthor=M.+Xiongauthor=Y.+Xiaauthor=F.+Yangauthor=Y.+Shiauthor=Y.+Weiauthor=L.+Zhangauthor=L.+Yu&title=Selective+inhibition+of+EZH2+by+ZLD1039+blocks+H3K27methylation+and+leads+to+potent+anti-tumor+activity+in+breast+cancer&doi=10.1038%2Fsrep20864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer</span></div><div class="casAuthors">Song, Xuejiao; Gao, Tiantao; Wang, Ningyu; Feng, Qiang; You, Xinyu; Ye, Tinghong; Lei, Qian; Zhu, Yongxia; Xiong, Menghua; Xia, Yong; Yang, Fangfang; Shi, Yaojie; Wei, Yuquan; Zhang, Lidan; Yu, Luoting</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20864</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Enhancer of zeste homolog 2 (EZH2) is a candidate oncogenic driver due to its prevalent overexpression and aberrant repression of tumor suppressor genes in diverse cancers.  Therefore, blocking EZH2 enzyme activity may present a valid therapeutic strategy for the treatment of cancers with EZH2 overexpression including breast cancers.  Here, we described ZLD1039 a potent, highly selective, and orally bioavailable small mol. inhibitor of EZH2, which inhibited breast tumor growth and metastasis.  ZLD1039 considerably inhibited EZH2 methyltransferase activity with nanomolar potency, decreased global histone-3 lysine-27 (H3K27) methylation, and reactivated silenced tumor suppressors connected to increased survival of patients with breast cancer.  Comparable to conditional silencing of EZH2, its inhibition by ZLD1039 decreased cell proliferation, cell cycle arrest, and induced apoptosis.  Comparably, treatment of xenograft-bearing mice with ZLD1039 led to tumor growth regression and metastasis inhibition.  These data confirmed the dependency of breast cancer progression on EZH2 activity and the usefulness of ZLD1039 as a promising treatment for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTMqYUMcMi-bVg90H21EOLACvtfcHk0lh1Mw7VM816qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSltbw%253D&md5=c2e138e7f887dd17f1e2be3851f0e3b7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsrep20864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep20864%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DSelective%2520inhibition%2520of%2520EZH2%2520by%2520ZLD1039%2520blocks%2520H3K27methylation%2520and%2520leads%2520to%2520potent%2520anti-tumor%2520activity%2520in%2520breast%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D20864%26doi%3D10.1038%2Fsrep20864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Gao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. T.</span><span> </span><span class="NLM_article-title">ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">28512</span><span class="NLM_x">–</span> <span class="NLM_lpage">28521</span><span class="refDoi"> DOI: 10.1039/C6RA00618C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1039%2FC6RA00618C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=28512-28521&author=T.+T.+Gaoauthor=L.+D.+Zhangauthor=Y.+X.+Zhuauthor=X.+J.+Songauthor=Q.+Fengauthor=Q.+Leiauthor=S.+X.+Shiauthor=H.+X.+Dengauthor=M.+H.+Xiongauthor=X.+Y.+Youauthor=W.+Q.+Zuoauthor=L.+Liuauthor=C.+T.+Pengauthor=N.+Y.+Wangauthor=T.+H.+Yeauthor=Y.+Xiaauthor=L.+T.+Yu&title=ZLD1122%2C+a+novel+EZH2+and+EZH1+small+molecular+inhibitor%2C+blocks+H3K27+methylation+and+diffuse+large+B+cell+lymphoma+cell+growth&doi=10.1039%2FC6RA00618C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth</span></div><div class="casAuthors">Gao, Tiantao; Zhang, Lidan; Zhu, Yongxia; Song, Xuejiao; Feng, Qiang; Lei, Qian; Shi, Suxia; Deng, Hongxia; Xiong, Menghua; You, Xinyu; Zuo, Weiqiong; Liu, Li; Peng, Cuiting; Wang, Ningyu; Ye, Tinghong; Xia, Yong; Yu, Luoting</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">28512-28521</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of zeste homolog 2 (EZH2) has been reported to be overexpressed in a variety of cancers and is assocd. with tumor malignancy.  This is mainly because EZH2 catalyzes the hypertrimethylation of histone 3 at lysine 27 (H3K27) at the promoter of target genes, leading to the silencing of downstream tumor suppressor genes.  Hence, blocking its catalytic function may be a therapeutic strategy for the treatment of tumors which over-express or have a gain-of-function mutation in EZH2, such as lymphomas.  Here, we reported a novel, selective, small-mol. inhibitor of EZH2 and EZH1 synthesized by us, ZLD1122, which inhibited both EZH1 and wild type and mutant EZH2 activities with nanomolar potency.  ZLD1122 significantly inhibited intracellular H3K27 trimethylation without affecting the levels of H3, H3K9me3, and H3K4me3, indicating its selective inhibition of polycomb repressive complex 2 (PRC2) Me catalytic function.  Moreover, ZLD1122 induced G0/G1 phase arrest in diffuse large B cell lymphoma (DLBCL) cells in a dose-dependent manner via downregulation of cyclinE and CDK4 as well as upregulation of p21 and cyclinD1.  Furthermore, it induced apoptosis and loss of mitochondrial membrane potential (Δψm), and elevated the levels of cleaved caspase-9 in Su-DHL-6 and Pfeiffer cells, suggesting that ZLD1122 suppresses the viability of DLBCL cells by inducing caspase-mediated intrinsic apoptosis.  Taken together, these data demonstrated that ZLD1122, owing to its pharmacol. inhibitory activity against EZH2, could be a promising agent for the treatment of lymphomas with EZH2 gain-of-function mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyK0JgpETzI7Vg90H21EOLACvtfcHk0lh1Mw7VM816qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKhsrg%253D&md5=06762ba0bd806ad3985b20e8b7063887</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC6RA00618C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA00618C%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DSong%26aufirst%3DX.%2BJ.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DS.%2BX.%26aulast%3DDeng%26aufirst%3DH.%2BX.%26aulast%3DXiong%26aufirst%3DM.%2BH.%26aulast%3DYou%26aufirst%3DX.%2BY.%26aulast%3DZuo%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DC.%2BT.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DYe%26aufirst%3DT.%2BH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%2BT.%26atitle%3DZLD1122%252C%2520a%2520novel%2520EZH2%2520and%2520EZH1%2520small%2520molecular%2520inhibitor%252C%2520blocks%2520H3K27%2520methylation%2520and%2520diffuse%2520large%2520B%2520cell%2520lymphoma%2520cell%2520growth%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D28512%26epage%3D28521%26doi%3D10.1039%2FC6RA00618C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Leung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Methyl effects on protein-ligand binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4489</span><span class="NLM_x">–</span> <span class="NLM_lpage">4500</span><span class="refDoi"> DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&author=C.+S.+Leungauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein-ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38α MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0ljFC52Zy8nmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein-ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter-Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span> </span><span class="NLM_article-title">The importance of being me: magic methyls, methyltransferase inhibitors, and the siscovery of Tazemetostat</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+importance+of+being+me%3A+magic+methyls%2C+methyltransferase+inhibitors%2C+and+the+siscovery+of+Tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520importance%2520of%2520being%2520me%253A%2520magic%2520methyls%252C%2520methyltransferase%2520inhibitors%252C%2520and%2520the%2520siscovery%2520of%2520Tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0lj5KuWcSU5Jcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Scholfield, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanden, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonding (X-bonding): a biological perspective</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1002/pro.2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1002%2Fpro.2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23225628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=139-152&author=M.+R.+Scholfieldauthor=C.+M.+Zandenauthor=M.+Carterauthor=P.+S.+Ho&title=Halogen+bonding+%28X-bonding%29%3A+a+biological+perspective&doi=10.1002%2Fpro.2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonding (X-bonding): A biological perspective</span></div><div class="casAuthors">Scholfield, Matthew R.; Vander Zanden, Crystal M.; Carter, Megan; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-152</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The concept of the halogen bond (or X-bond) has become recognized as contributing significantly to the specificity in recognition of a large class of halogenated compds.  The interaction is most easily understood as primarily an electrostatically driven mol. interaction, where an electropos. crown, or σ-hole, serves as a Lewis acid to attract a variety of electron-rich Lewis bases, in analogous fashion to a classic hydrogen bonding (H-bond) interaction.  We present here a broad overview of X-bonds from the perspective of a biologist who may not be familiar with this recently rediscovered class of interactions and, consequently, may be interested in how they can be applied as a highly directional and specific component of the mol. toolbox.  This overview includes a discussion for where X-bonds are found in biomol. structures, and how their structure-energy relationships are studied exptl. and modeled computationally.  In total, our understanding of these basic concepts will allow X-bonds to be incorporated into strategies for the rational design of new halogenated inhibitors against biomol. targets or toward mol. engineering of new biol.-based materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq19qA2u5B5-7Vg90H21EOLACvtfcHk0lj5KuWcSU5Jcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOnsbw%253D&md5=22dead5c9f6aaab61d17bcd565c532e8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fpro.2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2201%26sid%3Dliteratum%253Aachs%26aulast%3DScholfield%26aufirst%3DM.%2BR.%26aulast%3DZanden%26aufirst%3DC.%2BM.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonding%2520%2528X-bonding%2529%253A%2520a%2520biological%2520perspective%26jtitle%3DProtein%2520Sci.%26date%3D2013%26volume%3D22%26spage%3D139%26epage%3D152%26doi%3D10.1002%2Fpro.2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span> </span><span class="NLM_article-title">PLANTS: Application of ant colony optimization to structure-based drug design</span> <span class="citation_source-journal">Lect. Notes Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4150</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1007/11839088_22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1007%2F11839088_22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4150&publication_year=2006&pages=247-258&author=O.+Korbauthor=T.+Stutzleauthor=T.+E.+Exner&title=PLANTS%3A+Application+of+ant+colony+optimization+to+structure-based+drug+design&doi=10.1007%2F11839088_22"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F11839088_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F11839088_22%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DStutzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DPLANTS%253A%2520Application%2520of%2520ant%2520colony%2520optimization%2520to%2520structure-based%2520drug%2520design%26jtitle%3DLect.%2520Notes%2520Comput.%2520Sci.%26date%3D2006%26volume%3D4150%26spage%3D247%26epage%3D258%26doi%3D10.1007%2F11839088_22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span> <span class="citation_source-book">Small-Molecule Drug Discovery Suite 2015-4: Glide</span>, <span class="NLM_edition">version 6.9</span>;; <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2015-4%3A+Glide%2C+version+6.9%3B%3B+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSmall-Molecule%2520Drug%2520Discovery%2520Suite%25202015-4%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Marcou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1021/ci600342e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints&doi=10.1021%2Fci600342e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0lgFz4P_P85nXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1021%2Fci600342e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Daohai Du, Dandan Xu, Licheng Zhu, Giulia Stazi, Clemens Zwergel, Yanli Liu, Zhongyuan Luo, Yuanqing Li, Yuanyuan Zhang, Kongkai Zhu, Yiluan Ding, Jingqiu Liu, Shijie Fan, Kaiyan Zhao, Naixia Zhang, Xiangqian Kong, Hualiang Jiang, Kaixian Chen, Kehao Zhao, Sergio Valente, Jinrong Min, Wenhu Duan, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2–EED Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8194-8207. <a href="https://doi.org/10.1021/acs.jmedchem.0c02261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDevelopment%252Bof%252BSmall-Molecule%252BPRC2%252BInhibitors%252BTargeting%252BEZH2%2525E2%252580%252593EED%252BInteraction%26aulast%3DDu%26aufirst%3DDaohai%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30122020%26date%3D02062021%26volume%3D64%26issue%3D12%26spage%3D8194%26epage%3D8207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">M. Cynthia Martin, Guihua Zeng, Jindan Yu, <span class="NLM_string-name hlFld-ContribAuthor">Gary E. Schiltz</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15344-15370. <a href="https://doi.org/10.1021/acs.jmedchem.0c01344" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01344%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BApproaches%252Bfor%252BTargeting%252Bthe%252BPolycomb%252BRepressive%252BComplex%252B2%252B%252528PRC2%252529%252Bin%252BCancer%26aulast%3DMartin%26aufirst%3DM.%2BCynthia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31072020%26date%3D07122020%26volume%3D63%26issue%3D24%26spage%3D15344%26epage%3D15370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lihai Yu, Nikola Despotovic, Michael S. Kovacs, Christopher L. Pin, <span class="NLM_string-name hlFld-ContribAuthor">Leonard G. Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 334-340. <a href="https://doi.org/10.1021/acsmedchemlett.8b00613" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D18F-Labeled%252BPET%252BProbe%252BTargeting%252BEnhancer%252Bof%252BZeste%252BHomologue%252B2%252B%252528EZH2%252529%252Bfor%252BCancer%252BImaging%26aulast%3DYu%26aufirst%3DLihai%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06122018%26date%3D21022019%26date%3D27022019%26volume%3D10%26issue%3D3%26spage%3D334%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Zhang, Sailan Chang, Shanliang Dong, Lihua Qiu, <span class="NLM_string-name hlFld-ContribAuthor">Xinfang Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-Promoted Bicyclization of Diaryl Alkynes: Synthesis of 2H-Indazoles with in Situ Generated Diazonium Salt as Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9125-9136. <a href="https://doi.org/10.1021/acs.joc.8b01199" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01199%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcid-Promoted%252BBicyclization%252Bof%252BDiaryl%252BAlkynes%25253A%252BSynthesis%252Bof%252B2H-Indazoles%252Bwith%252Bin%252BSitu%252BGenerated%252BDiazonium%252BSalt%252Bas%252BNitrogen%252BSource%26aulast%3DZhang%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10052018%26date%3D21062018%26date%3D08062018%26volume%3D83%26issue%3D16%26spage%3D9125%26epage%3D9136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Siegfried H. Reich, Paul A. Sprengeler, Gary G. Chiang, James R. Appleman, Joan Chen, Jeff Clarine, Boreth Eam, Justin T. Ernst, Qing Han, Vikas K. Goel, Edward Z. R. Han, Vera Huang, Ivy N. J. Hung, Adrianna Jemison, Katti A. Jessen, Jolene Molter, Douglas Murphy, Melissa Neal, Gregory S. Parker, Michael Shaghafi, Samuel Sperry, Jocelyn Staunton, Craig R. Stumpf, Peggy A. Thompson, Chinh Tran, Stephen E. Webber, Christopher J. Wegerski, Hong Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Kevin R. Webster</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3516-3540. <a href="https://doi.org/10.1021/acs.jmedchem.7b01795" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252BDesign%252Bof%252BPyridone%2525E2%252580%252593Aminal%252BeFT508%252BTargeting%252BDysregulated%252BTranslation%252Bby%252BSelective%252BMitogen-activated%252BProtein%252BKinase%252BInteracting%252BKinases%252B1%252Band%252B2%252B%252528MNK1%25252F2%252529%252BInhibition%26aulast%3DReich%26aufirst%3DSiegfried%2BH.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D29032018%26date%3D10032018%26volume%3D61%26issue%3D8%26spage%3D3516%26epage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Michael L.  Martini</span>, and <span class="hlFld-ContribAuthor ">Jian  Jin</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Protein Methyltransferases and Demethylases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 989-1068. <a href="https://doi.org/10.1021/acs.chemrev.6b00801" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00801%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DInhibitors%252Bof%252BProtein%252BMethyltransferases%252Band%252BDemethylases%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259Cmit%26date%3D2018%26date%3D2017%26date%3D2016%26date%3D30112016%26date%3D24032017%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D989%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmei  Chen</span>, <span class="hlFld-ContribAuthor ">Yumei  Chen</span>, <span class="hlFld-ContribAuthor ">Qingmei  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaohan  Zhang</span>, <span class="hlFld-ContribAuthor ">Weike  Liao</span>, <span class="hlFld-ContribAuthor ">Zhixu  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and vibrational properties of N-(8-(3-(3-(tert-butyl)ureido)phenyl)imidazo[1,2-a]pyridin-6-yl)acetamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1245 </em>, 131101. <a href="https://doi.org/10.1016/j.molstruc.2021.131101" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bvibrational%252Bproperties%252Bof%252BN-%2525288-%2525283-%2525283-%252528tert-butyl%252529ureido%252529phenyl%252529imidazo%25255B1%25252C2-a%25255Dpyridin-6-yl%252529acetamide%26aulast%3DChen%26aufirst%3DDongmei%26date%3D2021%26volume%3D1245%26spage%3D131101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamakoti P.  Bhat</span>, <span class="hlFld-ContribAuthor ">H.  Ümit Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Or  Gozani</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>20 </em>
                                    (4)
                                     , 265-286. <a href="https://doi.org/10.1038/s41573-020-00108-x" title="DOI URL">https://doi.org/10.1038/s41573-020-00108-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-020-00108-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-020-00108-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DEpigenetics%252Band%252Bbeyond%25253A%252Btargeting%252Bwriters%252Bof%252Bprotein%252Blysine%252Bmethylation%252Bto%252Btreat%252Bdisease%26aulast%3DBhat%26aufirst%3DKamakoti%2BP.%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D4%26spage%3D265%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiangsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi  Hu</span>, <span class="hlFld-ContribAuthor ">Lu  Li</span>, <span class="hlFld-ContribAuthor ">Lidan  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoquan  Wan</span>, <span class="hlFld-ContribAuthor ">Qiang  Feng</span>, <span class="hlFld-ContribAuthor ">Yongxia  Zhu</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of SKLB-0335 as a paralog-selective EZH2 covalent inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (24)
                                     , 3006-3009. <a href="https://doi.org/10.1039/D0CC04670A" title="DOI URL">https://doi.org/10.1039/D0CC04670A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC04670A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC04670A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DThe%252Bdiscovery%252Bof%252BSKLB-0335%252Bas%252Ba%252Bparalog-selective%252BEZH2%252Bcovalent%252Binhibitor%26aulast%3DZhang%26aufirst%3DQiangsheng%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D24%26spage%3D3006%26epage%3D3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milly  Dockerill</span>, <span class="hlFld-ContribAuthor ">Clare  Gregson</span>, <span class="hlFld-ContribAuthor ">Daniel H.  O’ Donovan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (2)
                                     , 119-135. <a href="https://doi.org/10.1080/13543776.2021.1841167" title="DOI URL">https://doi.org/10.1080/13543776.2021.1841167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1841167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1841167%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTargeting%252BPRC2%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252B%2525282016%252B-%252B2020%252529%26aulast%3DDockerill%26aufirst%3DMilly%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D2%26spage%3D119%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anqi  Ma</span>, <span class="hlFld-ContribAuthor ">Elias  Stratikopoulos</span>, <span class="hlFld-ContribAuthor ">Kwang-Su  Park</span>, <span class="hlFld-ContribAuthor ">Jieli  Wei</span>, <span class="hlFld-ContribAuthor ">Tiphaine C.  Martin</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Megan  Schwarz</span>, <span class="hlFld-ContribAuthor ">Violetta  Leshchenko</span>, <span class="hlFld-ContribAuthor ">Alexander  Rialdi</span>, <span class="hlFld-ContribAuthor ">Brandon  Dale</span>, <span class="hlFld-ContribAuthor ">Alessandro  Lagana</span>, <span class="hlFld-ContribAuthor ">Ernesto  Guccione</span>, <span class="hlFld-ContribAuthor ">Samir  Parekh</span>, <span class="hlFld-ContribAuthor ">Ramon  Parsons</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a first-in-class EZH2 selective degrader. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (2)
                                     , 214-222. <a href="https://doi.org/10.1038/s41589-019-0421-4" title="DOI URL">https://doi.org/10.1038/s41589-019-0421-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0421-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0421-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bfirst-in-class%252BEZH2%252Bselective%252Bdegrader%26aulast%3DMa%26aufirst%3DAnqi%26date%3D2020%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D214%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas L.  Clarke</span>, <span class="hlFld-ContribAuthor ">Ran  Tang</span>, <span class="hlFld-ContribAuthor ">Damayanti  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Capucine  Van Rechem</span>, <span class="hlFld-ContribAuthor ">Fei  Ji</span>, <span class="hlFld-ContribAuthor ">Sweta  Mishra</span>, <span class="hlFld-ContribAuthor ">Anqi  Ma</span>, <span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Michael S.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Ruslan I.  Sadreyev</span>, <span class="hlFld-ContribAuthor ">Johnathan R.  Whetstine</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Lysine Methylation Dynamics Control
              EGFR
              DNA Copy-Number Amplification. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 306-325. <a href="https://doi.org/10.1158/2159-8290.CD-19-0463" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-19-0463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-19-0463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-19-0463%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DHistone%252BLysine%252BMethylation%252BDynamics%252BControl%252BEGFR%252BDNA%252BCopy-Number%252BAmplification%26aulast%3DClarke%26aufirst%3DThomas%2BL.%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D2%26spage%3D306%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junghyun L.  Suh</span>, <span class="hlFld-ContribAuthor ">Kimberly D.  Barnash</span>, <span class="hlFld-ContribAuthor ">Tigran M.  Abramyan</span>, <span class="hlFld-ContribAuthor ">Fengling  Li</span>, <span class="hlFld-ContribAuthor ">Juliana  The</span>, <span class="hlFld-ContribAuthor ">Isabelle A.  Engelberg</span>, <span class="hlFld-ContribAuthor ">Masoud  Vedadi</span>, <span class="hlFld-ContribAuthor ">Peter J.  Brown</span>, <span class="hlFld-ContribAuthor ">Dmitri B.  Kireev</span>, <span class="hlFld-ContribAuthor ">Cheryl H.  Arrowsmith</span>, <span class="hlFld-ContribAuthor ">Lindsey I.  James</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective activators of PRC2 mutant EED-I363M. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-43005-z" title="DOI URL">https://doi.org/10.1038/s41598-019-43005-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-43005-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-43005-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Bselective%252Bactivators%252Bof%252BPRC2%252Bmutant%252BEED-I363M%26aulast%3DSuh%26aufirst%3DJunghyun%2BL.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Du</span>, <span class="hlFld-ContribAuthor ">Xiuheng  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Weng</span>, <span class="hlFld-ContribAuthor ">Jia  Guo</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2019.10359" title="DOI URL">https://doi.org/10.3892/ol.2019.10359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2019.10359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2019.10359%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DEZH2%252Binhibition%252Bsuppresses%252Bbladder%252Bcancer%252Bcell%252Bgrowth%252Band%252Bmetastasis%252Bvia%252Bthe%252BJAK2%25252FSTAT3%252Bsignaling%252Bpathway%26aulast%3DChen%26aufirst%3DZhiyuan%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 351-368. <a href="https://doi.org/10.1016/j.ejmech.2019.01.069" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.069%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Bmethyl%252Btransferases%25253A%252BA%252Bclass%252Bof%252Bepigenetic%252Bopportunities%252Bto%252Bcounter%252Buncontrolled%252Bcell%252Bproliferation%26aulast%3DSingh%26aufirst%3DPankaj%2BKumar%26date%3D2019%26volume%3D166%26spage%3D351%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Fioravanti</span>, <span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Six Years (2012–2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2‐Pyridone Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1818-1832. <a href="https://doi.org/10.1002/tcr.201800091" title="DOI URL">https://doi.org/10.1002/tcr.201800091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201800091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201800091%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DSix%252BYears%252B%2525282012%2525E2%252580%2525932018%252529%252Bof%252BResearches%252Bon%252BCatalytic%252BEZH2%252BInhibitors%25253A%252BThe%252BBoom%252Bof%252Bthe%252B2%2525E2%252580%252590Pyridone%252BCompounds%26aulast%3DFioravanti%26aufirst%3DRossella%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1818%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Bratkowski</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-27175-w" title="DOI URL">https://doi.org/10.1038/s41598-018-27175-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-27175-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-27175-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAn%252BEvolutionarily%252BConserved%252BStructural%252BPlatform%252Bfor%252BPRC2%252BInhibition%252Bby%252Ba%252BClass%252Bof%252BEzh2%252BInhibitors%26aulast%3DBratkowski%26aufirst%3DMatthew%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingjiu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Xia</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Wen  Hu</span>, <span class="hlFld-ContribAuthor ">Yunchang  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2018,</strong> <em>29 </em>
                                    (8)
                                     , 767-773. <a href="https://doi.org/10.1097/CAD.0000000000000645" title="DOI URL">https://doi.org/10.1097/CAD.0000000000000645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000000645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000000645%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DLncRNA%252BMALAT1%252Bpromotes%252Bepithelial-to-mesenchymal%252Btransition%252Bof%252Besophageal%252Bcancer%252Bthrough%252BEzh2-Notch1%252Bsignaling%252Bpathway%26aulast%3DChen%26aufirst%3DMingjiu%26date%3D2018%26volume%3D29%26issue%3D8%26spage%3D767%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunshou  Zhu</span>, <span class="hlFld-ContribAuthor ">Yujie  Deng</span>, <span class="hlFld-ContribAuthor ">Guoxing  Weng</span>, <span class="hlFld-ContribAuthor ">Dan  Hu</span>, <span class="hlFld-ContribAuthor ">Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Keitaro  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Takeshi  Nagayasu</span>, <span class="hlFld-ContribAuthor ">Takehiko  Koji</span>, <span class="hlFld-ContribAuthor ">Xiongwei  Zheng</span>, <span class="hlFld-ContribAuthor ">Wenhui  Jiang</span>, <span class="hlFld-ContribAuthor ">Gen  Lin</span>, <span class="hlFld-ContribAuthor ">Yibin  Cai</span>, <span class="hlFld-ContribAuthor ">Guibin  Weng</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2018.8100" title="DOI URL">https://doi.org/10.3892/ol.2018.8100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2018.8100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2018.8100%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DAnalysis%252Bof%252BH3K27me3%252Bexpression%252Band%252BDNA%252Bmethylation%252Bat%252BCCGG%252Bsites%252Bin%252Bsmoking%252Band%252Bnon-smoking%252Bpatients%252Bwith%252Bnon-small%252Bcell%252Blung%252Bcancer%252Band%252Btheir%252Bclinical%252Bsignificance%26aulast%3DZhu%26aufirst%3DKunshou%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashutosh  Kumar</span>, <span class="hlFld-ContribAuthor ">Kam Y. J.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A cross docking pipeline for improving pose prediction and virtual screening performance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2018,</strong> <em>32 </em>
                                    (1)
                                     , 163-173. <a href="https://doi.org/10.1007/s10822-017-0048-z" title="DOI URL">https://doi.org/10.1007/s10822-017-0048-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-017-0048-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-017-0048-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DA%252Bcross%252Bdocking%252Bpipeline%252Bfor%252Bimproving%252Bpose%252Bprediction%252Band%252Bvirtual%252Bscreening%252Bperformance%26aulast%3DKumar%26aufirst%3DAshutosh%26date%3D2018%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D163%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 inhibitors: a patent review (2014-2016). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 797-813. <a href="https://doi.org/10.1080/13543776.2017.1316976" title="DOI URL">https://doi.org/10.1080/13543776.2017.1316976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1316976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1316976%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEZH2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-2016%252529%26aulast%3DStazi%26aufirst%3DGiulia%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D797%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported small-molecule inhibitors of EZH2 and EZH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regions of compound <b>5</b> investigated for EZH2 and EZH1 selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked pose of compound <b>5</b> in the human PRC2 structure. (A) Docked pose of compound <b>5</b> (pink). (B) A 2D representation of molecular interactions between compound <b>5</b> and the residues of the binding site. (C) Superimposition of compound <b>5</b> and SAH (aligned from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). The pyridone moiety of compound <b>5</b> mimics the homocysteine moiety of SAH (green). (D) Binding site of PRC2 complex where compound <b>5</b> binds through a groove formed by the SET domain and the activation loop of EZH2 (aqua) and the EED complex (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Syntheses of Key Intermediates and Derivatives of <b>5</b> for SAR Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding site in the SET domain of EZH2. (A) Close view on the pyridone moiety of compound <b>5</b> from its docked pose in human PRC2 complex. Substitution at 4-position of the pyridone ring allows the compound to make more van der Waals contacts with F665, R685 and F686. (B) Close view on the pyridone moiety of compound <b>31</b> from its docked pose in human PRC2 complex. White surface, EZH2 binding pocket; purple, van der Waals surface of the ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two possible docking poses for compound <b>63</b>. (A) The indazole moiety rotates 180° in relation to compound <b>5</b>, and the hexanol interacts through hydrogen bonds with Y658 and R679. (B) The hexanol group is outside the catalytic binding site and interacts with K211 of EED.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/medium/jm-2016-00855m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Two possible docking poses for compound <b>76</b>. (A) The bromo group is an acceptor of hydrogen bond from C663 and the benzene ring of the indazole stacks with Y111 of the activation loop. (B) A 180° rotation around the benzamide bond leads to both indazole rings stacking with Y111.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00855/20160819/images/large/jm-2016-00855m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00855&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Role of histone H3 lysine 27 methylation in Polycomb-group silencing</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span><span class="refDoi"> DOI: 10.1126/science.1076997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1126%2Fscience.1076997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12351676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot12rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1039-1043&author=R.+Caoauthor=L.+Wangauthor=H.+Wangauthor=L.+Xiaauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=R.+S.+Jonesauthor=Y.+Zhang&title=Role+of+histone+H3+lysine+27+methylation+in+Polycomb-group+silencing&doi=10.1126%2Fscience.1076997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing</span></div><div class="casAuthors">Cao, Ru; Wang, Liangjun; Wang, Hengbin; Xia, Li; Erdjument-Bromage, Hediye; Tempst, Paul; Jones, Richard S.; Zhang, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5595</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins play important roles in maintaining the silent state of HOX genes.  Recent studies have implicated histone methylation in long-term gene silencing.  However, a connection between PcG-mediated gene silencing and histone methylation has not been established.  Here the authors report the purifn. and characterization of an EED-EZH2 complex, the human counterpart of the Drosophila ESC-E(Z) complex.  They demonstrate that the complex specifically methylates nucleosomal histone H3 at lysine 27 (H3-K27).  Using chromatin immunopptn. assays, the authors show that H3-K27 methylation colocalizes with, and is dependent on, E(Z) binding at an Ultrabithorax med° (Ubx) Polycomb response element (PRE), and that this methylation correlates with Ubx repression.  Methylation on H3-K27 facilitates binding of Polycomb (PC), a component of the PRC1 complex, to histone H3 amino-terminal tail.  Thus, these studies establish a link between histone methylation and PcG-mediated gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnqusXKZEbLVg90H21EOLACvtfcHk0lgn1oDyJ_ZdSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot12rs7g%253D&md5=8f24c05ec935c9110b2ff85b65911396</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076997%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DRole%2520of%2520histone%2520H3%2520lysine%252027%2520methylation%2520in%2520Polycomb-group%2520silencing%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1039%26epage%3D1043%26doi%3D10.1126%2Fscience.1076997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kuzmichev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span><span class="refDoi"> DOI: 10.1101/gad.1035902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1101%2Fgad.1035902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12435631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVejsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2893-2905&author=A.+Kuzmichevauthor=K.+Nishiokaauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+Reinberg&title=Histone+methyltransferase+activity+associated+with+a+human+multiprotein+complex+containing+the+Enhancer+of+Zeste+protein&doi=10.1101%2Fgad.1035902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein</span></div><div class="casAuthors">Kuzmichev, Andrei; Nishioka, Kenichi; Erdjument-Bromage, Hediye; Tempst, Paul; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2893-2905</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Enhancer of Zeste [E(z)] is a Polycomb-group transcriptional repressor and one of the founding members of the family of SET domain-contg. proteins.  Several SET-domain proteins possess intrinsic histone methyltransferase (HMT) activity.  However, recombinant E(z) protein was found to be inactive in a HMT assay.  Here we report the isolation of a multiprotein E(z) complex that contains extra sex combs, suppressor of zeste-12 [Su(z)12], and the histone binding proteins RbAp46/RbAp48.  This complex, which we termed Polycomb repressive complex (PRC) 2, possesses HMT activity with specificity for Lys 9 (K9) and Lys 27 (K27) of histone H3.  The HMT activity of PRC2 is dependent on an intact SET domain in the E(z) protein.  We hypothesize that transcriptional repression by the E(z) protein involves methylation-dependent recruitment of PRC1.  The presence of Su(z)12, a strong suppressor of position effect variegation, in PRC2 suggests that PRC2 may play a widespread role in heterochromatin-mediated silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxD09IiaeCvLVg90H21EOLACvtfcHk0lhUJOp3wBkaEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVejsLY%253D&md5=b61767bc9b30b403f5fc7bb202281da1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.1035902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1035902%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmichev%26aufirst%3DA.%26aulast%3DNishioka%26aufirst%3DK.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DHistone%2520methyltransferase%2520activity%2520associated%2520with%2520a%2520human%2520multiprotein%2520complex%2520containing%2520the%2520Enhancer%2520of%2520Zeste%2520protein%26jtitle%3DGenes%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D2893%26epage%3D2905%26doi%3D10.1101%2Fgad.1035902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">The Polycomb complex PRC2 and its mark in life</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1038/nature09784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature09784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=21248841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=343-349&author=R.+Margueronauthor=D.+Reinberg&title=The+Polycomb+complex+PRC2+and+its+mark+in+life&doi=10.1038%2Fnature09784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Polycomb complex PRC2 and its mark in life</span></div><div class="casAuthors">Margueron, Raphael; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7330</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure.  In mammals, 2 main Polycomb group complexes exist: Polycomb repressive complex 1 (PRC1) and 2 (PRC2).  PRC1 compacts chromatin and catalyzes the monoubiquitination of histone H2A.  PRC2 also contributes to chromatin compaction, and catalyzes the methylation of histone H3 at Lys-27.  PRC2 is involved in various biol. processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity.  Recent studies of PRC2 have expanded the perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fYmuBqnMA7Vg90H21EOLACvtfcHk0lhUJOp3wBkaEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D&md5=5f15e91cc6ff765f649842041f333841</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09784%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DThe%2520Polycomb%2520complex%2520PRC2%2520and%2520its%2520mark%2520in%2520life%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D343%26epage%3D349%26doi%3D10.1038%2Fnature09784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Di Croce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Transcriptional regulation by polycomb group proteins</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1038/nsmb.2669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnsmb.2669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24096405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOiurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1147-1155&author=L.+Di+Croceauthor=K.+Helin&title=Transcriptional+regulation+by+polycomb+group+proteins&doi=10.1038%2Fnsmb.2669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional regulation by Polycomb group proteins</span></div><div class="casAuthors">Di Croce, Luciano; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1147-1155</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group (PcG) proteins are epigenetic regulators of transcription that have key roles in stem-cell identity, differentiation and disease.  Mechanistically, they function within multiprotein complexes, called Polycomb repressive complexes (PRCs), which modify histones (and other proteins) and silence target genes.  The dynamics of PRC1 and PRC2 components has been the focus of recent research.  Here we discuss our current knowledge of the PRC complexes, how they are targeted to chromatin and how the high diversity of the PcG proteins allows these complexes to influence cell identity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNyrbNU897Vg90H21EOLACvtfcHk0lgJZCSm6Z07lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOiurrP&md5=004c2682edbda681e9f6de84ba87e639</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2669%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCroce%26aufirst%3DL.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DTranscriptional%2520regulation%2520by%2520polycomb%2520group%2520proteins%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1147%26epage%3D1155%26doi%3D10.1038%2Fnsmb.2669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Vizan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Croce, L.</span><span> </span><span class="NLM_article-title">Role of PRC2-associated factors in stem cells and disease</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span><span class="refDoi"> DOI: 10.1111/febs.13083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1111%2Ffebs.13083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=1723-1735&author=P.+Vizanauthor=M.+Beringerauthor=C.+Ballareauthor=L.+Di+Croce&title=Role+of+PRC2-associated+factors+in+stem+cells+and+disease&doi=10.1111%2Ffebs.13083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13083%26sid%3Dliteratum%253Aachs%26aulast%3DVizan%26aufirst%3DP.%26aulast%3DBeringer%26aufirst%3DM.%26aulast%3DBallare%26aufirst%3DC.%26aulast%3DDi%2BCroce%26aufirst%3DL.%26atitle%3DRole%2520of%2520PRC2-associated%2520factors%2520in%2520stem%2520cells%2520and%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D1723%26epage%3D1735%26doi%3D10.1111%2Ffebs.13083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.molcel.2004.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.molcel.2004.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=15225548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFejurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=57-67&author=R.+Caoauthor=Y.+Zhang&title=SUZ12+is+required+for+both+the+histone+methyltransferase+activity+and+the+silencing+function+of+the+EED-EZH2+complex&doi=10.1016%2Fj.molcel.2004.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex</span></div><div class="casAuthors">Cao, Ru; Zhang, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies have revealed the intrinsic histone methyltransferase (HMTase) activity of the EED-EZH2 complex and its role in Hox gene silencing, X inactivation, and cancer metastasis.  In this study, we focus on the function of individual components.  We found that the HMTase activity requires a min. of three components - EZH2, EED, and SUZ12 - while AEBP2 is required for optimal enzymic activity.  Using a stable SUZ12 knockdown cell line, we show SUZ12 knockdown results in cell growth defects, which correlate with genome-wide alteration on H3-K27 methylation as well as upregulation of a no. of Hox genes.  Chromatin immunopptn. (ChIP) assay identified a 500 bp region located 4 kb upstream of the HoxA9 transcription initiation site as a SUZ12 binding site, which responds to SUZ12 knockdown and might play an important role in regulating HoxA9 expression.  Thus, our study establishes a crit. role of SUZ12 in H3-lysine 27 methylation and Hox gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWQGRfTk9TrVg90H21EOLACvtfcHk0lj1yw1Y-_deAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFejurc%253D&md5=4b26382db05fda3e55b5f05dc2e1da9a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSUZ12%2520is%2520required%2520for%2520both%2520the%2520histone%2520methyltransferase%2520activity%2520and%2520the%2520silencing%2520function%2520of%2520the%2520EED-EZH2%2520complex%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fj.molcel.2004.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Montgomery, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalantry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, T.</span><span> </span><span class="NLM_article-title">The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1016/j.cub.2005.04.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.cub.2005.04.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=15916951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=942-947&author=N.+D.+Montgomeryauthor=D.+Yeeauthor=A.+Chenauthor=S.+Kalantryauthor=S.+J.+Chamberlainauthor=A.+P.+Otteauthor=T.+Magnuson&title=The+murine+polycomb+group+protein+Eed+is+required+for+global+histone+H3+lysine-27+methylation&doi=10.1016%2Fj.cub.2005.04.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation</span></div><div class="casAuthors">Montgomery, Nathan D.; Yee, Della; Chen, Andrew; Kalantry, Sundeep; Chamberlain, Stormy J.; Otte, Arie P.; Magnuson, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">942-947</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PcG proteins mediate heritable transcriptional silencing by generating and recognizing covalent histone modifications.  One conserved PcG complex, PRC2, is composed of several proteins including the histone methyltransferase (HMTase) Ezh2, the WD-repeat protein Eed, and the Zn-finger protein Suz12.  Ezh2 methylates histone H3 on lysine 27 (H3K27) [1-4], which serves as an epigenetic mark mediating silencing.  H3K27 can be mono-, di-, or trimethylated (1mH3K27, 2mH3K27, and 3mH3K27, resp.) [5].  Hence, either PRC2 must be regulated so as to add one Me group to certain nucleosomes but two or three to others, or distinct complexes must be responsible for 1m-, 2m-, and 3mH3K27.  Consistent with the latter possibility, 2mH3K27 and 3mH3K27, but not 1mH3K27, are absent in Suz12-/- embryos, which lack both Suz12 and Ezh2 protein [6].  Mammalian proteins required for 1mH3K27 have not been identified.  Here, authors demonstrate that unlike Suz12 and Ezh2, Eed is required not only for 2m- and 3mH3K27 but also global 1mH3K27.  These results provide a functionally important distinction between PRC2 complex components and implicate Eed in PRC2-independent histone methylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5aUVC-VrdLVg90H21EOLACvtfcHk0lj1yw1Y-_deAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gjt7k%253D&md5=2d378f554b3593f129cf512a04a69b75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.04.051%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DN.%2BD.%26aulast%3DYee%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKalantry%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DS.%2BJ.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DMagnuson%26aufirst%3DT.%26atitle%3DThe%2520murine%2520polycomb%2520group%2520protein%2520Eed%2520is%2520required%2520for%2520global%2520histone%2520H3%2520lysine-27%2520methylation%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D942%26epage%3D947%26doi%3D10.1016%2Fj.cub.2005.04.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drury, W. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Role of the polycomb protein EED in the propagation of repressive histone marks</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">762</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span><span class="refDoi"> DOI: 10.1038/nature08398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature08398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=19767730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=762-767&author=R.+Margueronauthor=N.+Justinauthor=K.+Ohnoauthor=M.+L.+Sharpeauthor=J.+Sonauthor=W.+J.+Druryauthor=P.+Voigtauthor=S.+R.+Martinauthor=W.+R.+Taylorauthor=V.+De+Marcoauthor=V.+Pirrottaauthor=D.+Reinbergauthor=S.+J.+Gamblin&title=Role+of+the+polycomb+protein+EED+in+the+propagation+of+repressive+histone+marks&doi=10.1038%2Fnature08398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the polycomb protein EED in the propagation of repressive histone marks</span></div><div class="casAuthors">Margueron, Raphael; Justin, Neil; Ohno, Katsuhito; Sharpe, Miriam L.; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Pirrotta, Vincenzo; Reinberg, Danny; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7265</span>),
    <span class="NLM_cas:pages">762-767</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb group proteins have an essential role in the epigenetic maintenance of repressive chromatin states.  The gene-silencing activity of the Polycomb repressive complex 2 (PRC2) depends on its ability to trimethylate lysine 27 of histone H3 (H3K27) by the catalytic SET domain of the EZH2 subunit, and at least two other subunits of the complex: SUZ12 and EED.  Here we show that the carboxy-terminal domain of EED specifically binds to histone tails carrying trimethyl-lysine residues assocd. with repressive chromatin marks, and that this leads to the allosteric activation of the methyltransferase activity of PRC2.  Mutations in EED that prevent it from recognizing repressive trimethyl-lysine marks abolish the activation of PRC2 in vitro and, in Drosophila, reduce global methylation and disrupt development.  These findings suggest a model for the propagation of the H3K27me3 mark that accounts for the maintenance of repressive chromatin domains and for the transmission of a histone modification from mother to daughter cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSke4t5N1P3LVg90H21EOLACvtfcHk0liwo6Sxca1M4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjt73N&md5=63ee782ee42fb9c711a5d2fdf7d4e022</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08398%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DOhno%26aufirst%3DK.%26aulast%3DSharpe%26aufirst%3DM.%2BL.%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DDrury%26aufirst%3DW.%2BJ.%26aulast%3DVoigt%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DPirrotta%26aufirst%3DV.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DRole%2520of%2520the%2520polycomb%2520protein%2520EED%2520in%2520the%2520propagation%2520of%2520repressive%2520histone%2520marks%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D762%26epage%3D767%26doi%3D10.1038%2Fnature08398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">The polycomb group protein Suz12 is required for embryonic stem cell differentiation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3779</span><span class="refDoi"> DOI: 10.1128/MCB.01432-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1128%2FMCB.01432-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=17339329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlant7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3769-3779&author=D.+Pasiniauthor=A.+P.+Brackenauthor=J.+B.+Hansenauthor=M.+Capilloauthor=K.+Helin&title=The+polycomb+group+protein+Suz12+is+required+for+embryonic+stem+cell+differentiation&doi=10.1128%2FMCB.01432-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein Suz12 is required for embryonic stem cell differentiation</span></div><div class="casAuthors">Pasini, Diego; Bracken, Adrian P.; Hansen, Jacob B.; Capillo, Manuela; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3769-3779</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins form multi-protein complexes, called Polycomb repressive complexes (PRCs).  PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through methylation of lysine (K) 27 of histone H3.  Suz12 is essential for PRC2 activity and its inactivation results in early lethality of mouse embryos.  Here, we demonstrate that Suz12-/- mouse embryonic stem (ES) cells can be established and expanded in tissue culture.  The Suz12-/- ES cells are characterized by global loss of H3K27 trimethylation (H3K27me3) and higher expression levels of differentiation-specific genes.  Moreover, Suz12-/- ES cells are impaired in proper differentiation, resulting in a lack of repression of ES cell markers as well as activation of differentiation-specific genes.  Finally, we demonstrate that the PcGs are actively recruited to several genes during ES cell differentiation, which despite an increase in H3K27me3 levels is not always sufficient to prevent transcriptional activation.  In summary, we demonstrate that Suz12 is required for the establishment of specific expression programs required for ES cell differentiation.  Furthermore, we provide evidence that PcGs have different mechanisms to regulate transcription during cellular differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLmYgFw82E7Vg90H21EOLACvtfcHk0liwo6Sxca1M4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlant7w%253D&md5=43476df10242b490e5f819551bfb58fe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.01432-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01432-06%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26aulast%3DCapillo%26aufirst%3DM.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DThe%2520polycomb%2520group%2520protein%2520Suz12%2520is%2520required%2520for%2520embryonic%2520stem%2520cell%2520differentiation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D3769%26epage%3D3779%26doi%3D10.1128%2FMCB.01432-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzerini Denchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4061</span><span class="NLM_x">–</span> <span class="NLM_lpage">4071</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fsj.emboj.7600402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4061-4071&author=D.+Pasiniauthor=A.+P.+Brackenauthor=M.+R.+Jensenauthor=E.+Lazzerini+Denchiauthor=K.+Helin&title=Suz12+is+essential+for+mouse+development+and+for+EZH2+histone+methyltransferase+activity&doi=10.1038%2Fsj.emboj.7600402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600402%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DLazzerini%2BDenchi%26aufirst%3DE.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DSuz12%2520is%2520essential%2520for%2520mouse%2520development%2520and%2520for%2520EZH2%2520histone%2520methyltransferase%2520activity%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D4061%26epage%3D4071%26doi%3D10.1038%2Fsj.emboj.7600402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83737</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1371%2Fjournal.pone.0083737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83737&author=H.+Wuauthor=H.+Zengauthor=A.+Dongauthor=F.+Liauthor=H.+Heauthor=G.+Senisterraauthor=A.+Seitovaauthor=S.+Duanauthor=P.+J.+Brownauthor=M.+Vedadiauthor=C.+H.+Arrowsmithauthor=M.+Schapira&title=Structure+of+the+catalytic+domain+of+EZH2+reveals+conformational+plasticity+in+cofactor+and+substrate+binding+sites+and+explains+oncogenic+mutations&doi=10.1371%2Fjournal.pone.0083737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083737%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DSeitova%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520EZH2%2520reveals%2520conformational%2520plasticity%2520in%2520cofactor%2520and%2520substrate%2520binding%2520sites%2520and%2520explains%2520oncogenic%2520mutations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83737%26doi%3D10.1371%2Fjournal.pone.0083737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Antonysamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druzina, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanno, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately Luz, J.</span><span> </span><span class="NLM_article-title">Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84147</span><span class="refDoi"> DOI: 10.1371/journal.pone.0084147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1371%2Fjournal.pone.0084147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24367637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e84147&author=S.+Antonysamyauthor=B.+Condonauthor=Z.+Druzinaauthor=J.+B.+Bonannoauthor=T.+Gheyiauthor=F.+Zhangauthor=I.+MacEwanauthor=A.+Zhangauthor=S.+Ashokauthor=L.+Rodgersauthor=M.+Russellauthor=J.+Gately+Luz&title=Structural+context+of+disease-associated+mutations+and+putative+mechanism+of+autoinhibition+revealed+by+X-ray+crystallographic+analysis+of+the+EZH2-SET+domain&doi=10.1371%2Fjournal.pone.0084147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain</span></div><div class="casAuthors">Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Bonanno, Jeffrey B.; Gheyi, Tarun; Zhang, Feiyu; MacEwan, Iain; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e84147/1-e84147/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The enhancer-of-zeste homolog 2 (EZH2) gene product is an 87 kDa polycomb group (PcG) protein contg. a C-terminal methyltransferase SET domain.  EZH2, along with binding partners, i.e., EED and SUZ12, upon which it is dependent for activity forms the core of the polycomb repressive complex 2 (PRC2).  PRC2 regulates gene silencing by catalyzing the methylation of histone H3 at lysine 27.  Both overexpression and mutation of EZH2 are assocd. with the incidence and aggressiveness of various cancers.  The novel crystal structure of the SET domain was detd. in order to understand disease-assocd. EZH2 mutations and derive an explanation for its inactivity independent of complex formation.  The 2.00 Å crystal structure reveals that, in its uncomplexed form, the EZH2 C-terminus folds back into the active site blocking engagement with substrate.  Furthermore, the S-adenosyl-L-methionine (SAM) binding pocket obsd. in the crystal structure of homologous SET domains is notably absent.  This suggests that a conformational change in the EZH2 SET domain, dependent upon complex formation, must take place for cofactor and substrate binding activities to be recapitulated.  In addn., the data provide a structural context for clin. significant mutations found in the EZH2 SET domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj6NrYMrUF8rVg90H21EOLACvtfcHk0lhdJcA-C8CjyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVeqtrk%253D&md5=a9b259a7e1a5cabd80294be481d7b70b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0084147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0084147%26sid%3Dliteratum%253Aachs%26aulast%3DAntonysamy%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DDruzina%26aufirst%3DZ.%26aulast%3DBonanno%26aufirst%3DJ.%2BB.%26aulast%3DGheyi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DMacEwan%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DAshok%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DGately%2BLuz%26aufirst%3DJ.%26atitle%3DStructural%2520context%2520of%2520disease-associated%2520mutations%2520and%2520putative%2520mechanism%2520of%2520autoinhibition%2520revealed%2520by%2520X-ray%2520crystallographic%2520analysis%2520of%2520the%2520EZH2-SET%2520domain%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De84147%26doi%3D10.1371%2Fjournal.pone.0084147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">aac4383</span><span class="refDoi"> DOI: 10.1126/science.aac4383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1126%2Fscience.aac4383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26472914" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac4383&author=L.+Jiaoauthor=X.+Liu&title=Structural+basis+of+histone+H3K27+trimethylation+by+an+active+polycomb+repressive+complex+2&doi=10.1126%2Fscience.aac4383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac4383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac4383%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520of%2520histone%2520H3K27%2520trimethylation%2520by%2520an%2520active%2520polycomb%2520repressive%2520complex%25202%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac4383%26doi%3D10.1126%2Fscience.aac4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grable, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span> </span><span class="NLM_article-title">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11384</span><span class="refDoi"> DOI: 10.1038/ncomms11384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fncomms11384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=27122193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11384&author=A.+Broounauthor=K.+S.+Gajiwalaauthor=Y.+L.+Dengauthor=W.+Liuauthor=B.+Bolanosauthor=P.+Binghamauthor=Y.+A.+Heauthor=W.+Diehlauthor=N.+Grableauthor=P.+P.+Kungauthor=S.+Suttonauthor=K.+A.+Maegleyauthor=X.+Yuauthor=A.+E.+Stewart&title=Polycomb+repressive+complex+2+structure+with+inhibitor+reveals+a+mechanism+of+activation+and+drug+resistance&doi=10.1038%2Fncomms11384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span></div><div class="casAuthors">Brooun, Alexei; Gajiwala, Ketan S.; Deng, Ya-Li; Liu, Wei; Bolanos, Ben; Bingham, Patrick; He, You-Ai; Diehl, Wade; Grable, Nicole; Kung, Pei-Pei; Sutton, Scott; Maegley, Karen A.; Yu, Xiu; Stewart, Al E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11384</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) mediates gene silencing through chromatin reorganization by methylation of histone H3 lysine 27 (H3K27).  Overexpression of the complex and point mutations in the individual subunits of PRC2 have been shown to contribute to tumorigenesis.  Several inhibitors of the PRC2 activity have shown efficacy in EZH2-mutated lymphomas and are currently in clin. development, although the mol. basis of inhibitor recognition remains unknown.  Here we report the crystal structures of the inhibitor-bound wild-type and Y641N PRC2.  The structures illuminate an important role played by a stretch of 17 residues in the N-terminal region of EZH2, we call the activation loop, in the stimulation of the enzyme activity, inhibitor recognition and the potential development of the mutation-mediated drug resistance.  The work presented here provides new avenues for the design and development of next-generation PRC2 inhibitors through establishment of a structure-based drug design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuWyWQoRoObVg90H21EOLACvtfcHk0liwzyDnWamf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D&md5=15ded613fdc3cafe35bee914678ab65e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms11384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11384%26sid%3Dliteratum%253Aachs%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DGrable%26aufirst%3DN.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26atitle%3DPolycomb%2520repressive%2520complex%25202%2520structure%2520with%2520inhibitor%2520reveals%2520a%2520mechanism%2520of%2520activation%2520and%2520drug%2520resistance%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11384%26doi%3D10.1038%2Fncomms11384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haire, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11316</span><span class="refDoi"> DOI: 10.1038/ncomms11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fncomms11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=27121947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11316&author=N.+Justinauthor=Y.+Zhangauthor=C.+Tarriconeauthor=S.+R.+Martinauthor=S.+Chenauthor=E.+Underwoodauthor=V.+De+Marcoauthor=L.+F.+Haireauthor=P.+A.+Walkerauthor=D.+Reinbergauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Structural+basis+of+oncogenic+histone+H3K27M+inhibition+of+human+polycomb+repressive+complex+2&doi=10.1038%2Fncomms11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span></div><div class="casAuthors">Justin, Neil; Zhang, Ying; Tarricone, Cataldo; Martin, Stephen R.; Chen, Shuyang; Underwood, Elizabeth; De Marco, Valeria; Haire, Lesley F.; Walker, Philip A.; Reinberg, Danny; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11316</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) silences gene expression through trimethylation of K27 of histone H3 (H3K27me3) via its catalytic SET domain.  A missense mutation in the substrate of PRC2, histone H3K27M, is assocd. with certain pediatric brain cancers and is linked to a global decrease of H3K27me3 in the affected cells thought to be mediated by inhibition of PRC2 activity.  We present here the crystal structure of human PRC2 in complex with the inhibitory H3K27M peptide bound to the active site of the SET domain, with the methionine residue located in the pocket that normally accommodates the target lysine residue.  The structure and binding studies suggest a mechanism for the oncogenic inhibition of H3K27M.  The structure also reveals how binding of repressive marks, like H3K27me3, to the EED subunit of the complex leads to enhancement of the catalytic efficiency of the SET domain and thus the propagation of this repressive histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwqJGbneSdbVg90H21EOLACvtfcHk0linE4bsWLLQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D&md5=516a8ef27712c9776e8ee0681cd91289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11316%26sid%3Dliteratum%253Aachs%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520oncogenic%2520histone%2520H3K27M%2520inhibition%2520of%2520human%2520polycomb%2520repressive%2520complex%25202%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11316%26doi%3D10.1038%2Fncomms11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bracken, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosperini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5335</span><span class="refDoi"> DOI: 10.1093/emboj/cdg542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1093%2Femboj%2Fcdg542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5323-5335&author=A.+P.+Brackenauthor=D.+Pasiniauthor=M.+Capraauthor=E.+Prosperiniauthor=E.+Colliauthor=K.+Helin&title=EZH2+is+downstream+of+the+pRB-E2F+pathway%2C+essential+for+proliferation+and+amplified+in+cancer&doi=10.1093%2Femboj%2Fcdg542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg542%26sid%3Dliteratum%253Aachs%26aulast%3DBracken%26aufirst%3DA.%2BP.%26aulast%3DPasini%26aufirst%3DD.%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DColli%26aufirst%3DE.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DEZH2%2520is%2520downstream%2520of%2520the%2520pRB-E2F%2520pathway%252C%2520essential%2520for%2520proliferation%2520and%2520amplified%2520in%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5323%26epage%3D5335%26doi%3D10.1093%2Femboj%2Fcdg542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. A.</span><span> </span><span class="NLM_article-title">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">647</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.mrfmmm.2008.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.mrfmmm.2008.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=18723033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=647&publication_year=2008&pages=21-29&author=J.+A.+Simonauthor=C.+A.+Lange&title=Roles+of+the+EZH2+histone+methyltransferase+in+cancer+epigenetics&doi=10.1016%2Fj.mrfmmm.2008.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span></div><div class="casAuthors">Simon, Jeffrey A.; Lange, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">647</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  EZH2 is the catalytic subunit of Polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3.  This methylated H3-K27 chromatin mark is commonly assocd. with silencing of differentiation genes in organisms ranging from plants to flies to humans.  Studies on human tumors show that EZH2 is frequently over-expressed in a wide variety of cancerous tissue types, including prostate and breast.  Although the mechanistic contributions of EZH2 to cancer progression are not yet detd., functional links between EZH2-mediated histone methylation and DNA methylation suggest partnership with the gene silencing machinery implicated in tumor suppressor loss.  Here we review the basic mol. biol. of EZH2 and the findings that implicate EZH2 in different cancers.  We also discuss EZH2 connections to other silencing enzymes, such as DNA methyltransferases and histone deacetylases, and we consider progress on deciphering mechanistic consequences of EZH2 overabundance and its potential roles in tumorigenesis.  Finally, we review recent findings that link EZH2 roles in stem cells and cancer, and we consider prospects for integrating EZH2 blockade into strategies for developing epigenetic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_YxVHv1IGDrVg90H21EOLACvtfcHk0linE4bsWLLQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP&md5=e80ac4a2ba07b9e1ab4256ba6c73b23f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2008.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2008.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DLange%26aufirst%3DC.%2BA.%26atitle%3DRoles%2520of%2520the%2520EZH2%2520histone%2520methyltransferase%2520in%2520cancer%2520epigenetics%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2008%26volume%3D647%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.mrfmmm.2008.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ding, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merajver, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span> </span><span class="NLM_article-title">Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4099</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1158%2F0008-5472.CAN-05-4300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4095-4099&author=L.+Dingauthor=C.+Erdmannauthor=A.+M.+Chinnaiyanauthor=S.+D.+Merajverauthor=C.+G.+Kleer&title=Identification+of+EZH2+as+a+molecular+marker+for+a+precancerous+state+in+morphologically+normal+breast+tissues&doi=10.1158%2F0008-5472.CAN-05-4300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4300%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DL.%26aulast%3DErdmann%26aufirst%3DC.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DMerajver%26aufirst%3DS.%2BD.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26atitle%3DIdentification%2520of%2520EZH2%2520as%2520a%2520molecular%2520marker%2520for%2520a%2520precancerous%2520state%2520in%2520morphologically%2520normal%2520breast%2520tissues%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4095%26epage%3D4099%26doi%3D10.1158%2F0008-5472.CAN-05-4300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11606</span><span class="NLM_x">–</span> <span class="NLM_lpage">11611</span><span class="refDoi"> DOI: 10.1073/pnas.1933744100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1933744100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=14500907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11606-11611&author=C.+G.+Kleerauthor=Q.+Caoauthor=S.+Varamballyauthor=R.+Shenauthor=I.+Otaauthor=S.+A.+Tomlinsauthor=D.+Ghoshauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=D.+F.+Hayesauthor=M.+S.+Sabelauthor=D.+Livantauthor=S.+J.+Weissauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=EZH2+is+a+marker+of+aggressive+breast+cancer+and+promotes+neoplastic+transformation+of+breast+epithelial+cells&doi=10.1073%2Fpnas.1933744100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span></div><div class="casAuthors">Kleer, Celina G.; Cao, Qi; Varambally, Sooryanarayana; Shen, Ronglai; Ota, Ichiro; Tomlins, Scott A.; Ghosh, Debashis; Sewalt, Richard G. A. B.; Otte, Arie P.; Hayes, Daniel F.; Sabel, Michael S.; Livant, Donna; Weiss, Stephen J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11606-11611</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer.  Here the authors investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression.  EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia.  Tissue microarray anal., which included 917 samples from 280 patients, demonstrated that EZH2 protein levels were strongly assocd. with breast cancer aggressiveness.  Overexpression of EZH2 in immortalized human mammary epithelial cell lines promotes anchorage-independent growth and cell invasion.  EZH2-mediated cell invasion required an intact SET domain and histone deacetylase activity.  This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3vRwhSLDh7Vg90H21EOLACvtfcHk0ljBkqR0mU6PkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D&md5=a362e2d0f3c61c8e8b3afd5cea992255</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1933744100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1933744100%26sid%3Dliteratum%253Aachs%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DSabel%26aufirst%3DM.%2BS.%26aulast%3DLivant%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520is%2520a%2520marker%2520of%2520aggressive%2520breast%2520cancer%2520and%2520promotes%2520neoplastic%2520transformation%2520of%2520breast%2520epithelial%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11606%26epage%3D11611%26doi%3D10.1073%2Fpnas.1933744100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrette, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">The polycomb group protein EZH2 is involved in progression of prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1038/nature01075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature01075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=12374981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=624-629&author=S.+Varamballyauthor=S.+M.+Dhanasekaranauthor=M.+Zhouauthor=T.+R.+Barretteauthor=C.+Kumar-Sinhaauthor=M.+G.+Sandaauthor=D.+Ghoshauthor=K.+J.+Pientaauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=The+polycomb+group+protein+EZH2+is+involved+in+progression+of+prostate+cancer&doi=10.1038%2Fnature01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is involved in progression of prostate cancer</span></div><div class="casAuthors">Varambally, Sooryanarayana; Dhanasekaran, Saravana M.; Zhou, Ming; Barrette, Terrence R.; Kumar-Sinha, Chandan; Sanda, Martin G.; Ghosh, Debashis; Pienta, Kenneth J.; Sewalt, Richard G. A. B.; Otte, Arie P.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6907</span>),
    <span class="NLM_cas:pages">624-629</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer.  Although effective surgical and radiation treatments exist for clin. localized prostate cancer, metastatic prostate cancer remains essentially incurable.  Here we show, through gene expression profiling, that the polycomb group protein enhancer of zeste homolog 2 (EZH2) is overexpressed in hormone-refractory, metastatic prostate cancer.  Small interfering RNA (siRNA) duplexes targeted against EZH2 reduce the amts. of EZH2 protein present in prostate cells and also inhibit cell proliferation in vitro.  Ectopic expression of EZH2 in prostate cells induces transcriptional repression of a specific cohort of genes.  Gene silencing mediated by EZH2 requires the SET domain and is attenuated by inhibiting histone deacetylase activity.  Amts. of both EZH2 mRNA and EZH2 protein are increased in metastatic prostate cancer; in addn., clin. localized prostate cancers that express higher concns. of EZH2 show a poorer prognosis.  Thus, dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.  Supplementary information on the gene expression profile can be obtained at: http://www.nature.com/nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW_h7gunzd7Vg90H21EOLACvtfcHk0ljBkqR0mU6PkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D&md5=c38f80915b4183472aa7be4f9f3ecc67</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01075%26sid%3Dliteratum%253Aachs%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DBarrette%26aufirst%3DT.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DSanda%26aufirst%3DM.%2BG.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DThe%2520polycomb%2520group%2520protein%2520EZH2%2520is%2520involved%2520in%2520progression%2520of%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D624%26epage%3D629%26doi%3D10.1038%2Fnature01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Velichutina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elemento, O.</span><span> </span><span class="NLM_article-title">EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">5247</span><span class="NLM_x">–</span> <span class="NLM_lpage">5255</span><span class="refDoi"> DOI: 10.1182/blood-2010-04-280149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1182%2Fblood-2010-04-280149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=20736451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1I%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=5247-5255&author=I.+Velichutinaauthor=R.+Shaknovichauthor=H.+Gengauthor=N.+A.+Johnsonauthor=R.+D.+Gascoyneauthor=A.+M.+Melnickauthor=O.+Elemento&title=EZH2-mediated+epigenetic+silencing+in+germinal+center+B+cells+contributes+to+proliferation+and+lymphomagenesis&doi=10.1182%2Fblood-2010-04-280149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis</span></div><div class="casAuthors">Velichutina, Irina; Shaknovich, Rita; Geng, Huimin; Johnson, Nathalie A.; Gascoyne, Randy D.; Melnick, Ari M.; Elemento, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5247-5255</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">EZH2 is the catalytic subunit of the PRC2 Polycomb complex and mediates transcriptional repression through its histone methyltransferase activity.  EZH2 is up-regulated in normal germinal center (GC) B cells and is implicated in lymphomagenesis.  To explore the transcriptional programs controlled by EZH2, we performed chromatin immunopptn. (ChIP-on-chip) in GC cells and found that it binds approx. 1800 promoters, often assocd. with DNA sequences similar to Drosophila Polycomb response elements.  While EZH2 targets overlapped extensively between GC B cells and embryonic stem cells, we also obsd. a large GC-specific EZH2 regulatory program.  These genes are preferentially histone 3 lysine 27-trimethylated and repressed in GC B cells and include several key cell cycle-related tumor suppressor genes.  Accordingly, siRNA-mediated down-regulation of EZH2 in diffuse large B-cell lymphoma (DLBCL) cells resulted in acute cell cycle arrest at the G1/S transition and up-regulation of its tumor suppressor target genes.  At the DNA level, EZH2-bound promoters are hypomethylated in GC B cells, but many of them are aberrantly hypermethylated in DLBCL, suggesting disruption of normal epigenetic processes in these cells.  EZH2 is thus involved in regulating a specific epigenetic program in normal GCs, including silencing of antiproliferative genes, which may contribute to the malignant transformation of GC B cells into DLBCLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobqjlF41Jsh7Vg90H21EOLACvtfcHk0li_k12bXbIjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1I%253D&md5=4f50ce144655d0b3a3b4de12c069ee22</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-04-280149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-04-280149%26sid%3Dliteratum%253Aachs%26aulast%3DVelichutina%26aufirst%3DI.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%2BM.%26aulast%3DElemento%26aufirst%3DO.%26atitle%3DEZH2-mediated%2520epigenetic%2520silencing%2520in%2520germinal%2520center%2520B%2520cells%2520contributes%2520to%2520proliferation%2520and%2520lymphomagenesis%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D5247%26epage%3D5255%26doi%3D10.1182%2Fblood-2010-04-280149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Morin, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungall, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolcock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchenbauer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimbara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashkin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlot, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherpakov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varhol, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smailus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moksa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birol, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M. A.</span><span> </span><span class="NLM_article-title">Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1038/ng.518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fng.518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=20081860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=181-185&author=R.+D.+Morinauthor=N.+A.+Johnsonauthor=T.+M.+Seversonauthor=A.+J.+Mungallauthor=J.+Anauthor=R.+Goyaauthor=J.+E.+Paulauthor=M.+Boyleauthor=B.+W.+Woolcockauthor=F.+Kuchenbauerauthor=D.+Yapauthor=R.+K.+Humphriesauthor=O.+L.+Griffithauthor=S.+Shahauthor=H.+Zhuauthor=M.+Kimbaraauthor=P.+Shashkinauthor=J.+F.+Charlotauthor=M.+Tcherpakovauthor=R.+Corbettauthor=A.+Tamauthor=R.+Varholauthor=D.+Smailusauthor=M.+Moksaauthor=Y.+Zhaoauthor=A.+Delaneyauthor=H.+Qianauthor=I.+Birolauthor=J.+Scheinauthor=R.+Mooreauthor=R.+Holtauthor=D.+E.+Horsmanauthor=J.+M.+Connorsauthor=S.+Jonesauthor=S.+Aparicioauthor=M.+Hirstauthor=R.+D.+Gascoyneauthor=M.+A.+Marra&title=Somatic+mutations+altering+EZH2+%28Tyr641%29+in+follicular+and+diffuse+large+B-cell+lymphomas+of+germinal-center+origin&doi=10.1038%2Fng.518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin</span></div><div class="casAuthors">Morin, Ryan D.; Johnson, Nathalie A.; Severson, Tesa M.; Mungall, Andrew J.; An, Jianghong; Goya, Rodrigo; Paul, Jessica E.; Boyle, Merrill; Woolcock, Bruce W.; Kuchenbauer, Florian; Yap, Damian; Humphries, R. Keith; Griffith, Obi L.; Shah, Sohrab; Zhu, Henry; Kimbara, Michelle; Shashkin, Pavel; Charlot, Jean F.; Tcherpakov, Marianna; Corbett, Richard; Tam, Angela; Varhol, Richard; Smailus, Duane; Moksa, Michelle; Zhao, Yongjun; Delaney, Allen; Qian, Hong; Birol, Inanc; Schein, Jacqueline; Moore, Richard; Holt, Robert; Horsman, Doug E.; Connors, Joseph M.; Jones, Steven; Aparicio, Samuel; Hirst, Martin; Gascoyne, Randy D.; Marra, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-185</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL) derive from germinal center B cells.  Targeted resequencing studies have revealed mutations in various genes encoding proteins in the NF-κB pathway that contribute to the activated B-cell (ABC) DLBCL subtype, but thus far few GCB-specific mutations have been identified.  Here the authors report recurrent somatic mutations affecting the polycomb-group oncogene EZH2, which encodes a histone methyltransferase responsible for trimethylating Lys27 of histone H3 (H3K27).  After the recent discovery of mutations in KDM6A (UTX), which encodes the histone H3K27me3 demethylase UTX, in several cancer types, EZH2 is the second histone methyltransferase gene mutated in cancer.  These mutations, which result in the replacement of a single tyrosine in the SET domain of the EZH2 protein (Tyr641), occur in 21.7% of GCB DLBCLs and 7.2% of FLs and are absent from ABC DLBCLs.  The authors' data are consistent with the notion that EZH2 proteins with mutant Tyr641 have reduced enzymic activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvpFnajONCXbVg90H21EOLACvtfcHk0li_k12bXbIjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVGitQ%253D%253D&md5=ab68fe6e8932e720c4e7be82fe35932a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fng.518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.518%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DR.%2BD.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DSeverson%26aufirst%3DT.%2BM.%26aulast%3DMungall%26aufirst%3DA.%2BJ.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DGoya%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DJ.%2BE.%26aulast%3DBoyle%26aufirst%3DM.%26aulast%3DWoolcock%26aufirst%3DB.%2BW.%26aulast%3DKuchenbauer%26aufirst%3DF.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DHumphries%26aufirst%3DR.%2BK.%26aulast%3DGriffith%26aufirst%3DO.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DKimbara%26aufirst%3DM.%26aulast%3DShashkin%26aufirst%3DP.%26aulast%3DCharlot%26aufirst%3DJ.%2BF.%26aulast%3DTcherpakov%26aufirst%3DM.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DVarhol%26aufirst%3DR.%26aulast%3DSmailus%26aufirst%3DD.%26aulast%3DMoksa%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDelaney%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DBirol%26aufirst%3DI.%26aulast%3DSchein%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DR.%26aulast%3DHolt%26aufirst%3DR.%26aulast%3DHorsman%26aufirst%3DD.%2BE.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DHirst%26aufirst%3DM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMarra%26aufirst%3DM.%2BA.%26atitle%3DSomatic%2520mutations%2520altering%2520EZH2%2520%2528Tyr641%2529%2520in%2520follicular%2520and%2520diffuse%2520large%2520B-cell%2520lymphomas%2520of%2520germinal-center%2520origin%26jtitle%3DNat.%2520Genet.%26date%3D2010%26volume%3D42%26spage%3D181%26epage%3D185%26doi%3D10.1038%2Fng.518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hernando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelato, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesche, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steigemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stresemann, C.</span><span> </span><span class="NLM_article-title">EZH2 Inhibition blocks multiple myeloma mell mrowth through upregulation of epithelial tumor suppressor genes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1158%2F1535-7163.MCT-15-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26590165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVWrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=287-298&author=H.+Hernandoauthor=K.+A.+Gelatoauthor=R.+Lescheauthor=G.+Beckmannauthor=S.+Koehrauthor=S.+Ottoauthor=P.+Steigemannauthor=C.+Stresemann&title=EZH2+Inhibition+blocks+multiple+myeloma+mell+mrowth+through+upregulation+of+epithelial+tumor+suppressor+genes&doi=10.1158%2F1535-7163.MCT-15-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes</span></div><div class="casAuthors">Hernando, Henar; Gelato, Kathy A.; Lesche, Ralf; Beckmann, Georg; Koehr, Silke; Otto, Saskia; Steigemann, Patrick; Stresemann, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-298</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple myeloma is a plasma cell malignancy characterized by marked heterogeneous genomic instability including frequent genetic alterations in epigenetic enzymes.  In particular, the histone methyltransferase Enhancer of Zeste Homolog 2 (EZH2) is overexpressed in multiple myeloma.  EZH2 is the catalytic component of the polycomb repressive complex 2 (PRC2), a master transcriptional regulator of differentiation.  EZH2 catalyzes methylation of lysine 27 on histone H3 and its deregulation in cancer has been reported to contribute to silencing of tumor suppressor genes, resulting in a more undifferentiated state, and thereby contributing to the multiple myeloma phenotype.  In this study, we propose the use of EZH2 inhibitors as a new therapeutic approach for the treatment of multiple myeloma.  We demonstrate that EZH2 inhibition causes a global redn. of H3K27me3 in multiple myeloma cells, promoting reexpression of EZH2-repressed tumor suppressor genes in a subset of cell lines.  As a result of this transcriptional activation, multiple myeloma cells treated with EZH2 inhibitors become more adherent and less proliferative compared with untreated cells.  The antitumor efficacy of EZH2 inhibitors is also confirmed in vivo in a multiple myeloma xenograft model in mice.  Together, our data suggest that EZH2 inhibition may provide a new therapy for multiple myeloma treatment and a promising addn. to current treatment options.  Mol Cancer Ther; 15(2); 287-98. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuIp0VXeZaHLVg90H21EOLACvtfcHk0liX8DfJ20ICPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVWrs70%253D&md5=9412dddc1ca18950a9250519db0828dc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0486%26sid%3Dliteratum%253Aachs%26aulast%3DHernando%26aufirst%3DH.%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DLesche%26aufirst%3DR.%26aulast%3DBeckmann%26aufirst%3DG.%26aulast%3DKoehr%26aufirst%3DS.%26aulast%3DOtto%26aufirst%3DS.%26aulast%3DSteigemann%26aufirst%3DP.%26aulast%3DStresemann%26aufirst%3DC.%26atitle%3DEZH2%2520Inhibition%2520blocks%2520multiple%2520myeloma%2520mell%2520mrowth%2520through%2520upregulation%2520of%2520epithelial%2520tumor%2520suppressor%2520genes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D287%26epage%3D298%26doi%3D10.1158%2F1535-7163.MCT-15-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Shih, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span> </span><span class="NLM_article-title">The role of mutations in epigenetic regulators in myeloid malignancies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.1038/nrc3343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnrc3343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=22898539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=599-612&author=A.+H.+Shihauthor=O.+Abdel-Wahabauthor=J.+P.+Patelauthor=R.+L.+Levine&title=The+role+of+mutations+in+epigenetic+regulators+in+myeloid+malignancies&doi=10.1038%2Fnrc3343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mutations in epigenetic regulators in myeloid malignancies</span></div><div class="casAuthors">Shih, Alan H.; Abdel-Wahab, Omar; Patel, Jay P.; Levine, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">599-612</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent genomic studies have identified novel recurrent somatic mutations in patients with myeloid malignancies, including myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).  In some cases these mutations occur in genes with known roles in regulating chromatin and/or methylation states in haematopoietic progenitors, and in other cases genetic and functional studies have elucidated a role for specific mutations in altering epigenetic patterning in myeloid malignancies.  In this Review we discuss recent genetic and functional data implicating mutations in epigenetic modifiers, including tet methylcytosine dioxygenase 2 (TET2), isocitrate dehydrogenase 1 (IDH1), IDH2, addnl. sex combs-like 1 (ASXL1), enhancer of zeste homolog 2 (EZH2) and DNA methyltransferase 3A (DNMT3A), in the pathogenesis of MPN, MDS and AML, and discuss how this knowledge is leading to novel clin., biol. and therapeutic insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxgjNkbc-nkrVg90H21EOLACvtfcHk0liX8DfJ20ICPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt7zF&md5=d892316de7dc7d677e971913b9ecf156</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrc3343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3343%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DA.%2BH.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DPatel%26aufirst%3DJ.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26atitle%3DThe%2520role%2520of%2520mutations%2520in%2520epigenetic%2520regulators%2520in%2520myeloid%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D599%26epage%3D612%26doi%3D10.1038%2Fnrc3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Neff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khattab, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orkin, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, S. A.</span><span> </span><span class="NLM_article-title">Polycomb repressive complex 2 is required for MLL-AF9 leukemia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5028</span><span class="NLM_x">–</span> <span class="NLM_lpage">5033</span><span class="refDoi"> DOI: 10.1073/pnas.1202258109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1202258109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5028-5033&author=T.+Neffauthor=A.+U.+Sinhaauthor=M.+J.+Klukauthor=N.+Zhuauthor=M.+H.+Khattabauthor=L.+Steinauthor=H.+Xieauthor=S.+H.+Orkinauthor=S.+A.+Armstrong&title=Polycomb+repressive+complex+2+is+required+for+MLL-AF9+leukemia&doi=10.1073%2Fpnas.1202258109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202258109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202258109%26sid%3Dliteratum%253Aachs%26aulast%3DNeff%26aufirst%3DT.%26aulast%3DSinha%26aufirst%3DA.%2BU.%26aulast%3DKluk%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DN.%26aulast%3DKhattab%26aufirst%3DM.%2BH.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DOrkin%26aufirst%3DS.%2BH.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26atitle%3DPolycomb%2520repressive%2520complex%25202%2520is%2520required%2520for%2520MLL-AF9%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5028%26epage%3D5033%26doi%3D10.1073%2Fpnas.1202258109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.1038/onc.2012.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fonc.2012.110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=930-938&author=J.+Shiauthor=E.+Wangauthor=J.+Zuberauthor=A.+Rappaportauthor=M.+Taylorauthor=C.+Johnsauthor=S.+W.+Loweauthor=C.+R.+Vakoc&title=The+Polycomb+complex+PRC2+supports+aberrant+self-renewal+in+a+mouse+model+of+MLL-AF9%3BNras%28G12D%29+acute+myeloid+leukemia&doi=10.1038%2Fonc.2012.110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.110%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DRappaport%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Polycomb%2520complex%2520PRC2%2520supports%2520aberrant%2520self-renewal%2520in%2520a%2520mouse%2520model%2520of%2520MLL-AF9%253BNras%2528G12D%2529%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D930%26epage%3D938%26doi%3D10.1038%2Fonc.2012.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">On, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span> </span><span class="NLM_article-title">Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1182/blood-2014-06-581082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1182%2Fblood-2014-06-581082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=346-357&author=B.+Xuauthor=D.+M.+Onauthor=A.+Maauthor=T.+Partonauthor=K.+D.+Konzeauthor=S.+G.+Pattendenauthor=D.+F.+Allisonauthor=L.+Caiauthor=S.+Rockowitzauthor=S.+Liuauthor=Y.+Liuauthor=F.+Liauthor=M.+Vedadiauthor=S.+V.+Fryeauthor=B.+A.+Garciaauthor=D.+Zhengauthor=J.+Jinauthor=G.+G.+Wang&title=Selective+inhibition+of+EZH2+and+EZH1+enzymatic+activity+by+a+small+molecule+suppresses+MLL-rearranged+leukemia&doi=10.1182%2Fblood-2014-06-581082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-06-581082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-06-581082%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.%26aulast%3DOn%26aufirst%3DD.%2BM.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DAllison%26aufirst%3DD.%2BF.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DRockowitz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DZheng%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%2BG.%26atitle%3DSelective%2520inhibition%2520of%2520EZH2%2520and%2520EZH1%2520enzymatic%2520activity%2520by%2520a%2520small%2520molecule%2520suppresses%2520MLL-rearranged%2520leukemia%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26spage%3D346%26epage%3D357%26doi%3D10.1182%2Fblood-2014-06-581082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aller, G. S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machutta, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/ml3003346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1091-1096&author=S.+K.+Vermaauthor=X.+Tianauthor=L.+V.+LaFranceauthor=C.+Duquenneauthor=D.+P.+Suarezauthor=K.+A.+Newlanderauthor=S.+P.+Romerilauthor=J.+L.+Burgessauthor=S.+W.+Grantauthor=J.+A.+Brackleyauthor=A.+P.+Gravesauthor=D.+A.+Scherzerauthor=A.+Shuauthor=C.+Thompsonauthor=H.+M.+Ottauthor=G.+S.+V.+Allerauthor=C.+A.+Machuttaauthor=E.+Diazauthor=Y.+Jiangauthor=N.+W.+Johnsonauthor=S.+D.+Knightauthor=R.+G.+Krugerauthor=M.+T.+McCabeauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Creasyauthor=W.+H.+Miller&title=Identification+of+potent%2C+selective%2C+cell-active+inhibitors+of+the+histone+lysine+methyltransferase+EZH2&doi=10.1021%2Fml3003346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2</span></div><div class="casAuthors">Verma, Sharad K.; Tian, Xinrong; LaFrance, Louis V.; Duquenne, Celine; Suarez, Dominic P.; Newlander, Kenneth A.; Romeril, Stuart P.; Burgess, Joelle L.; Grant, Seth W.; Brackley, James A.; Graves, Alan P.; Scherzer, Daryl A.; Shu, Art; Thompson, Christine; Ott, Heidi M.; Van Aller, Glenn S.; Machutta, Carl A.; Diaz, Elsie; Jiang, Yong; Johnson, Neil W.; Knight, Steven D.; Kruger, Ryan G.; McCabe, Michael T.; Dhanak, Dashyant; Tummino, Peter J.; Creasy, Caretha L.; Miller, William H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1091-1096</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The histone H3-lysine 27 (H3K27) methyltransferase EZH2 plays a crit. role in regulating gene expression, and its aberrant activity is linked to the onset and progression of cancer.  As part of a drug discovery program targeting EZH2, we have identified highly potent, selective, S-(S'-adenosyl)-L-methionine (SAM)-competitive, and cell-active EZH2 inhibitors, including GSK926 I (R1 = Me, R2 = Q) and GSK343 I (R1 = n-Pr, R2 = Q1).  These compds. are small mol. chem. tools that would be useful to further explore the biol. of EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NUzf0zjo0bVg90H21EOLACvtfcHk0lhUwGnLifhnrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChs77K&md5=a6540bb712ee52cba05bd0b074d8b26a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fml3003346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003346%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DSuarez%26aufirst%3DD.%2BP.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DBrackley%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%2BA.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DAller%26aufirst%3DG.%2BS.%2BV.%26aulast%3DMachutta%26aufirst%3DC.%2BA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DIdentification%2520of%2520potent%252C%2520selective%252C%2520cell-active%2520inhibitors%2520of%2520the%2520histone%2520lysine%2520methyltransferase%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1091%26epage%3D1096%26doi%3D10.1021%2Fml3003346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavadil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynlacht, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/j.molcel.2008.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.molcel.2008.11.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=503-518&author=R.+Margueronauthor=G.+Liauthor=K.+Sarmaauthor=A.+Blaisauthor=J.+Zavadilauthor=C.+L.+Woodcockauthor=B.+D.+Dynlachtauthor=D.+Reinberg&title=Ezh1+and+Ezh2+maintain+repressive+chromatin+through+different+mechanisms&doi=10.1016%2Fj.molcel.2008.11.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DBlais%26aufirst%3DA.%26aulast%3DZavadil%26aufirst%3DJ.%26aulast%3DWoodcock%26aufirst%3DC.%2BL.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DEzh1%2520and%2520Ezh2%2520maintain%2520repressive%2520chromatin%2520through%2520different%2520mechanisms%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D32%26spage%3D503%26epage%3D518%26doi%3D10.1016%2Fj.molcel.2008.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Laible, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nislow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebersorger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popkin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenuwein, T.</span><span> </span><span class="NLM_article-title">Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3219</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span><span class="refDoi"> DOI: 10.1093/emboj/16.11.3219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1093%2Femboj%2F16.11.3219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=3219-3232&author=G.+Laibleauthor=A.+Wolfauthor=R.+Dornauthor=G.+Reuterauthor=C.+Nislowauthor=A.+Lebersorgerauthor=D.+Popkinauthor=L.+Pillusauthor=T.+Jenuwein&title=Mammalian+homologues+of+the+Polycomb-group+gene+Enhancer+of+zeste+mediate+gene+silencing+in+Drosophila+heterochromatin+and+at+S.+cerevisiae+telomeres&doi=10.1093%2Femboj%2F16.11.3219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.11.3219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.11.3219%26sid%3Dliteratum%253Aachs%26aulast%3DLaible%26aufirst%3DG.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DR.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DNislow%26aufirst%3DC.%26aulast%3DLebersorger%26aufirst%3DA.%26aulast%3DPopkin%26aufirst%3DD.%26aulast%3DPillus%26aufirst%3DL.%26aulast%3DJenuwein%26aufirst%3DT.%26atitle%3DMammalian%2520homologues%2520of%2520the%2520Polycomb-group%2520gene%2520Enhancer%2520of%2520zeste%2520mediate%2520gene%2520silencing%2520in%2520Drosophila%2520heterochromatin%2520and%2520at%2520S.%2520cerevisiae%2520telomeres%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D3219%26epage%3D3232%26doi%3D10.1093%2Femboj%2F16.11.3219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Visser, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunster, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluin-Nelemans, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manders, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaphorst, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span> </span><span class="NLM_article-title">The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span><span class="refDoi"> DOI: 10.1046/j.1365-2141.2001.02641.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1046%2Fj.1365-2141.2001.02641.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=11298590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsV2ru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2001&pages=950-958&author=H.+P.+Visserauthor=M.+J.+Gunsterauthor=H.+C.+Kluin-Nelemansauthor=E.+M.+Mandersauthor=F.+M.+Raaphorstauthor=C.+J.+Meijerauthor=R.+Willemzeauthor=A.+P.+Otte&title=The+Polycomb+group+protein+EZH2+is+upregulated+in+proliferating%2C+cultured+human+mantle+cell+lymphoma&doi=10.1046%2Fj.1365-2141.2001.02641.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma</span></div><div class="casAuthors">Visser, Hein P. J.; Gunster, Marco J.; Kluin-Nelemans, Hanneke C.; Manders, Erik M. M.; Raaphorst, Frank M.; Meijer, Chris J. L. M.; Willemze, Roel; Otte, Arie P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">950-958</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Polycomb group (PcG) proteins are involved in the stable transmittance of the repressive state of their gene targets throughout the cell cycle.  Mis-expression of PcG proteins can lead to proliferative defects and tumorigenesis.  There are 2 sep. multimeric PcG protein complexes: an EED-EZH2-contg. complex and a BMI1-RING1-contg. complex.  In the normal human follicle mantle, both PcG complexes have mutually exclusive expression patterns.  BMI1-RING1 is expressed, but EZH2-EED is not.  Here, the authors studied the expression of both complexes in 6 cases of mantle cell lymphoma (MCL), which is derived from the follicle mantle.  MCL cells can be cultured in vitro and stimulated to proliferation.  We found that resting MCL cells expressed BMI1-RING1, but not EZH2-EED, like normal mantle cells.  Proliferating MCL cells, however, showed strongly enhanced expression of EZH2.  Also, BMI1 and RING1 continued to be expressed in proliferating MCL.  This is the first demonstration that EZH2 expression can be upregulated in fresh lymphoma cells.  To test whether the enhanced EZH2 expression was causal for the increased proliferation in MCL, the authors overexpressed EZH2 in 2 different cell lines.  In the B cell-derived Ramos cell line, EZH2 overexpression caused an increase in the proliferation rate.  This suggests a possible causal effect between EZH2 upregulation and increased proliferation in hematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9euSBA7jIrVg90H21EOLACvtfcHk0lhrHDK89H0RpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsV2ru70%253D&md5=7858a0d35ee29de952670e6701165dd1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2001.02641.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2001.02641.x%26sid%3Dliteratum%253Aachs%26aulast%3DVisser%26aufirst%3DH.%2BP.%26aulast%3DGunster%26aufirst%3DM.%2BJ.%26aulast%3DKluin-Nelemans%26aufirst%3DH.%2BC.%26aulast%3DManders%26aufirst%3DE.%2BM.%26aulast%3DRaaphorst%26aufirst%3DF.%2BM.%26aulast%3DMeijer%26aufirst%3DC.%2BJ.%26aulast%3DWillemze%26aufirst%3DR.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26atitle%3DThe%2520Polycomb%2520group%2520protein%2520EZH2%2520is%2520upregulated%2520in%2520proliferating%252C%2520cultured%2520human%2520mantle%2520cell%2520lymphoma%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2001%26volume%3D112%26spage%3D950%26epage%3D958%26doi%3D10.1046%2Fj.1365-2141.2001.02641.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2677</span><span class="refDoi"> DOI: 10.1101/gad.225888.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1101%2Fgad.225888.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2663-2677&author=J.+Sonauthor=S.+S.+Shenauthor=R.+Margueronauthor=D.+Reinberg&title=Nucleosome-binding+activities+within+JARID2+and+EZH1+regulate+the+function+of+PRC2+on+chromatin&doi=10.1101%2Fgad.225888.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1101%2Fgad.225888.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.225888.113%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DS.%2BS.%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DNucleosome-binding%2520activities%2520within%2520JARID2%2520and%2520EZH1%2520regulate%2520the%2520function%2520of%2520PRC2%2520on%2520chromatin%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D2663%26epage%3D2677%26doi%3D10.1101%2Fgad.225888.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span> </span><span class="NLM_article-title">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1038/nchembio.1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnchembio.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23023262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=890-896&author=S.+K.+Knutsonauthor=T.+J.+Wigleauthor=N.+M.+Warholicauthor=C.+J.+Sneeringerauthor=C.+J.+Allainauthor=C.+R.+Klausauthor=J.+D.+Sacksauthor=A.+Raimondiauthor=C.+R.+Majerauthor=J.+Songauthor=M.+P.+Scottauthor=L.+Jinauthor=J.+J.+Smithauthor=E.+J.+Olhavaauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=V.+M.+Richonauthor=R.+A.+Copelandauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=K.+W.+Kuntz&title=A+selective+inhibitor+of+EZH2+blocks+H3K27+methylation+and+kills+mutant+lymphoma+cells&doi=10.1038%2Fnchembio.1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span></div><div class="casAuthors">Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27).  Point mutations of EZH2 at Tyr 641 and Ala 677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation.  Here the authors report the discovery of EPZ005687, a potent inhibitor of EZH2 (Ki of 24 nM).  EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1.  The compd. reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr 641 or Ala 677 mutant cells, with minimal effects on the proliferation of wild-type cells.  These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr 641 or Ala 677) results in a crit. dependency on enzymic activity for proliferation (i.e., the equiv. of oncogene addiction), thus portending the clin. use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohlduVbTgWJrVg90H21EOLACvtfcHk0li9CDKvk9m8qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP&md5=a9ad7a41505e3fd4aa087d9f5dae8825</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1084%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DSacks%26aufirst%3DJ.%2BD.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520EZH2%2520blocks%2520H3K27%2520methylation%2520and%2520kills%2520mutant%2520lymphoma%2520cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D890%26epage%3D896%26doi%3D10.1038%2Fnchembio.1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iii, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span> </span><span class="NLM_article-title">EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fnature11606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23051747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=108-112&author=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+Ganjiauthor=S.+Korenchukauthor=C.+Thompsonauthor=G.+S.+Van+Allerauthor=Y.+Liuauthor=A.+P.+Gravesauthor=A.+D.+Iiiauthor=E.+Diazauthor=L.+V.+Lafranceauthor=M.+Mellingerauthor=C.+Duquenneauthor=X.+Tianauthor=R.+G.+Krugerauthor=C.+F.+McHughauthor=M.+Brandtauthor=W.+H.+Millerauthor=D.+Dhanakauthor=S.+K.+Vermaauthor=P.+J.+Tumminoauthor=C.+L.+Creasy&title=EZH2+inhibition+as+a+therapeutic+strategy+for+lymphoma+with+EZH2-activating+mutations&doi=10.1038%2Fnature11606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations</span></div><div class="casAuthors">McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Graves, Alan P.; Della Pietra, Anthony , III; Diaz, Elsie; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Brandt, Martin; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7427</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In eukaryotes, post-translational modification of histones is crit. for regulation of chromatin structure and gene expression.  EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and is involved in repressing gene expression through methylation of histone H3 on lysine 27 (H3K27).  EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumor types.  Addnl., somatic heterozygous mutations of Y641 and A677 residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.  The Y641 residue is the most frequently mutated residue, with up to 22% of germinal center B-cell DLBCL and follicular lymphoma harbouring mutations at this site.  These lymphomas have increased H3K27 tri-methylation (H3K27me3) owing to altered substrate preferences of the mutant enzymes.  However, it is unknown whether specific, direct inhibition of EZH2 methyltransferase activity will be effective in treating EZH2 mutant lymphomas.  Here we demonstrate that GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-mol. inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes.  GSK126 effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice.  Together, these data demonstrate that pharmacol. inhibition of EZH2 activity may provide a promising treatment for EZH2 mutant lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxw5cLmW3Lc7Vg90H21EOLACvtfcHk0li9CDKvk9m8qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyktbjL&md5=a1dff99556de004c48aae88bc45dffab</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11606%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DIii%26aufirst%3DA.%2BD.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DLafrance%26aufirst%3DL.%2BV.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26atitle%3DEZH2%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520lymphoma%2520with%2520EZH2-activating%2520mutations%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardayfio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span> </span><span class="NLM_article-title">Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">21360</span><span class="NLM_x">–</span> <span class="NLM_lpage">21365</span><span class="refDoi"> DOI: 10.1073/pnas.1210371110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1210371110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23236167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21360-21365&author=W.+Qiauthor=H.+Chanauthor=L.+Tengauthor=L.+Liauthor=S.+Chuaiauthor=R.+Zhangauthor=J.+Zengauthor=M.+Liauthor=H.+Fanauthor=Y.+Linauthor=J.+Guauthor=O.+Ardayfioauthor=J.-H.+Zhangauthor=X.+Yanauthor=J.+Fangauthor=Y.+Miauthor=M.+Zhangauthor=T.+Zhouauthor=G.+Fengauthor=Z.+Chenauthor=G.+Liauthor=T.+Yangauthor=K.+Zhaoauthor=X.+Liuauthor=Z.+Yuauthor=C.+X.+Luauthor=P.+Atadjaauthor=E.+Li&title=Selective+inhibition+of+Ezh2+by+a+small+molecule+inhibitor+blocks+tumor+cells+proliferation&doi=10.1073%2Fpnas.1210371110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation</span></div><div class="casAuthors">Qi, Wei; Chan, Homan; Teng, Lin; Li, Ling; Chuai, Shannon; Zhang, Ruipeng; Zeng, Jue; Li, Min; Fan, Hong; Lin, Ying; Gu, Justin; Ardayfio, Ophelia; Zhang, Ji-Hu; Yan, Xiaoxia; Fang, Jialuo; Mi, Yuan; Zhang, Man; Zhou, Tao; Feng, Grace; Chen, Zijun; Li, Guobin; Yang, Teddy; Zhao, Kehao; Liu, Xianghui; Yu, Zhengtian; Lu, Chris X.; Atadja, Peter; Li, En</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">21360-21365, S21360/1-S21360/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ezh2 (Enhancer of zeste homolog 2) protein is the enzymic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by methylating lysine 27 of histone H3 (H3K27) and regulates cell proliferation and differentiation during embryonic development.  Recently, hot-spot mutations of Ezh2 were identified in diffused large B-cell lymphomas and follicular lymphomas.  To investigate if tumor growth is dependent on the enzymic activity of Ezh2, the authors developed a potent and selective small mol. inhibitor, EI1, which inhibits the enzymic activity of Ezh2 through direct binding to the enzyme and competing with the Me group donor S-Adenosyl methionine.  EI1-treated cells exhibit genome-wide loss of H3K27 methylation and activation of PRC2 target genes.  Furthermore, inhibition of Ezh2 by EI1 in diffused large B-cell lymphomas cells carrying the Y641 mutations results in decreased proliferation, cell cycle arrest, and apoptosis.  These results provide strong validation of Ezh2 as a potential therapeutic target for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR1oWnCAdMmrVg90H21EOLACvtfcHk0lgORrE26uQuKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSnsA%253D%253D&md5=b85578201119e39887e323aad25d959b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210371110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210371110%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChuai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DArdayfio%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DC.%2BX.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DE.%26atitle%3DSelective%2520inhibition%2520of%2520Ezh2%2520by%2520a%2520small%2520molecule%2520inhibitor%2520blocks%2520tumor%2520cells%2520proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21360%26epage%3D21365%26doi%3D10.1073%2Fpnas.1210371110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNevin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1021/cb400133j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400133j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1324-1334&author=K.+D.+Konzeauthor=A.+Maauthor=F.+Liauthor=D.+Barsyte-Lovejoyauthor=T.+Partonauthor=C.+J.+MacNevinauthor=F.+Liuauthor=C.+Gaoauthor=X.+P.+Huangauthor=E.+Kuznetsovaauthor=M.+Rougieauthor=A.+Jiangauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=L.+I.+Jamesauthor=B.+L.+Rothauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=K.+M.+Hahnauthor=G.+G.+Wangauthor=M.+Vedadiauthor=J.+Jin&title=An+orally+bioavailable+chemical+probe+of+the+lysine+methyltransferases+EZH2+and+EZH1&doi=10.1021%2Fcb400133j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span></div><div class="casAuthors">Konze, Kyle D.; Ma, Anqi; Li, Fengling; Barsyte-Lovejoy, Dalia; Parton, Trevor; MacNevin, Christopher J.; Liu, Feng; Gao, Cen; Huang, Xi-Ping; Kuznetsova, Ekaterina; Rougie, Marie; Jiang, Alice; Pattenden, Samantha G.; Norris, Jacqueline L.; James, Lindsey I.; Roth, Bryan L.; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Hahn, Klaus M.; Wang, Gang Greg; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1324-1334</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylation of histone H3 lysine 27 (H3K27).  The trimethylation of H3K27 (H3K27me3) is a transcriptionally repressive post-translational modification.  Overexpression of EZH2 and hypertrimethylation of H3K27 have been implicated in a no. of cancers.  Several selective inhibitors of EZH2 have been reported recently.  Herein we disclose UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wild-type and mutant EZH2 as well as EZH1, a closely related H3K27 methyltransferase that shares 96% sequence identity with EZH2 in their resp. catalytic domains.  UNC1999 was highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM and non-competitive with the peptide substrate.  This inhibitor potently reduced H3K27me3 levels in cells and selectively killed diffused large B cell lymphoma cell lines harboring the EZH2Y641N mutant.  Importantly, UNC1999 was orally bioavailable in mice, making this inhibitor a valuable tool for investigating the role of EZH2 and EZH1 in chronic animal studies.  We also designed and synthesized UNC2400, a close analog of UNC1999 with potency >1,000-fold lower than that of UNC1999 as a neg. control for cell-based studies.  Finally, we created a biotin-tagged UNC1999 (UNC2399), which enriched EZH2 in pull-down studies, and a UNC1999-dye conjugate (UNC2239) for co-localization studies with EZH2 in live cells.  Taken together, these compds. represent a set of useful tools for the biomedical community to investigate the role of EZH2 and EZH1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzhUO0iAe8BbVg90H21EOLACvtfcHk0lgORrE26uQuKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D&md5=311d77f5f0cc0b9e2610d8d002a6709c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400133j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400133j%26sid%3Dliteratum%253Aachs%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DMacNevin%26aufirst%3DC.%2BJ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DKuznetsova%26aufirst%3DE.%26aulast%3DRougie%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DA.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DJames%26aufirst%3DL.%2BI.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DHahn%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DG.%2BG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DAn%2520orally%2520bioavailable%2520chemical%2520probe%2520of%2520the%2520lysine%2520methyltransferases%2520EZH2%2520and%2520EZH1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1324%26epage%3D1334%26doi%3D10.1021%2Fcb400133j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span> </span><span class="NLM_article-title">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7922</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1073/pnas.1303800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1073%2Fpnas.1303800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23620515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=7922-7927&author=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=T.+J.+Wigleauthor=C.+R.+Klausauthor=C.+J.+Allainauthor=A.+Raimondiauthor=M.+Porter+Scottauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=V.+M.+Richonauthor=R.+M.+Pollockauthor=K.+W.+Kuntzauthor=H.+Keilhack&title=Durable+tumor+regression+in+genetically+altered+malignant+rhabdoid+tumors+by+inhibition+of+methyltransferase+EZH2&doi=10.1073%2Fpnas.1303800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span></div><div class="casAuthors">Knutson, Sarah K.; Warholic, Natalie M.; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Scott, Margaret Porter; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Pollock, Roy M.; Kuntz, Kevin W.; Keilhack, Heike</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7922-7927, S7922/1-S7922/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid rhabdoid tumors.  This alteration is hypothesized to confer oncogenic dependency on EZH2 in these cancers.  The authors report the discovery of a potent, selective, and orally bioavailable small-mol. inhibitor of EZH2 enzymic activity, (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide).  The compd. induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.  Treatment of xenograft-bearing mice with (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide) leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation.  These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRIJfPhwLA7Vg90H21EOLACvtfcHk0lgRBUYviEW-jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D&md5=c2c6470d48a13ab8343db0a09465ba42</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1303800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1303800110%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DPorter%2BScott%26aufirst%3DM.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26atitle%3DDurable%2520tumor%2520regression%2520in%2520genetically%2520altered%2520malignant%2520rhabdoid%2520tumors%2520by%2520inhibition%2520of%2520methyltransferase%2520EZH2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D7922%26epage%3D7927%26doi%3D10.1073%2Fpnas.1303800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT02082977. A study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2816126 in subjects with relapsed/refractory diffuse large B cell and transformed follicular lymphoma (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT02082977.+A+study+to+investigate+the+safety%2C+pharmacokinetics%2C+pharmacodynamics+and+clinical+activity+of+GSK2816126+in+subjects+with+relapsed%2Frefractory+diffuse+large+B+cell+and+transformed+follicular+lymphoma+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT01897571. An open-label, multicenter, phase 1/2 study of E7438 (EZH2 histone methyl transferase [HMT] inhibitor) as a single agent in subjects with advanced solid tumors or with B-cell lymphomas (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT01897571.+An+open-label%2C+multicenter%2C+phase+1%2F2+study+of+E7438+%28EZH2+histone+methyl+transferase+%5BHMT%5D+inhibitor%29+as+a+single+agent+in+subjects+with+advanced+solid+tumors+or+with+B-cell+lymphomas+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kaniskan, H. Ü.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Selective inhibitors of protein methyltransferases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span><span class="refDoi"> DOI: 10.1021/jm501234a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501234a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1596-1629&author=H.+%C3%9C.+Kaniskanauthor=K.+D.+Konzeauthor=J.+Jin&title=Selective+inhibitors+of+protein+methyltransferases&doi=10.1021%2Fjm501234a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of protein methyltransferases</span></div><div class="casAuthors">Kaniskan, H. Umit; Konze, Kyle D.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1596-1629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mounting evidence suggests that protein methyltransferases (PMTs), which catalyze the methylation of histone and non-histone proteins, play a crucial role in diverse biol. processes and human diseases.  In particular, PMTs have been recognized as major players in regulating gene expression and chromatin state.  PMTs are divided into 2 categories: protein lysine methyltransferases (PKMTs) and protein arginine methyltransferases (PRMTs).  There has been a steadily growing interest in these enzymes as potential therapeutic targets and therefore discovery of PMT inhibitors has also been pursued increasingly over the past decade.  Here, the authors present a perspective on selective, small-mol. inhibitors of PMTs with an emphasis on their discovery, characterization, and applicability as chem. tools for deciphering the target PMTs' physiol. functions and involvement in human diseases.  The authors highlight the current state of PMT inhibitors and discuss future directions and opportunities for PMT inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEWF_XeLEY1rVg90H21EOLACvtfcHk0lgRBUYviEW-jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqtbbJ&md5=8fb2b2d21d306c02a2da60a3fb88c430</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm501234a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501234a%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibitors%2520of%2520protein%2520methyltransferases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1596%26epage%3D1629%26doi%3D10.1021%2Fjm501234a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kaniskan, H. Ü.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Chemical probes of histone lysine methyltransferases</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1021/cb500785t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500785t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOht7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=40-50&author=H.+%C3%9C.+Kaniskanauthor=J.+Jin&title=Chemical+probes+of+histone+lysine+methyltransferases&doi=10.1021%2Fcb500785t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probes of histone lysine methyltransferases</span></div><div class="casAuthors">Kaniskan, H. Umit; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Growing evidence suggests that histone-lysine methyltransferases (HMTs, also known as protein methyltransferases (PMTs)) play an important role in diverse biol. processes and human diseases by regulating gene expression and the chromatin state.  Therefore, HMTs have been increasingly recognized by the biomedical community as a class of potential therapeutic targets.  High quality chem. probes of HMTs, as tools for deciphering their physiol. functions and roles in human diseases and testing therapeutic hypotheses, are crit. for advancing this promising field.  Here, the authors focus on the discovery, characterization, and biol. applications of chem. probes for HMTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8kb_c7Xl57Vg90H21EOLACvtfcHk0lgAFqSJMczQsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOht7%252FE&md5=4eb8a696e2227c60686df8d3c60777ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcb500785t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500785t%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DChemical%2520probes%2520of%2520histone%2520lysine%2520methyltransferases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D40%26epage%3D50%26doi%3D10.1021%2Fcb500785t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.chembiol.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=24183969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1329-1339&author=S.+Garapaty-Raoauthor=C.+Nasveschukauthor=A.+Gagnonauthor=E.+Y.+Chanauthor=P.+Sandyauthor=J.+Busbyauthor=S.+Balasubramanianauthor=R.+Campbellauthor=F.+Zhaoauthor=L.+Bergeronauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.+C.+Harmangeauthor=R.+Cummingsauthor=P.+Trojer&title=Identification+of+EZH2+and+EZH1+small+molecule+inhibitors+with+selective+impact+on+diffuse+large+B+cell+lymphoma+cell+growth&doi=10.1016%2Fj.chembiol.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span></div><div class="casAuthors">Garapaty-Rao, Shivani; Nasveschuk, Christopher; Gagnon, Alexandre; Chan, Eric Y.; Sandy, Peter; Busby, Jennifer; Balasubramanian, Srividya; Campbell, Robert; Zhao, Feng; Bergeron, Louise; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe; Cummings, Richard; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of Zeste homolog 2 (EZH2) is a candidate oncogene due to its prevalent overexpression in malignant diseases, including late stage prostate and breast cancers.  The dependency of cancer cells on EZH2 activity is also predicated by recurrent missense mutations residing in the catalytic domain of EZH2 that have been identified in subtypes of diffuse large B cell lymphoma, follicular lymphoma and melanoma.  Herein, we report the identification of a highly selective small mol. inhibitor series of EZH2 and EZH1.  These compds. inhibit wild-type and mutant versions of EZH2 with nanomolar potency, suppress global histone H3-lysine 27 methylation, affect gene expression, and cause selective proliferation defects.  These compds. represent a structurally distinct EZH2 inhibitor chemotype for the exploration of the role of Polycomb Repressive Complex 2-mediated H3K27 methylation in various biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNGhFRO6LRbVg90H21EOLACvtfcHk0lgAFqSJMczQsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP&md5=6079ba01ae1f1964ac1d8108aa5e1227</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DNasveschuk%26aufirst%3DC.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DE.%2BY.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520EZH2%2520and%2520EZH1%2520small%2520molecule%2520inhibitors%2520with%2520selective%2520impact%2520on%2520diffuse%2520large%2520B%2520cell%2520lymphoma%2520cell%2520growth%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.chembiol.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design, and synthesis of indole-based EZH2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+synthesis+of+indole-based+EZH2+inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520synthesis%2520of%2520indole-based%2520EZH2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bradley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">EZH2 inhibitor efficacy in non-Hodgkin’s lymphoma does not require suppression of H3K27 monomethylation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1016%2Fj.chembiol.2014.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=25457180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1463-1475&author=W.+D.+Bradleyauthor=S.+Aroraauthor=J.+Busbyauthor=S.+Balasubramanianauthor=V.+S.+Gehlingauthor=C.+G.+Nasveschukauthor=R.+G.+Vaswaniauthor=C.+C.+Yuanauthor=C.+Hattonauthor=F.+Zhaoauthor=K.+E.+Williamsonauthor=P.+Iyerauthor=J.+Mendezauthor=R.+Campbellauthor=N.+Cantoneauthor=S.+Garapaty-Raoauthor=J.+E.+Audiaauthor=A.+S.+Cookauthor=L.+A.+Dakinauthor=B.+K.+Albrechtauthor=J.+C.+Harmangeauthor=D.+L.+Danielsauthor=R.+T.+Cummingsauthor=B.+M.+Bryantauthor=E.+Normantauthor=P.+Trojer&title=EZH2+inhibitor+efficacy+in+non-Hodgkin%E2%80%99s+lymphoma+does+not+require+suppression+of+H3K27+monomethylation&doi=10.1016%2Fj.chembiol.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span></div><div class="casAuthors">Bradley, William D.; Arora, Shilpi; Busby, Jennifer; Balasubramanian, Srividya; Gehling, Victor S.; Nasveschuk, Christopher G.; Vaswani, Rishi G.; Yuan, Chih-Chi; Hatton, Charlie; Zhao, Feng; Williamson, Kaylyn E.; Iyer, Priyadarshini; Mendez, Jacqui; Campbell, Robert; Cantone, Nico; Garapaty-Rao, Shivani; Audia, James E.; Cook, Andrew S.; Dakin, Les A.; Albrecht, Brian K.; Harmange, Jean-Christophe; Daniels, Danette L.; Cummings, Richard T.; Bryant, Barbara M.; Normant, Emmanuel; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1475</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone lysine methyltransferase (MT) Enhancer of Zeste Homolog 2 (EZH2) is considered an oncogenic driver in a subset of germinal center B-cell-like diffuse large B cell lymphoma (GCB-DLBCL) and follicular lymphoma due to the presence of recurrent, monoallelic mutations in the EZH2 catalytic domain.  These genomic data suggest that targeting the EZH2 MT activity is a valid therapeutic strategy for the treatment of lymphoma patients with EZH2 mutations.  Here we report the identification of highly potent and selective EZH2 small mol. inhibitors, their validation by a cellular thermal shift assay, application across a large cell panel representing various non-Hodgkin's lymphoma (NHL) subtypes, and their efficacy in EZH2 mutant-contg. GCB-DLBCL xenograft models.  Surprisingly, our EZH2 inhibitors selectively affect the turnover of trimethylated, but not monomethylated histone H3 lysine 27 at pharmacol. relevant doses.  Importantly, we find that these inhibitors are broadly efficacious also in NHL models with wild-type EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxrMoLW0OWCbVg90H21EOLACvtfcHk0ljLDzg7h_iKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE&md5=40b8f604e762dda9420afedede75fd36</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DW.%2BD.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DYuan%26aufirst%3DC.%2BC.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWilliamson%26aufirst%3DK.%2BE.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DMendez%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DEZH2%2520inhibitor%2520efficacy%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520does%2520not%2520require%2520suppression%2520of%2520H3K27%2520monomethylation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1463%26epage%3D1475%26doi%3D10.1016%2Fj.chembiol.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><div class="note"><p class="first last">ClinicalTrials.gov Identifier: NCT02395601. A study evaluating CPI-1205 in patients with B-cell lymphomas (accessed July 8, 2016).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Identifier%3A+NCT02395601.+A+study+evaluating+CPI-1205+in+patients+with+B-cell+lymphomas+%28accessed+July+8%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">EPZ011989, A potent, orally-available EZH2 inhibitor with robust in vivo activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=491-495&author=J.+E.+Campbellauthor=K.+W.+Kuntzauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=H.+Keilhackauthor=T.+J.+Wigleauthor=A.+Raimondiauthor=C.+R.+Klausauthor=N.+Riouxauthor=A.+Yokoiauthor=S.+Kawanoauthor=Y.+Minoshimaauthor=H.+W.+Choiauthor=M.+Porter+Scottauthor=N.+J.+Watersauthor=J.+J.+Smithauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copeland&title=EPZ011989%2C+A+potent%2C+orally-available+EZH2+inhibitor+with+robust+in+vivo+activity&doi=10.1021%2Facsmedchemlett.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity</span></div><div class="casAuthors">Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Porter Scott, Margaret; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications.  The ability of the scientific community to explore fully the spectrum of EZH2-assocd. pathobiol. has been hampered by the lack of in vivo-active tool compds. for this enzyme.  Here the authors report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties.  EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma.  Hence, this compd. represents a powerful tool for the expanded exploration of EZH2 activity in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqfVfbr3kS67Vg90H21EOLACvtfcHk0ljLDzg7h_iKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D&md5=21fa182b2474678f663459a9dc2878e6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DYokoi%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DS.%26aulast%3DMinoshima%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DPorter%2BScott%26aufirst%3DM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEPZ011989%252C%2520A%2520potent%252C%2520orally-available%2520EZH2%2520inhibitor%2520with%2520robust%2520in%2520vivo%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D491%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span> </span><span class="NLM_article-title">Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">20864</span><span class="refDoi"> DOI: 10.1038/srep20864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1038%2Fsrep20864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=26868841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=20864&author=X.+Songauthor=T.+Gaoauthor=N.+Wangauthor=Q.+Fengauthor=X.+Youauthor=T.+Yeauthor=Q.+Leiauthor=Y.+Zhuauthor=M.+Xiongauthor=Y.+Xiaauthor=F.+Yangauthor=Y.+Shiauthor=Y.+Weiauthor=L.+Zhangauthor=L.+Yu&title=Selective+inhibition+of+EZH2+by+ZLD1039+blocks+H3K27methylation+and+leads+to+potent+anti-tumor+activity+in+breast+cancer&doi=10.1038%2Fsrep20864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer</span></div><div class="casAuthors">Song, Xuejiao; Gao, Tiantao; Wang, Ningyu; Feng, Qiang; You, Xinyu; Ye, Tinghong; Lei, Qian; Zhu, Yongxia; Xiong, Menghua; Xia, Yong; Yang, Fangfang; Shi, Yaojie; Wei, Yuquan; Zhang, Lidan; Yu, Luoting</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20864</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Enhancer of zeste homolog 2 (EZH2) is a candidate oncogenic driver due to its prevalent overexpression and aberrant repression of tumor suppressor genes in diverse cancers.  Therefore, blocking EZH2 enzyme activity may present a valid therapeutic strategy for the treatment of cancers with EZH2 overexpression including breast cancers.  Here, we described ZLD1039 a potent, highly selective, and orally bioavailable small mol. inhibitor of EZH2, which inhibited breast tumor growth and metastasis.  ZLD1039 considerably inhibited EZH2 methyltransferase activity with nanomolar potency, decreased global histone-3 lysine-27 (H3K27) methylation, and reactivated silenced tumor suppressors connected to increased survival of patients with breast cancer.  Comparable to conditional silencing of EZH2, its inhibition by ZLD1039 decreased cell proliferation, cell cycle arrest, and induced apoptosis.  Comparably, treatment of xenograft-bearing mice with ZLD1039 led to tumor growth regression and metastasis inhibition.  These data confirmed the dependency of breast cancer progression on EZH2 activity and the usefulness of ZLD1039 as a promising treatment for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTMqYUMcMi-bVg90H21EOLACvtfcHk0limbYenQDcFmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSltbw%253D&md5=c2e138e7f887dd17f1e2be3851f0e3b7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsrep20864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep20864%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DSelective%2520inhibition%2520of%2520EZH2%2520by%2520ZLD1039%2520blocks%2520H3K27methylation%2520and%2520leads%2520to%2520potent%2520anti-tumor%2520activity%2520in%2520breast%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D20864%26doi%3D10.1038%2Fsrep20864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Gao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. T.</span><span> </span><span class="NLM_article-title">ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">28512</span><span class="NLM_x">–</span> <span class="NLM_lpage">28521</span><span class="refDoi"> DOI: 10.1039/C6RA00618C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1039%2FC6RA00618C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=28512-28521&author=T.+T.+Gaoauthor=L.+D.+Zhangauthor=Y.+X.+Zhuauthor=X.+J.+Songauthor=Q.+Fengauthor=Q.+Leiauthor=S.+X.+Shiauthor=H.+X.+Dengauthor=M.+H.+Xiongauthor=X.+Y.+Youauthor=W.+Q.+Zuoauthor=L.+Liuauthor=C.+T.+Pengauthor=N.+Y.+Wangauthor=T.+H.+Yeauthor=Y.+Xiaauthor=L.+T.+Yu&title=ZLD1122%2C+a+novel+EZH2+and+EZH1+small+molecular+inhibitor%2C+blocks+H3K27+methylation+and+diffuse+large+B+cell+lymphoma+cell+growth&doi=10.1039%2FC6RA00618C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth</span></div><div class="casAuthors">Gao, Tiantao; Zhang, Lidan; Zhu, Yongxia; Song, Xuejiao; Feng, Qiang; Lei, Qian; Shi, Suxia; Deng, Hongxia; Xiong, Menghua; You, Xinyu; Zuo, Weiqiong; Liu, Li; Peng, Cuiting; Wang, Ningyu; Ye, Tinghong; Xia, Yong; Yu, Luoting</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">28512-28521</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of zeste homolog 2 (EZH2) has been reported to be overexpressed in a variety of cancers and is assocd. with tumor malignancy.  This is mainly because EZH2 catalyzes the hypertrimethylation of histone 3 at lysine 27 (H3K27) at the promoter of target genes, leading to the silencing of downstream tumor suppressor genes.  Hence, blocking its catalytic function may be a therapeutic strategy for the treatment of tumors which over-express or have a gain-of-function mutation in EZH2, such as lymphomas.  Here, we reported a novel, selective, small-mol. inhibitor of EZH2 and EZH1 synthesized by us, ZLD1122, which inhibited both EZH1 and wild type and mutant EZH2 activities with nanomolar potency.  ZLD1122 significantly inhibited intracellular H3K27 trimethylation without affecting the levels of H3, H3K9me3, and H3K4me3, indicating its selective inhibition of polycomb repressive complex 2 (PRC2) Me catalytic function.  Moreover, ZLD1122 induced G0/G1 phase arrest in diffuse large B cell lymphoma (DLBCL) cells in a dose-dependent manner via downregulation of cyclinE and CDK4 as well as upregulation of p21 and cyclinD1.  Furthermore, it induced apoptosis and loss of mitochondrial membrane potential (Δψm), and elevated the levels of cleaved caspase-9 in Su-DHL-6 and Pfeiffer cells, suggesting that ZLD1122 suppresses the viability of DLBCL cells by inducing caspase-mediated intrinsic apoptosis.  Taken together, these data demonstrated that ZLD1122, owing to its pharmacol. inhibitory activity against EZH2, could be a promising agent for the treatment of lymphomas with EZH2 gain-of-function mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyK0JgpETzI7Vg90H21EOLACvtfcHk0limbYenQDcFmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKhsrg%253D&md5=06762ba0bd806ad3985b20e8b7063887</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC6RA00618C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA00618C%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DSong%26aufirst%3DX.%2BJ.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DS.%2BX.%26aulast%3DDeng%26aufirst%3DH.%2BX.%26aulast%3DXiong%26aufirst%3DM.%2BH.%26aulast%3DYou%26aufirst%3DX.%2BY.%26aulast%3DZuo%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DC.%2BT.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DYe%26aufirst%3DT.%2BH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%2BT.%26atitle%3DZLD1122%252C%2520a%2520novel%2520EZH2%2520and%2520EZH1%2520small%2520molecular%2520inhibitor%252C%2520blocks%2520H3K27%2520methylation%2520and%2520diffuse%2520large%2520B%2520cell%2520lymphoma%2520cell%2520growth%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D28512%26epage%3D28521%26doi%3D10.1039%2FC6RA00618C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Leung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Methyl effects on protein-ligand binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4489</span><span class="NLM_x">–</span> <span class="NLM_lpage">4500</span><span class="refDoi"> DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&author=C.+S.+Leungauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein-ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38α MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0limbYenQDcFmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein-ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter-Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span> </span><span class="NLM_article-title">The importance of being me: magic methyls, methyltransferase inhibitors, and the siscovery of Tazemetostat</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+importance+of+being+me%3A+magic+methyls%2C+methyltransferase+inhibitors%2C+and+the+siscovery+of+Tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520importance%2520of%2520being%2520me%253A%2520magic%2520methyls%252C%2520methyltransferase%2520inhibitors%252C%2520and%2520the%2520siscovery%2520of%2520Tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0ljSoomSvMF5tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Scholfield, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanden, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonding (X-bonding): a biological perspective</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1002/pro.2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1002%2Fpro.2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=23225628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=139-152&author=M.+R.+Scholfieldauthor=C.+M.+Zandenauthor=M.+Carterauthor=P.+S.+Ho&title=Halogen+bonding+%28X-bonding%29%3A+a+biological+perspective&doi=10.1002%2Fpro.2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonding (X-bonding): A biological perspective</span></div><div class="casAuthors">Scholfield, Matthew R.; Vander Zanden, Crystal M.; Carter, Megan; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-152</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The concept of the halogen bond (or X-bond) has become recognized as contributing significantly to the specificity in recognition of a large class of halogenated compds.  The interaction is most easily understood as primarily an electrostatically driven mol. interaction, where an electropos. crown, or σ-hole, serves as a Lewis acid to attract a variety of electron-rich Lewis bases, in analogous fashion to a classic hydrogen bonding (H-bond) interaction.  We present here a broad overview of X-bonds from the perspective of a biologist who may not be familiar with this recently rediscovered class of interactions and, consequently, may be interested in how they can be applied as a highly directional and specific component of the mol. toolbox.  This overview includes a discussion for where X-bonds are found in biomol. structures, and how their structure-energy relationships are studied exptl. and modeled computationally.  In total, our understanding of these basic concepts will allow X-bonds to be incorporated into strategies for the rational design of new halogenated inhibitors against biomol. targets or toward mol. engineering of new biol.-based materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq19qA2u5B5-7Vg90H21EOLACvtfcHk0lh-PSM64Cu4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOnsbw%253D&md5=22dead5c9f6aaab61d17bcd565c532e8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fpro.2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2201%26sid%3Dliteratum%253Aachs%26aulast%3DScholfield%26aufirst%3DM.%2BR.%26aulast%3DZanden%26aufirst%3DC.%2BM.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonding%2520%2528X-bonding%2529%253A%2520a%2520biological%2520perspective%26jtitle%3DProtein%2520Sci.%26date%3D2013%26volume%3D22%26spage%3D139%26epage%3D152%26doi%3D10.1002%2Fpro.2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span> </span><span class="NLM_article-title">PLANTS: Application of ant colony optimization to structure-based drug design</span> <span class="citation_source-journal">Lect. Notes Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4150</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1007/11839088_22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=10.1007%2F11839088_22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4150&publication_year=2006&pages=247-258&author=O.+Korbauthor=T.+Stutzleauthor=T.+E.+Exner&title=PLANTS%3A+Application+of+ant+colony+optimization+to+structure-based+drug+design&doi=10.1007%2F11839088_22"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F11839088_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F11839088_22%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DStutzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DPLANTS%253A%2520Application%2520of%2520ant%2520colony%2520optimization%2520to%2520structure-based%2520drug%2520design%26jtitle%3DLect.%2520Notes%2520Comput.%2520Sci.%26date%3D2006%26volume%3D4150%26spage%3D247%26epage%3D258%26doi%3D10.1007%2F11839088_22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span> <span class="citation_source-book">Small-Molecule Drug Discovery Suite 2015-4: Glide</span>, <span class="NLM_edition">version 6.9</span>;; <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2015-4%3A+Glide%2C+version+6.9%3B%3B+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSmall-Molecule%2520Drug%2520Discovery%2520Suite%25202015-4%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Marcou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1021/ci600342e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints&doi=10.1021%2Fci600342e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0lh-PSM64Cu4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1021%2Fci600342e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7','PDB','5IJ7'); return false;">PDB: 5IJ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN','PDB','5HYN'); return false;">PDB: 5HYN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00855">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34443"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00855">10.1021/acs.jmedchem.6b00855</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic methods and conditions for the synthesis of intermediates and spectral data for these intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00855/suppl_file/jm6b00855_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00855/suppl_file/jm6b00855_si_001.pdf">jm6b00855_si_001.pdf (4.02 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00855%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00855" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999ab5c9ea238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
